Walter Curran Jr MD

Department of Radiation Oncology
Professor Emeritus

(404) 778-5323
wcurran@emory.edu

Overview

Walter J. Curran, Jr., MD, FACR, is Professor Emeritus and former Chairman of the Department of Radiation Oncology at Emory University School of Medicine. He served for 11 years as the Executive Director of Winship Cancer Institute of Emory University, the first and only National Cancer Institute-designated comprehensive cancer center in the state of Georgia.

Dr. Curran is considered an international expert in the management of patients with locally advanced lung cancer and malignant brain tumors. He has led several landmark clinical and translational trials in both areas and is responsible for defining a universally adopted staging system for patients with malignant glioma.

Dr. Curran has served as the group chairman and principal investigator of NRG Oncology, formerly the Radiation Therapy Oncology Group, a National Cancer Institute-funded cooperative group dedicated to advancing patient treatment and care through clinical trials and research. He was the first radiation oncologist to serve as Director of a National Cancer Institute-designated comprehensive cancer center.

Dr. Curran is a Fellow and served on the board of directors of the American Society of Clinical Oncology (ASCO). He was also named a Georgia Research Alliance Eminent Scholar and Chair in Cancer Research in 2013.

Before joining Emory, Dr. Curran was Professor and Chairman of Radiation Oncology at Thomas Jefferson University (Jefferson) in Philadelphia and Clinical Director of Jeffersons Kimmel Cancer Center.

Dr. Curran is a Fellow in the American College of Radiology and has been awarded honorary memberships in the European Society of Therapeutic Radiology and Oncology and the Canadian Association of Radiation Oncology. In 2006, he was named the leading radiation oncologist/cancer researcher in a peer survey by the journal Medical Imaging.

Under Dr. Curran's leadership Emory's Radiation Oncology Department has been selected as a "Top Five Radiation Therapy Centers to Watch in 2009" by Imaging Technology News. This review recognizes the most forward-thinking, U.S.-based cancer treatment centers, which have adopted advanced technology to optimize treatment and make a difference in patient care. Dr. Curran has received numerous honors and is listed in Atlanta Magazine's Top Doctors for Radiation Oncology. In 2019, Dr. Curran received the Gold Medal from the American Society for Radiation Oncology.

Dr. Curran has authored or co-authored more than seven hundred abstracts and scholarly papers, as well as numerous presentations, reviews and book chapters. He has been chairman or co-chairman of more than 40 clinical trials and a reviewer for twelve national/international journals. He serves as the founding secretary/treasurer of the Coalition of Cancer Cooperative Groups and a board member of the Georgia Center for Oncology Research and Education (Georgia CORE).

Academic Appointment

Professor Emeritus, Department of Radiation Oncology, Emory University School of Medicine

Education

Degrees

MD from Medical College of Georgia
A.B. from Dartmouth College

Research

Focus

I direct clinical and translational research efforts to identify transformational progress in the management of patients with cranial and thoracic tumors. This research involves optimizing both the biophysical aspects of radiation therapy and the pharmacologic aspects of novel drug delivery.

Publications

Quality-of-life outcomes from NRG Oncology NSABP B-39/RTOG 0413: whole-breast irradiation vs accelerated partial-breast irradiation after breast-conserving surgery.
J Natl Cancer Inst Volume: 117 Page(s): 103 - 111
01/01/2025 Authors: Ganz PA; Cecchini RS; White JR; Vicini FA; Arthur DW; Rabinovitch RA; Kuske RR; Julian TB; Parda DS; Scheier MF
Why Basic Science Education Matters in Radiation Oncology.
Am J Clin Oncol Volume: 47 Page(s): 563 - 565
12/01/2024 Authors: Wallner PE; Steinberg ML; Burmeister J; Curran WJ; Das P; Davis BJ; Haffty BG; Marples B; Zietman AL
Primary Results of NRG-RTOG1106/ECOG-ACRIN 6697: A Randomized Phase II Trial of Individualized Adaptive (chemo)Radiotherapy Using Midtreatment 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Stage III Non-Small Cell Lung Cancer.
J Clin Oncol Volume: 42 Page(s): 3935 - 3946
11/20/2024 Authors: Kong F-MS; Hu C; Pryma DA; Duan F; Matuszak M; Xiao Y; Ten Haken R; Siegel MJ; Hanna L; Curran WJ
Cancer Informatics for Cancer Centers: Sharing Ideas on How to Build an Artificial Intelligence-Ready Informatics Ecosystem for Radiation Oncology.
JCO Clin Cancer Inform Volume: 7 Page(s): e2300136
09/01/2023 Authors: Bitterman DS; Gensheimer MF; Jaffray D; Pryma DA; Jiang SB; Morin O; Ginart JB; Upadhaya T; Vallis KA; Buatti JM
Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy: The NRG/RTOG 9514 and 0630 Nonrandomized Clinical Trials.
JAMA Oncol Volume: 9 Page(s): 646 - 655
05/01/2023 Authors: Wang D; Harris J; Kraybill WG; Eisenberg B; Kirsch DG; Ettinger DS; Kane JM; Barry PN; Naghavi A; Freeman CR
Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies.
J Clin Oncol Volume: 41 Page(s): 2020 - 2028
04/10/2023 Authors: Unger JM; LeBlanc M; George S; Wolmark N; Curran WJ; O'Dwyer PJ; Schnall MD; Mannel RS; Mandrekar SJ; Gray RJ
Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504.
Int J Radiat Oncol Biol Phys Volume: 115 Page(s): 847 - 860
03/15/2023 Authors: Gillison ML; Ferris RL; Harris J; Colevas AD; Mell LK; Kong C; Jordan RC; Moore KL; Truong M-T; Kirsch C
Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.
Neuro Oncol Volume: 25 Page(s): 339 - 350
02/14/2023 Authors: Lassman AB; Pugh SL; Wang TJC; Aldape K; Gan HK; Preusser M; Vogelbaum MA; Sulman EP; Won M; Zhang P
Preliminary efficacy and safety analysis: 12-month results in 83 patients using a novel approach of widefield radiation therapy for extensive skin field cancerization with or without keratinocyte cancers.
J Dermatolog Treat Volume: 33 Page(s): 2634 - 2642
08/01/2022 Authors: Potter AE; Baker C; Shumack S; Sinclair R; Curran WJ; Christie D; Wong B; Foley P; O'Brien P; Spelman L
Artificial Intelligence in Quantitative Ultrasound Imaging: A Survey.
J Ultrasound Med Volume: 41 Page(s): 1329 - 1342
06/01/2022 Authors: Zhou B; Yang X; Curran WJ; Liu T
Surgical Outcomes for Early Stage Non-small Cell Lung Cancer at Facilities With Stereotactic Body Radiation Therapy Programs.
Chest Volume: 161 Page(s): 833 - 844
03/01/2022 Authors: Syed YA; Stokes W; Rupji M; Liu Y; Khullar O; Sebastian N; Higgins K; Bradley JD; Curran WJ; Ramalingam S
Multi-organ auto-delineation in head-and-neck MRI for radiation therapy using regional convolutional neural network.
Phys Med Biol Volume: 67
01/21/2022 Authors: Dai X; Lei Y; Wang T; Zhou J; Rudra S; McDonald M; Curran WJ; Liu T; Yang X
Learning-based synthetic dual energy CT imaging from single energy CT for stopping power ratio calculation in proton radiation therapy.
Br J Radiol Volume: 95 Page(s): 20210644
01/01/2022 Authors: Charyyev S; Wang T; Lei Y; Ghavidel B; Beitler JJ; McDonald M; Curran WJ; Liu T; Zhou J; Yang X
Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617.
Cancers (Basel) Volume: 13
12/08/2021 Authors: Jin J-Y; Hu C; Xiao Y; Zhang H; Paulus R; Ellsworth SG; Schild SE; Bogart JA; Dobelbower MC; Kavadi VS
MRI classification using semantic random forest with auto-context model.
Quant Imaging Med Surg Volume: 11 Page(s): 4753 - 4766
12/01/2021 Authors: Lei Y; Wang T; Dong X; Tian S; Liu Y; Mao H; Curran WJ; Shu H-K; Liu T; Yang X
Deep learning-based motion tracking using ultrasound images.
Med Phys Volume: 48 Page(s): 7747 - 7756
12/01/2021 Authors: Dai X; Lei Y; Roper J; Chen Y; Bradley JD; Curran WJ; Liu T; Yang X
Synthetic CT-aided multiorgan segmentation for CBCT-guided adaptive pancreatic radiotherapy.
Med Phys Volume: 48 Page(s): 7063 - 7073
11/01/2021 Authors: Dai X; Lei Y; Wynne J; Janopaul-Naylor J; Wang T; Roper J; Curran WJ; Liu T; Patel P; Yang X
CA209-9KY: Phase II Study of IMRT Re-Irradiation and Concurrent/Adjuvant Nivolumab (Nivo) in Patients With Loco Regionally Recurrent or Second Primary Head and Neck Squamous Cell Carcinoma (HNSCC) - Toxicity and Quality of Life (QoL) Results.
Int J Radiat Oncol Biol Phys Volume: 111 Page(s): e361
11/01/2021 Authors: Saba NF; Wong S; Stokes WA; Rupji M; Liu Y; Rudra S; Bates JE; Steuer C; Remick JS; Cummings K
Deep learning-based thoracic CBCT correction with histogram matching.
Biomed Phys Eng Express Volume: 7
10/29/2021 Authors: Qiu RLJ; Lei Y; Shelton J; Higgins K; Bradley JD; Curran WJ; Liu T; Kesarwala AH; Yang X
Automated delineation of head and neck organs at risk using synthetic MRI-aided mask scoring regional convolutional neural network.
Med Phys Volume: 48 Page(s): 5862 - 5873
10/01/2021 Authors: Dai X; Lei Y; Wang T; Zhou J; Roper J; McDonald M; Beitler JJ; Curran WJ; Liu T; Yang X
Knowledge-based radiation treatment planning: A data-driven method survey.
J Appl Clin Med Phys Volume: 22 Page(s): 16 - 44
08/01/2021 Authors: Momin S; Fu Y; Lei Y; Roper J; Bradley JD; Curran WJ; Liu T; Yang X
Fully automated segmentation of brain tumor from multiparametric MRI using 3D context deep supervised U-Net.
Med Phys Volume: 48 Page(s): 4365 - 4374
08/01/2021 Authors: Lin M; Momin S; Lei Y; Wang H; Curran WJ; Liu T; Yang X
High through-plane resolution CT imaging with self-supervised deep learning.
Phys Med Biol Volume: 66
07/14/2021 Authors: Xie H; Lei Y; Wang T; Tian Z; Roper J; Bradley JD; Curran WJ; Tang X; Liu T; Yang X
Artificial intelligence in tumor subregion analysis based on medical imaging: A review.
J Appl Clin Med Phys Volume: 22 Page(s): 10 - 26
07/01/2021 Authors: Lin M; Wynne JF; Zhou B; Wang T; Lei Y; Curran WJ; Liu T; Yang X
Self-supervised learning for accelerated 3D high-resolution ultrasound imaging.
Med Phys Volume: 48 Page(s): 3916 - 3926
07/01/2021 Authors: Dai X; Lei Y; Wang T; Axente M; Xu D; Patel P; Jani AB; Curran WJ; Liu T; Yang X
Learning-based dose prediction for pancreatic stereotactic body radiation therapy using dual pyramid adversarial network.
Phys Med Biol Volume: 66
06/21/2021 Authors: Momin S; Lei Y; Wang T; Zhang J; Roper J; Bradley JD; Curran WJ; Patel P; Liu T; Yang X
Male pelvic multi-organ segmentation on transrectal ultrasound using anchor-free mask CNN.
Med Phys Volume: 48 Page(s): 3055 - 3064
06/01/2021 Authors: Lei Y; Wang T; Roper J; Jani AB; Patel SA; Curran WJ; Patel P; Liu T; Yang X
Automatic delineation of cardiac substructures using a region-based fully convolutional network.
Med Phys Volume: 48 Page(s): 2867 - 2876
06/01/2021 Authors: Harms J; Lei Y; Tian S; McCall NS; Higgins KA; Bradley JD; Curran WJ; Liu T; Yang X
Automatic quantification of myocardium and pericardial fat from coronary computed tomography angiography: a multicenter study.
Eur Radiol Volume: 31 Page(s): 3826 - 3836
06/01/2021 Authors: He X; Guo BJ; Lei Y; Wang T; Curran WJ; Liu T; Zhang LJ; Yang X
Head and neck multi-organ segmentation on dual-energy CT using dual pyramid convolutional neural networks.
Phys Med Biol Volume: 66
05/20/2021 Authors: Wang T; Lei Y; Roper J; Ghavidel B; Beitler JJ; McDonald M; Curran WJ; Liu T; Yang X
Echocardiographic image multi-structure segmentation using Cardiac-SegNet.
Med Phys Volume: 48 Page(s): 2426 - 2437
05/01/2021 Authors: Lei Y; Fu Y; Roper J; Higgins K; Bradley JD; Curran WJ; Liu T; Yang X
A review of deep learning based methods for medical image multi-organ segmentation.
Phys Med Volume: 85 Page(s): 107 - 122
05/01/2021 Authors: Fu Y; Lei Y; Wang T; Curran WJ; Liu T; Yang X
Male pelvic CT multi-organ segmentation using synthetic MRI-aided dual pyramid networks.
Phys Med Biol Volume: 66
04/16/2021 Authors: Lei Y; Wang T; Tian S; Fu Y; Patel P; Jani AB; Curran WJ; Liu T; Yang X
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with Coronavirus Disease 2019-Related Pneumonia.
Int J Radiat Oncol Biol Phys Volume: 109 Page(s): 867 - 879
03/15/2021 Authors: Hess CB; Nasti TH; Dhere VR; Kleber TJ; Switchenko JM; Buchwald ZS; Stokes WA; Weinberg BD; Rouphael N; Steinberg JP
Synthetic dual-energy CT for MRI-only based proton therapy treatment planning using label-GAN.
Phys Med Biol Volume: 66 Page(s): 065014
03/09/2021 Authors: Liu R; Lei Y; Wang T; Zhou J; Roper J; Lin L; McDonald MW; Bradley JD; Curran WJ; Liu T
YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype.
J Thorac Oncol Volume: 16 Page(s): 464 - 476
03/01/2021 Authors: Owonikoko TK; Dwivedi B; Chen Z; Zhang C; Barwick B; Ernani V; Zhang G; Gilbert-Ross M; Carlisle J; Khuri FR
Head-and-neck organs-at-risk auto-delineation using dual pyramid networks for CBCT-guided adaptive radiotherapy.
Phys Med Biol Volume: 66 Page(s): 045021
02/11/2021 Authors: Dai X; Lei Y; Wang T; Dhabaan AH; McDonald M; Beitler JJ; Curran WJ; Zhou J; Liu T; Yang X
Biomechanically constrained non-rigid MR-TRUS prostate registration using deep learning based 3D point cloud matching.
Med Image Anal Volume: 67 Page(s): 101845
01/01/2021 Authors: Fu Y; Lei Y; Wang T; Patel P; Jani AB; Mao H; Curran WJ; Liu T; Yang X
BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Oncology Volume: 99 Page(s): 580 - 588
01/01/2021 Authors: Vassilakopoulou M; Won M; Curran WJ; Souhami L; Prados MD; Langer CJ; Rimm DL; Hanna JA; Neumeister VM; Melian E
Learning-Based Stopping Power Mapping on Dual-Energy CT for Proton Radiation Therapy.
Int J Part Ther Volume: 7 Page(s): 46 - 60
01/01/2021 Authors: Wang T; Lei Y; Harms J; Ghavidel B; Lin L; Beitler JJ; McDonald M; Curran WJ; Liu T; Zhou J
Breast tumor segmentation in 3D automatic breast ultrasound using Mask scoring R-CNN.
Med Phys Volume: 48 Page(s): 204 - 214
01/01/2021 Authors: Lei Y; He X; Yao J; Wang T; Wang L; Li W; Curran WJ; Liu T; Xu D; Yang X
Deformable MR-CBCT prostate registration using biomechanically constrained deep learning networks.
Med Phys Volume: 48 Page(s): 253 - 263
01/01/2021 Authors: Fu Y; Wang T; Lei Y; Patel P; Jani AB; Curran WJ; Liu T; Yang X
A review on medical imaging synthesis using deep learning and its clinical applications.
J Appl Clin Med Phys Volume: 22 Page(s): 11 - 36
01/01/2021 Authors: Wang T; Lei Y; Fu Y; Wynne JF; Curran WJ; Liu T; Yang X
Leptomeningeal disease and neurologic death after surgical resection and radiosurgery for brain metastases: A multi-institutional analysis.
Adv Radiat Oncol Volume: 6 Page(s): 100644
01/01/2021 Authors: Prabhu RS; Turner BE; Asher AL; Marcrom SR; Fiveash JB; Foreman PM; Press RH; Buchwald ZS; Curran WJ; Patel KR
Deep learning-based real-time volumetric imaging for lung stereotactic body radiation therapy: a proof of concept study.
Phys Med Biol Volume: 65 Page(s): 235003
12/18/2020 Authors: Lei Y; Tian Z; Wang T; Higgins K; Bradley JD; Curran WJ; Liu T; Yang X
Multimodal MRI synthesis using unified generative adversarial networks.
Med Phys Volume: 47 Page(s): 6343 - 6354
12/01/2020 Authors: Dai X; Lei Y; Fu Y; Curran WJ; Liu T; Mao H; Yang X
Low-dose whole-lung radiation for COVID-19 pneumonia: Planned day 7 interim analysis of a registered clinical trial.
Cancer Volume: 126 Page(s): 5109 - 5113
12/01/2020 Authors: Hess CB; Buchwald ZS; Stokes W; Nasti TH; Switchenko JM; Weinberg BD; Steinberg JP; Godette KD; Murphy D; Ahmed R
What happened to the US cancer cooperative groups? A status update ten years after the Institute of Medicine report.
Cancer Volume: 126 Page(s): 5022 - 5029
12/01/2020 Authors: Bertagnolli MM; Blanke CD; Curran WJ; Hawkins DS; Mannel RS; O'Dwyer PJ; Schnall MD; Wolmark N
Patterns of Disease Progression after Carboplatin/Etoposide + Atezolizumab in Extensive-Stage Small-Cell Lung Cancer (ES-SCLC).
Volume: 108 Page(s): 1398
12/01/2020 Authors: Higgins KA; Curran WJ; Liu SV; Yu W; Brockman M; Johnson A; Bara I; Bradley JD
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study.
J Immunother Cancer Volume: 8
12/01/2020 Authors: Pakkala S; Higgins K; Chen Z; Sica G; Steuer C; Zhang C; Zhang G; Wang S; Hossain MS; Nazha B
The Influence of Histologic Grade on Outcomes of Elderly Women With Early Stage Breast Cancer Treated With Breast Conserving Surgery With or Without Radiotherapy.
Clin Breast Cancer Volume: 20 Page(s): e701 - e710
12/01/2020 Authors: Escott CE; Zaenger D; Switchencko JM; Lin JY; Abugideiri M; Arciero CA; Pfister NT; Xu KM; Meisel JL; Subhedar P
Immunomodulatory Low-Dose Whole-Lung Radiation for Patients with COVID-19-Related Pneumonia.
Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 1401
12/01/2020 Authors: Hess CB; Buchwald ZS; Stokes WA; Nasti T; Switchenko J; Weinberg BD; Rouphael N; Steinberg JP; Godette KD; Murphy DJ
Intensity non-uniformity correction in MR imaging using residual cycle generative adversarial network.
Phys Med Biol Volume: 65 Page(s): 215025
11/27/2020 Authors: Dai X; Lei Y; Liu Y; Wang T; Ren L; Curran WJ; Patel P; Liu T; Yang X
Ultrasound Elastography for Lung Disease Assessment.
IEEE Trans Ultrason Ferroelectr Freq Control Volume: 67 Page(s): 2249 - 2257
11/01/2020 Authors: Zhou B; Yang X; Zhang X; Curran WJ; Liu T
Thyroid gland delineation in noncontrast-enhanced CT using deep convolutional neural networks.
Phys Med Biol
10/28/2020 Authors: He X; Guo B; Lei Y; Tian S; Wang T; Curran WJ; Zhang L; Liu T; Yang X
Deep learning in medical image registration: a review.
Phys Med Biol Volume: 65 Page(s): 20TR01
10/22/2020 Authors: Fu Y; Lei Y; Wang T; Curran WJ; Liu T; Yang X
Automatic multi-needle localization in ultrasound images using large margin mask RCNN for ultrasound-guided prostate brachytherapy.
Phys Med Biol Volume: 65 Page(s): 205003
10/09/2020 Authors: Zhang Y; Tian Z; Lei Y; Wang T; Patel P; Jani AB; Curran WJ; Liu T; Yang X
Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy.
J Immunother Cancer Volume: 8
10/01/2020 Authors: Buchwald ZS; Nasti TH; Lee J; Eberhardt CS; Wieland A; Im SJ; Lawson D; Curran W; Ahmed R; Khan MK
Multicenter Clinical Cancer Research After COVID-19: A Perspective From NRG Oncology.
Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 483 - 485
10/01/2020 Authors: Gensheimer MF; Yom SS; Soto N; Dignam JJ; Le Q-T; Machtay M; Curran WJ
Brain tumor segmentation using 3D Mask R-CNN for dynamic susceptibility contrast enhanced perfusion imaging.
Phys Med Biol Volume: 65 Page(s): 185009
09/18/2020 Authors: Jeong J; Lei Y; Kahn S; Liu T; Curran WJ; Shu H-K; Mao H; Yang X
Head and neck multi-organ auto-segmentation on CT images aided by synthetic MRI.
Med Phys Volume: 47 Page(s): 4294 - 4302
09/01/2020 Authors: Liu Y; Lei Y; Fu Y; Wang T; Zhou J; Jiang X; McDonald M; Beitler JJ; Curran WJ; Liu T
CT-based multi-organ segmentation using a 3D self-attention U-net network for pancreatic radiotherapy.
Med Phys Volume: 47 Page(s): 4316 - 4324
09/01/2020 Authors: Liu Y; Lei Y; Fu Y; Wang T; Tang X; Jiang X; Curran WJ; Liu T; Patel P; Yang X
Cone-beam CT-derived relative stopping power map generation via deep learning for proton radiotherapy.
Med Phys Volume: 47 Page(s): 4416 - 4427
09/01/2020 Authors: Harms J; Lei Y; Wang T; McDonald M; Ghavidel B; Stokes W; Curran WJ; Zhou J; Liu T; Yang X
Impact of Sequencing Radiation Therapy and Immune Checkpoint Inhibitors in the Treatment of Melanoma Brain Metastases.
Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 157 - 163
09/01/2020 Authors: Pomeranz Krummel DA; Nasti TH; Izar B; Press RH; Xu M; Lowder L; Kallay L; Rupji M; Rosen H; Su J
Automatic multi-catheter detection using deeply supervised convolutional neural network in MRI-guided HDR prostate brachytherapy.
Med Phys Volume: 47 Page(s): 4115 - 4124
09/01/2020 Authors: Dai X; Lei Y; Zhang Y; Qiu RLJ; Wang T; Dresser SA; Curran WJ; Patel P; Liu T; Yang X
Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
Int J Radiat Oncol Biol Phys Volume: 108 Page(s): 304 - 313
09/01/2020 Authors: Tian S; Switchenko JM; Buchwald ZS; Patel PR; Shelton JW; Kahn SE; Pillai RN; Steuer CE; Owonikoko TK; Behera M
Machine learning in quantitative PET: A review of attenuation correction and low-count image reconstruction methods.
Phys Med Volume: 76 Page(s): 294 - 306
08/01/2020 Authors: Wang T; Lei Y; Fu Y; Curran WJ; Liu T; Nye JA; Yang X
Pelvic multi-organ segmentation on cone-beam CT for prostate adaptive radiotherapy.
Med Phys Volume: 47 Page(s): 3415 - 3422
08/01/2020 Authors: Fu Y; Lei Y; Wang T; Tian S; Patel P; Jani AB; Curran WJ; Liu T; Yang X
Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification.
Cancer Volume: 126 Page(s): 3255 - 3264
07/15/2020 Authors: Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan TM; Behera M; Sengupta S; Voloschin AD
Multi-Needle Detection in 3D Ultrasound Images Using Unsupervised Order-Graph Regularized Sparse Dictionary Learning.
IEEE Trans Med Imaging Volume: 39 Page(s): 2302 - 2315
07/01/2020 Authors: Zhang Y; He X; Tian Z; Jeong JJ; Lei Y; Wang T; Zeng Q; Jani AB; Curran WJ; Patel P
Multi-needle Localization with Attention U-Net in US-guided HDR Prostate Brachytherapy.
Med Phys Volume: 47 Page(s): 2735 - 2745
07/01/2020 Authors: Zhang Y; Lei Y; Qiu RLJ; Wang T; Wang H; Jani AB; Curran WJ; Patel P; Liu T; Yang X
Label-driven magnetic resonance imaging (MRI)-transrectal ultrasound (TRUS) registration using weakly supervised learning for MRI-guided prostate radiotherapy.
Phys Med Biol Volume: 65 Page(s): 135002
06/26/2020 Authors: Zeng Q; Fu Y; Tian Z; Lei Y; Zhang Y; Wang T; Mao H; Liu T; Curran WJ; Jani AB
Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma.
Neuro Oncol Volume: 22 Page(s): 830 - 837
06/09/2020 Authors: Breen WG; Anderson SK; Carrero XW; Brown PD; Ballman KV; O'Neill BP; Curran WJ; Abrams RA; Laack NN; Levitt R
Trimodality Therapy in the Treatment of Stage III N2-Positive Non-Small Cell Lung Cancer: A National Cancer Database Analysis.
Oncologist Volume: 25 Page(s): e964 - e975
06/01/2020 Authors: Behera M; Steuer CE; Liu Y; Fernandez F; Fu C; Higgins KA; Gillespie TW; Pakkala S; Pillai RN; Force S
A learning-based automatic segmentation and quantification method on left ventricle in gated myocardial perfusion SPECT imaging: A feasibility study.
J Nucl Cardiol Volume: 27 Page(s): 976 - 987
06/01/2020 Authors: Wang T; Lei Y; Tang H; He Z; Castillo R; Wang C; Li D; Higgins K; Liu T; Curran WJ
CBCT-based synthetic CT generation using deep-attention cycleGAN for pancreatic adaptive radiotherapy.
Med Phys Volume: 47 Page(s): 2472 - 2483
06/01/2020 Authors: Liu Y; Lei Y; Wang T; Fu Y; Tang X; Curran WJ; Liu T; Patel P; Yang X
Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
Mol Cancer Volume: 19 Page(s): 93
05/20/2020 Authors: Xu K; Park D; Magis AT; Zhang J; Zhou W; Sica GL; Ramalingam SS; Curran WJ; Deng X
Automatic segmentation and quantification of epicardial adipose tissue from coronary computed tomography angiography.
Phys Med Biol Volume: 65 Page(s): 095012
05/11/2020 Authors: He X; Guo BJ; Lei Y; Wang T; Fu Y; Curran WJ; Zhang LJ; Liu T; Yang X
Genomic copy number variation correlates with survival outcomes in WHO grade IV glioma.
Sci Rep Volume: 10 Page(s): 7355
04/30/2020 Authors: Buchwald ZS; Tian S; Rossi M; Smith GH; Switchenko J; Hauenstein JE; Moreno CS; Press RH; Prabhu RS; Zhong J
High quality proton portal imaging using deep learning for proton radiation therapy: a phantom study.
Biomed Phys Eng Express Volume: 6 Page(s): 035029
04/27/2020 Authors: Charyyev S; Lei Y; Harms J; Eaton B; McDonald M; Curran WJ; Liu T; Zhou J; Zhang R; Yang X
4D-CT deformable image registration using multiscale unsupervised deep learning.
Phys Med Biol Volume: 65 Page(s): 085003
04/20/2020 Authors: Lei Y; Fu Y; Wang T; Liu Y; Patel P; Curran WJ; Liu T; Yang X
Survival advantage of chemoradiotherapy in anaplastic thyroid carcinoma: Propensity score matched analysis with multiple subgroups.
Head Neck Volume: 42 Page(s): 678 - 687
04/01/2020 Authors: Tian S; Switchenko JM; Fei T; Press RH; Abugideiri M; Saba NF; Owonikoko TK; Chen AY; Beitler JJ; Curran WJ
LungRegNet: An unsupervised deformable image registration method for 4D-CT lung.
Med Phys Volume: 47 Page(s): 1763 - 1774
04/01/2020 Authors: Fu Y; Lei Y; Wang T; Higgins K; Bradley JD; Curran WJ; Liu T; Yang X
Automated left ventricular myocardium segmentation using 3D deeply supervised attention U-net for coronary computed tomography angiography; CT myocardium segmentation.
Med Phys Volume: 47 Page(s): 1775 - 1785
04/01/2020 Authors: Jun Guo B; He X; Lei Y; Harms J; Wang T; Curran WJ; Liu T; Jiang Zhang L; Yang X
Deep learning-based attenuation correction in the absence of structural information for whole-body positron emission tomography imaging.
Phys Med Biol Volume: 65 Page(s): 055011
03/02/2020 Authors: Dong X; Lei Y; Wang T; Higgins K; Liu T; Curran WJ; Mao H; Nye JA; Yang X
A planning study of focal dose escalations to multiparametric MRI-defined dominant intraprostatic lesions in prostate proton radiation therapy.
Br J Radiol Volume: 93 Page(s): 20190845
03/01/2020 Authors: Wang T; Zhou J; Tian S; Wang Y; Patel P; Jani AB; Langen KM; Curran WJ; Liu T; Yang X
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
J Clin Oncol Volume: 38 Page(s): 706 - 714
03/01/2020 Authors: Bradley JD; Hu C; Komaki RR; Masters GA; Blumenschein GR; Schild SE; Bogart JA; Forster KM; Magliocco AM; Kavadi VS
Male pelvic multi-organ segmentation aided by CBCT-based synthetic MRI.
Phys Med Biol Volume: 65 Page(s): 035013
02/04/2020 Authors: Lei Y; Wang T; Tian S; Dong X; Jani AB; Schuster D; Curran WJ; Patel P; Liu T; Yang X
CT prostate segmentation based on synthetic MRI-aided deep attention fully convolution network.
Med Phys Volume: 47 Page(s): 530 - 540
02/01/2020 Authors: Lei Y; Dong X; Tian Z; Liu Y; Tian S; Wang T; Jiang X; Patel P; Jani AB; Mao H
Moderately Hypofractionated Radiation for Benign Meningiomas and Schwannomas: A Report of 70 Patients Treated Between 2008 and 2018.
Adv Radiat Oncol Volume: 5 Page(s): 1147 - 1151
01/01/2020 Authors: Dhere VR; Tian S; Buchwald Z; Jiang X; Zhang C; Chen Z; Eaton BR; Shu H-KG; Curran WJ; Zhong J
Survival outcomes in patients with gastric and gastroesophageal junction adenocarcinomas treated with perioperative chemotherapy with or without preoperative radiotherapy.
Cancer Volume: 126 Page(s): 37 - 45
01/01/2020 Authors: Tian S; Jiang R; Madden NA; Ferris MJ; Buchwald ZS; Xu KM; Cardona K; Maithel SK; McDonald MW; Lin JY
Dosimetric Factors Related to Radiation Necrosis After 5-Fraction Radiosurgery for Patients With Resected Brain Metastases.
Pract Radiat Oncol Volume: 10 Page(s): 36 - 43
01/01/2020 Authors: Tanenbaum DG; Buchwald ZS; Jhaveri J; Schreibmann E; Switchenko JM; Prabhu RS; Chowdhary M; Abugideiri M; Pfister NT; Eaton B
Reduced-volume tumor-bed boost is not associated with inferior local control and survival outcomes in high-risk medulloblastoma.
Pediatr Blood Cancer Volume: 67 Page(s): e28027
01/01/2020 Authors: Tian S; Sudmeier LJ; Zhang C; Madden NA; Buchwald ZS; Shu H-KG; Curran WJ; Eaton BR; Esiashvili N
Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.
Cancer Res Volume: 79 Page(s): 6126 - 6138
12/15/2019 Authors: Chen G; Park D; Magis AT; Behera M; Ramalingam SS; Owonikoko TK; Sica GL; Ye K; Zhang C; Chen Z
Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial.
Lancet Volume: 394 Page(s): 2155 - 2164
12/14/2019 Authors: Vicini FA; Cecchini RS; White JR; Arthur DW; Julian TB; Rabinovitch RA; Kuske RR; Ganz PA; Parda DS; Scheier MF
Synthetic MRI-aided multi-organ segmentation on male pelvic CT using cycle consistent deep attention network.
Radiother Oncol Volume: 141 Page(s): 192 - 199
12/01/2019 Authors: Dong X; Lei Y; Tian S; Wang T; Patel P; Curran WJ; Jani AB; Liu T; Yang X
Synthetic CT generation from non-attenuation corrected PET images for whole-body PET imaging.
Phys Med Biol Volume: 64 Page(s): 215016
11/04/2019 Authors: Dong X; Wang T; Lei Y; Higgins K; Liu T; Curran WJ; Mao H; Nye JA; Yang X
Whole-body PET estimation from low count statistics using cycle-consistent generative adversarial networks.
Phys Med Biol Volume: 64 Page(s): 215017
11/04/2019 Authors: Lei Y; Dong X; Wang T; Higgins K; Liu T; Curran WJ; Mao H; Nye JA; Yang X
Survival Outcomes With Thoracic Radiotherapy in Extensive-Stage Small-Cell Lung Cancer: APropensity Score-Matched Analysis of the National Cancer Database.
Clin Lung Cancer Volume: 20 Page(s): 484 - 493.e6
11/01/2019 Authors: Tian S; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP
Hemorrhagic and Cystic Brain Metastases Are Associated With an Increased Risk of Leptomeningeal Dissemination After Surgical Resection and Adjuvant Stereotactic Radiosurgery.
Neurosurgery Volume: 85 Page(s): 632 - 641
11/01/2019 Authors: Press RH; Zhang C; Chowdhary M; Prabhu RS; Ferris MJ; Xu KM; Olson JJ; Eaton BR; Shu H-KG; Curran WJ
Evaluation of a deep learning-based pelvic synthetic CT generation technique for MRI-based prostate proton treatment planning.
Phys Med Biol Volume: 64 Page(s): 205022
10/21/2019 Authors: Liu Y; Lei Y; Wang Y; Shafai-Erfani G; Wang T; Tian S; Patel P; Jani AB; McDonald M; Curran WJ
Lung Stereotactic Body Radiotherapy and Concurrent Immunotherapy: A Multi-Center Safety and Toxicity Analysis
Volume: 14 Page(s): S248 - S248
10/01/2019 Authors: Tian S; Switchenko J; Patel P; Shelton J; Kahn S; Pillai R; Steuer C; Owonikoko T; Behera M; Curran W
Integration of Durvalumab into the Treatment of Stage III Non-Small Cell Lung Cancer: Real-World Considerations
Volume: 14 Page(s): S588 - S589
10/01/2019 Authors: Gorgens S; Schreibmann E; Behera M; Steuer C; Pillai R; Owonikoko T; Shelton J; Ramalingam S; Curran W; Higgins K
Inter-Fraction Variability of 18-FDG PET During Lung SBRT and the Effect of Systemic and Immunotherapy: Results of a Prospective Pilot Study
Volume: 14 Page(s): S607 - S608
10/01/2019 Authors: Tian S; Switchenko J; Sethi I; Yang X; Da Silva A; Owonikoko T; Schuster D; Curran W; Higgins K
Deep learning-based image quality improvement for low-dose computed tomography simulation in radiation therapy.
J Med Imaging (Bellingham) Volume: 6 Page(s): 043504
10/01/2019 Authors: Wang T; Lei Y; Tian Z; Dong X; Liu Y; Jiang X; Curran WJ; Liu T; Shu H-K; Yang X
MRI-US Registration Using Label-driven Weakly-supervised Learning for Multiparametric MRI-guided HDR Prostate Brachytherapy
Volume: 105 Page(s): E727 - E727
09/01/2019 Authors: Yang X; Zeng Q; Lei Y; Tian S; Wang T; Dong X; Jani A; Mao H; Curran WJ; Patel PR
Hypofractionated Radiation for Benign Meningiomas and Vestibular Schwannomas
Volume: 105 Page(s): E97 - E97
09/01/2019 Authors: Dhere VR; Sudmeier LJ; Buchwald ZS; Tian S; Jiang X; Zhang C; Chen Z; Eaton BR; Shu HKG; Crocker IR
MRI-based Proton Radiotherapy for Prostate Cancer Using Deep Convolutional Neural Networks
Volume: 105 Page(s): S200 - S200
09/01/2019 Authors: Yang X; Liu Y; Lei Y; Wang Y; Shafai-Erfani G; Wang T; Tian S; Patel PR; Jani A; Curran WJ
Radiomic Biomarkers Evaluation of the High Dose Arm of RTOG 0617
Volume: 105 Page(s): S119 - S120
09/01/2019 Authors: Sasankan N; Geng H; Zhong H; Fan Y; Rosen M; Bradley JD; Cao J; Garces Y; Iyengar P; Kavadi VS
The Effect of Dexamethasone on the Apd-1/L1 and Radiotherapy Stimulated Anti-Tumor Response
Volume: 105 Page(s): S122 - S123
09/01/2019 Authors: Buchwald ZS; Nasti T; Wieland A; Hudson W; Valanparambil R; Eberhardt C; Lawson D; Lin JY; Curran WJ; Ahmed R
Radiomic Analysis of Radiation Induced Fibrosis Following Stereotactic Body Radiation Therapy
Volume: 105 Page(s): E505 - E506
09/01/2019 Authors: Escott C; Madden NA; Schreibmann E; Tian S; Cassidy RJ; Sutter AI; Whitaker D; Switchenko J; Pfister NT; Xu KM
A Multi-institutional Analysis of Patterns of Salvage Therapy for Leptomeningeal Disease after Surgical Resection and Radiosurgery for Brain Metastases
Volume: 105 Page(s): E86 - E87
09/01/2019 Authors: Prabhu RS; Turner BE; Asher A; Marcrom S; Fiveash JB; Foreman PM; Press RH; Patel K; Curran WJ; Breen W
Prognostic value of radiographically defined extranodal extension in human papillomavirus-associated locally advanced oropharyngeal carcinoma.
Head Neck Volume: 41 Page(s): 3056 - 3063
09/01/2019 Authors: Tian S; Ferris MJ; Switchenko JM; Magliocca KR; Cassidy RJ; Jhaveri J; Aiken AH; Baugnon KL; Hudgins PA; Kendi ATK
Paired cycle-GAN-based image correction for quantitative cone-beam computed tomography.
Med Phys Volume: 46 Page(s): 3998 - 4009
09/01/2019 Authors: Harms J; Lei Y; Wang T; Zhang R; Zhou J; Tang X; Curran WJ; Liu T; Yang X
Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base.
Cancer Volume: 125 Page(s): 2782 - 2793
08/15/2019 Authors: Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW
A multi-institutional analysis of presentation and outcomes for leptomeningeal disease recurrence after surgical resection and radiosurgery for brain metastases.
Neuro Oncol Volume: 21 Page(s): 1049 - 1059
08/05/2019 Authors: Prabhu RS; Turner BE; Asher AL; Marcrom SR; Fiveash JB; Foreman PM; Press RH; Patel KR; Curran WJ; Breen WG
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma.
J Neurooncol Volume: 144 Page(s): 205 - 210
08/01/2019 Authors: Lassman AB; Aldape KD; Ansell PJ; Bain E; Curran WJ; Eoli M; French PJ; Kinoshita M; Looman J; Mehta M
MRI-only based synthetic CT generation using dense cycle consistent generative adversarial networks.
Med Phys Volume: 46 Page(s): 3565 - 3581
08/01/2019 Authors: Lei Y; Harms J; Wang T; Liu Y; Shu H-K; Jani AB; Curran WJ; Mao H; Liu T; Yang X
MRI-based treatment planning for liver stereotactic body radiotherapy: validation of a deep learning-based synthetic CT generation method.
Br J Radiol Volume: 92 Page(s): 20190067
08/01/2019 Authors: Liu Y; Lei Y; Wang T; Kayode O; Tian S; Liu T; Patel P; Curran WJ; Ren L; Yang X
Acetylation regulates ribonucleotide reductase activity and cancer cell growth.
Nat Commun Volume: 10 Page(s): 3213
07/19/2019 Authors: Chen G; Luo Y; Warncke K; Sun Y; Yu DS; Fu H; Behera M; Ramalingam SS; Doetsch PW; Duong DM
MRI-based treatment planning for proton radiotherapy: dosimetric validation of a deep learning-based liver synthetic CT generation method.
Phys Med Biol Volume: 64 Page(s): 145015
07/16/2019 Authors: Liu Y; Lei Y; Wang Y; Wang T; Ren L; Lin L; McDonald M; Curran WJ; Liu T; Zhou J
Machine-learning based classification of glioblastoma using delta-radiomic features derived from dynamic susceptibility contrast enhanced magnetic resonance images: Introduction.
Quant Imaging Med Surg Volume: 9 Page(s): 1201 - 1213
07/01/2019 Authors: Jeong J; Wang L; Ji B; Lei Y; Ali A; Liu T; Curran WJ; Mao H; Yang X
Tumor-draining lymph node irradiation reduces tumor-infiltrating stem-like CD8(+)T-cells and abrogates the abscopal effect
Volume: 79
07/01/2019 Authors: Buchwald ZS; Nasti TH; Eberhardt CS; Wieland A; Lawson D; Curran W; Ahmed R; Khan MK
Learning-based automatic segmentation of arteriovenous malformations on contrast CT images in brain stereotactic radiosurgery.
Med Phys Volume: 46 Page(s): 3133 - 3141
07/01/2019 Authors: Wang T; Lei Y; Tian S; Jiang X; Zhou J; Liu T; Dresser S; Curran WJ; Shu H-K; Yang X
Ultrasound prostate segmentation based on multidirectional deeply supervised V-Net.
Med Phys Volume: 46 Page(s): 3194 - 3206
07/01/2019 Authors: Lei Y; Tian S; He X; Wang T; Wang B; Patel P; Jani AB; Mao H; Curran WJ; Liu T
Identification of the GABAA receptor in melanoma brain metastases patient tumors and demonstration that it is a viable drug target using benzodiazepine-derivatives
Volume: 79
07/01/2019 Authors: Kaluzova M; Nasti T; Chen H-R; Lowder L; Press R; Rosen H; Rupji M; Kallay L; Patel R; Burnham A
Defining an Intermediate-risk Group for Low-grade Glioma: A National Cancer Database Analysis.
Anticancer Res Volume: 39 Page(s): 2911 - 2918
06/01/2019 Authors: Jairam V; Kann BH; Park HS; Miccio JA; Beckta JM; Yu JB; Prabhu RS; Gao SJ; Mehta MP; Curran WJ
A Most Likely Path (MLP) Validation of Spot Decomposition for Pencil Beam Scanning (PBS) in Proton Radiography (pRG) and Proton CT (pCT)
Volume: 46 Page(s): E181 - E181
06/01/2019 Authors: Sohn J; Liu T; Li X; Lin L; Ding X; Langen K; Eaton B; McDonald M; Curran W; Yang X
MRI-Based Attenuation Correction for Brain PET/MRI Based On Anatomic Signature and Machine Learning
Volume: 46 Page(s): E192 - E193
06/01/2019 Authors: Wang T; Lei Y; Dong X; Higgins K; Liu T; Shim H; Curran W; Mao H; Nye J; Yang X
MRI-Based Synthetic CT Generation Using Cycle Consistent Adversarial Network
Volume: 46 Page(s): E516 - E517
06/01/2019 Authors: Lei Y; Harms J; Wang T; Liu Y; Shu H; Jani A; Curran W; Mao H; Liu T; Yang X
Synthetic MRI-Aided Prostate Segmentation in CT Image
Volume: 46 Page(s): E505 - E505
06/01/2019 Authors: Lei Y; Tian S; Wang T; Liu Y; Dong X; Jiang X; Patel P; Jani A; Curran W; Liu T
Order-Graph Regularized Sparse Dictionary Learning for Unsupervised Multi-Needle Detection in 3D Ultrasound Images
Volume: 46 Page(s): E226 - E226
06/01/2019 Authors: Zhang Y; Lei Y; Jeong J; Tian Z; Liu Y; Wang T; Liu T; Jani A; Curran W; Patel P
MRI-Based Prostate Proton Radiotherapy Using Deep-Learning-Based Synthetic CT
Volume: 46 Page(s): E476 - E477
06/01/2019 Authors: Shafai-Erfani G; Liu Y; Lei Y; Wang Y; Wang T; Tian S; Jani A; McDonald M; Curran W; Liu T
Surface-Driven MRI-US Registration Using Weakly-Supervised Learning in Prostate Brachytherapy
Volume: 46 Page(s): E224 - E224
06/01/2019 Authors: Zeng Q; Jeong J; Lei Y; Tian Z; Wang T; Dong X; Jani A; Patel P; Mao H; Curran W
Reliability of Doppler Blood Flow Evaluation of Neurovascular Bundle Vessels in Patients Receiving Prostate Radiotherapy
Volume: 46 Page(s): E480 - E480
06/01/2019 Authors: He X; Yang X; Jani A; Sohn J; Patel P; Curran W; Liu T
Surface-Driven MRI-US Registration Using Weakly-Supervised Learning in Prostate Brachytherapy
Volume: 46 Page(s): E225 - E226
06/01/2019 Authors: Zeng Q; Jeong J; Lei Y; Tian Z; Wang T; Dong X; Jani A; Patel P; Mao H; Curran W
Order-Graph Regularized Sparse Dictionary Learning for Unsupervised Multi-Needle Detection in 3D Ultrasound Images
Volume: 46 Page(s): E225 - E225
06/01/2019 Authors: Zhang Y; Lei Y; Jeong J; Tian Z; Liu Y; Wang T; Liu T; Jani A; Curran W; Patel P
Whole-Body PET Estimation From Low Count Statistics Using Deep Convolutional Neural Networks
Volume: 46 Page(s): E193 - E193
06/01/2019 Authors: Dong X; Lei Y; Wang T; Higgins K; Liu T; Curran W; Mao H; Nye J; Yang X
JACK KROHMER JUNIOR INVESTIGATOR COMPETITION WINNER: Deep Learning-Based Self Attenuation Correction for Whole-Body PET Imaging
Volume: 46 Page(s): E192 - E192
06/01/2019 Authors: Dong X; Lei Y; Wang T; Higgins K; Liu T; Curran W; Mao H; Nye J; Yang X
Deep-Learning-Based Synthetic-CT Generation Method for CBCT-Guided Proton Therapy
Volume: 46 Page(s): E475 - E475
06/01/2019 Authors: Liu Y; Lei Y; Lin L; Dhabaan A; Liu T; Curran W; Zhou J; Yang X
A Novel Method of Generating Synthetic CT From MRI for Proton Treatment Planning for Base of Skull Tumors
Volume: 46 Page(s): E474 - E474
06/01/2019 Authors: Shafai-Erfani G; Lei Y; Zhou J; Tian Z; Zhong J; Wang T; McDonald M; Curran W; Liu T; Shu H
MRI-Based Treatment Planning for Liver Photon and Proton Radiotherapy
Volume: 46 Page(s): E318 - E319
06/01/2019 Authors: Liu Y; Lei Y; Wang T; Wang Y; Kayode O; Tian S; Lin L; Liu T; Patel P; Curran W
Dual-Energy CT-Based Accurate Stopping Power Mapping Using 3D Deep Convolutional Neural Networks for Head-And-Neck Patients
Volume: 46 Page(s): E233 - E233
06/01/2019 Authors: Wang T; Lei Y; Harms J; Liu Y; Ghavidel B; Lin L; Curran W; Beitler J; Liu T; Zhou J
Learning-Based Low Dose CT Reconstruction in Radiation Therapy
Volume: 46 Page(s): E275 - E275
06/01/2019 Authors: Wang T; Lei Y; Dong X; Tian Z; Liu Y; Jiang X; Liu T; Curran W; Shu H; Yang X
High-Resolution Ultrasound Imaging Reconstruction Using Deep Attention Generative Adversarial Networks
Volume: 46 Page(s): E491 - E491
06/01/2019 Authors: Lei Y; He X; Liu Y; Tian Z; Wang T; Curran W; Liu T; Yang X
Nonrigid 4D-CT Image Registration Using An Unsupervised Deep Convolutional Neural Network
Volume: 46 Page(s): E505 - E505
06/01/2019 Authors: Lei Y; Liu Y; Wang T; Tian Z; Tian S; Curran W; Liu T; Higgins K; Yang X
CBCT-Based Synthetic CT Using Deep Learning for Pancreatic Adaptive Radiotherapy
Volume: 46 Page(s): E131 - E132
06/01/2019 Authors: Liu Y; Lei Y; Wang T; Patel P; Liu T; Curran W; Yang X
A Deep-Learning-Based Intensity Inhomogeneity Correction for MR Imaging
Volume: 46 Page(s): E386 - E386
06/01/2019 Authors: Liu Y; Lei Y; Jeong J; Wang T; Curran W; Liu T; Patel P; Yang X
Chest Multiorgan Segmentation of CT Images with U-Net-GAN
Volume: 46 Page(s): E371 - E371
06/01/2019 Authors: Dong X; Lei Y; Wang T; Thomas M; Tang L; Curran W; Liu T; Yang X
Analytical Grayscale Transformation for Gain-Setting Calibration in Quantitative Ultrasound Radiomics
Volume: 46 Page(s): E491 - E491
06/01/2019 Authors: He X; Yang X; Wynne J; Yu D; Beitler J; Curran W; Liu T
The timing of chemoradiotherapy after surgical resection and its impact on overall survival in glioblastoma.
Volume: 37
05/20/2019 Authors: Press RH; Shafer SL; Jiang R; Buchwald ZS; Abugideiri M; Tian S; Morgan T; Behera M; Sengupta S; Voloschin AD
A randomized phase II study of tremelimumab and durvalumab with or without radiation for patients with relapsed small cell lung cancer (SCLC).
Volume: 37
05/20/2019 Authors: Owonikoko TK; Higgins KA; Chen Z; Zhang C; Pillai RN; Steuer CE; Saba NF; Pakkala S; Shin DM; Zhang G
Prospective International Pilot Study Evaluating the Efficacy of a Self-Guided Contouring Teaching Module With Integrated Feedback for Transitioning From 2D to 3D Treatment Planning.
J Glob Oncol Volume: 5 Page(s): 1 - 16
05/01/2019 Authors: Abugideiri M; Schreibmann E; Switchenko J; McDonald MW; Beitler JJ; Curran WJ; Bruner D; Patel P; Tigeneh W; Mijena M
Multiparametric MRI-guided dose boost to dominant intraprostatic lesions in CT-based High-dose-rate prostate brachytherapy.
Br J Radiol Volume: 92 Page(s): 20190089
05/01/2019 Authors: Wang T; Press RH; Giles M; Jani AB; Rossi P; Lei Y; Curran WJ; Patel P; Liu T; Yang X
The Impact of Graduates' Job Preferences on the Current Radiation Oncology Job Market.
Int J Radiat Oncol Biol Phys Volume: 104 Page(s): 27 - 32
05/01/2019 Authors: Chowdhary M; Switchenko JM; Sen N; Chhabra AM; Katz LM; Jegadeesh NK; Barry PN; Wang D; Royce TJ; Curran WJ
Automatic multiorgan segmentation in thorax CT images using U-net-GAN.
Med Phys Volume: 46 Page(s): 2157 - 2168
05/01/2019 Authors: Dong X; Lei Y; Wang T; Thomas M; Tang L; Curran WJ; Liu T; Yang X
Attenuation and Scatter Correction for Whole-body PET Using 3D Generative Adversarial Networks
Volume: 60
05/01/2019 Authors: Yang X; Lei Y; Dong X; Wang T; Higgins K; Liu T; Shim H; Curran W; Mao H; Nye J
Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
Mol Cancer Volume: 18 Page(s): 85
04/10/2019 Authors: Xu K; Park D; Magis AT; Zhang J; Zhou W; Sica GL; Ramalingam SS; Curran WJ; Deng X
MRI-based synthetic CT generation using semantic random forest with iterative refinement.
Phys Med Biol Volume: 64 Page(s): 085001
04/05/2019 Authors: Lei Y; Harms J; Wang T; Tian S; Zhou J; Shu H-K; Zhong J; Mao H; Curran WJ; Liu T
A Prospective International Pilot Study Evaluating the Efficacy of a Self-Guided Contouring Teaching Module with Integrated Feedback for Transitioning from 2D to 3D Treatment Planning
Volume: 103 Page(s): E6 - E6
04/01/2019 Authors: Abugideiri M; Schreibmann E; Switchenko J; McDonald MW; Beitler JJ; Curran WJ; Bruner D; Patel P; Tigeneh W; Mijena M
Deeply supervised 3D fully convolutional networks with group dilated convolution for automatic MRI prostate segmentation.
Med Phys Volume: 46 Page(s): 1707 - 1718
04/01/2019 Authors: Wang B; Lei Y; Tian S; Wang T; Liu Y; Patel P; Jani AB; Mao H; Curran WJ; Liu T
Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420.
Int J Radiat Oncol Biol Phys Volume: 103 Page(s): 878 - 886
03/15/2019 Authors: Lieberman FS; Wang M; Robins HI; Tsien CI; Curran WJ; Werner-Wasik M; Smith RP; Schultz C; Hartford AC; Zhang P
Smoking, age, nodal disease, T stage, p16 status, and risk of distant metastases in patients with squamous cell cancer of the oropharynx.
Cancer Volume: 125 Page(s): 704 - 711
03/01/2019 Authors: Beitler JJ; Switchenko JM; Dignam JJ; McDonald MW; Saba NF; Shin DM; Magliocca KR; Cassidy RJ; El-Deiry MW; Patel MR
Does size matter? Investigating the optimal planning target volume margin for postoperative stereotactic radiosurgery to resected brain metastases.
J Neurosurg Volume: 130 Page(s): 797 - 803
03/01/2019 Authors: Jhaveri J; Chowdhary M; Zhang X; Press RH; Switchenko JM; Ferris MJ; Morgan TM; Roper J; Dhabaan A; Elder E
Learning-based CBCT correction using alternating random forest based on auto-context model.
Med Phys Volume: 46 Page(s): 601 - 618
02/01/2019 Authors: Lei Y; Tang X; Higgins K; Lin J; Jeong J; Liu T; Dhabaan A; Wang T; Dong X; Press R
Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to whole breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence-free interval (IBCR-FI) in patients (pts) with pathologically positive axillary (PPAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC): NRG Oncology/NSABP B-51/RTOG 1304
Volume: 79
02/01/2019 Authors: Mamounas EP; Bandos H; White JR; Julian TB; Khan AJ; Shaitelman SF; Torres MA; Vicini FA; Ganz PA; McCloskey SA
Predictors of pneumonitis-free survival following lung stereotactic body radiation therapy.
Transl Lung Cancer Res Volume: 8 Page(s): 15 - 23
02/01/2019 Authors: Tian S; Switchenko JM; Cassidy RJ; Escott CE; Castillo R; Patel PR; Curran WJ; Higgins KA
Optimal virtual monoenergetic image in "TwinBeam" dual-energy CT for organs-at-risk delineation based on contrast-noise-ratio in head-and-neck radiotherapy.
J Appl Clin Med Phys Volume: 20 Page(s): 121 - 128
02/01/2019 Authors: Wang T; Ghavidel BB; Beitler JJ; Tang X; Lei Y; Curran WJ; Liu T; Yang X
MRI-based attenuation correction for brain PET/MRI based on anatomic signature and machine learning.
Phys Med Biol Volume: 64 Page(s): 025001
01/07/2019 Authors: Yang X; Wang T; Lei Y; Higgins K; Liu T; Shim H; Curran WJ; Mao H; Nye JA
Current Activities of the Coalition of Cancer Cooperative Groups.
J Natl Cancer Inst Volume: 111 Page(s): 11 - 18
01/01/2019 Authors: Bertagnolli MM; Blaney SM; Blanke CD; Curran WJ; Dancey J; Mannel RS; O'Dwyer PJ; Schnall MD; Wolmark N; Coalition of Cancer Cooperative Groups
Sparing Cardiac Substructures With Optimized Volumetric Modulated Arc Therapy and Intensity Modulated Proton Therapy in Thoracic Radiation for Locally Advanced Non-small Cell Lung Cancer.
Pract Radiat Oncol Volume: 9 Page(s): e473 - e481
01/01/2019 Authors: Ferris MJ; Martin KS; Switchenko JM; Kayode OA; Wolf J; Dang Q; Press RH; Curran WJ; Higgins KA
MRI-Based Proton Treatment Planning for Base of Skull Tumors.
Int J Part Ther Volume: 6 Page(s): 12 - 25
01/01/2019 Authors: Shafai-Erfani G; Lei Y; Liu Y; Wang Y; Wang T; Zhong J; Liu T; McDonald M; Curran WJ; Zhou J
Influence of Residual Disease Following Surgical Resection in Newly Diagnosed Glioblastoma on Clinical, Neurocognitive, and Patient Reported Outcomes.
Neurosurgery Volume: 84 Page(s): 66 - 76
01/01/2019 Authors: Hall WA; Pugh SL; Wefel JS; Armstrong TS; Gilbert MR; Brachman DG; Werner-Wasik M; Wendland MM; Brown PD; Chao ST
Interactive calculator for operating characteristics of phase I cancer clinical trials using standard 3+3 designs.
Contemp Clin Trials Commun Volume: 12 Page(s): 145 - 153
12/01/2018 Authors: Chen Z; Zheng Y; Wang Z; Kutner M; Curran WJ; Kowalski J
Optimal Virtual Monochromatic Image in "Twin-Beam" Imaging of Dual-Energy CT for Head-and-Neck Cancer Radiation Therapy
Volume: 102 Page(s): S104 - S105
11/01/2018 Authors: Yang X; Wang T; Ghavidel B; Beitler JJ; Tang X; Curran WJ; Liu T
A Learning-Based Method to Improve Pelvis Cone Beam CT Image Quality for Prostate Cancer Radiation Therapy
Volume: 102 Page(s): E377 - E378
11/01/2018 Authors: Yang X; Wang T; Lei Y; Jiang X; Jani A; Patel PR; Tang X; Dhabaan AH; Curran WJ; Liu T
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blocker use During Stereotactic Body Radiation Therapy Associated with Decreased Pneumonitis: A Multi-center Analysis
Volume: 102 Page(s): E680 - E681
11/01/2018 Authors: Escott C; Cassidy RJ; Tian S; Switchenko J; Pfister NT; Xu KM; Patel PR; Eaton BR; Force S; Ramalingam S
Patterns of Failure and Outcomes Based On Management of Leptomeningeal Disease after Surgical Resection and Radiosurgery for Brain Metastases: A Multi-Institutional Analysis
Volume: 102 Page(s): S142 - S143
11/01/2018 Authors: Prabhu RS; Soltys SG; Turner BE; Marcrom S; Fiveash JB; Foreman PM; Press RH; Patel K; Curran WJ; Breen W
Disparities among Domestic Radiation Oncology (RO) Graduates' Job Application Patterns and Top Choice Preferences
Volume: 102 Page(s): E414 - E414
11/01/2018 Authors: Chowdhary M; Switchenko J; Sen N; Chhabra AM; Katz LM; Barry PN; Wang D; Curran WJ; Wilson LD; Abrams RA
Defining an Intermediate Risk Group for Low Grade Glioma? An Analysis of the National Cancer Database
Volume: 102 Page(s): E249 - E250
11/01/2018 Authors: Jairam V; Kann BH; Park HSM; Miccio JA; Beckta JM; Yu JB; Gao S; Prabhu RS; Mehta MP; Curran WJ
T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient.
Cancer Immunol Immunother Volume: 67 Page(s): 1767 - 1776
11/01/2018 Authors: Wieland A; Kamphorst AO; Adsay NV; Masor JJ; Sarmiento J; Nasti TH; Darko S; Douek DC; Xue Y; Curran WJ
Survival Advantage to Combined Modality Therapy Seen in Multiple Subgroups Within Anaplastic Thyroid Carcinoma: A Propensity-Score Matched Analysis of the National Cancer Data Base
Volume: 102 Page(s): E356 - E357
11/01/2018 Authors: Tian S; Switchenko J; Fei T; Press RH; Abugideiri M; Saba NF; Owonikoko TK; Chen AY; Beitler JJ; Curran WJ
Report of Neurotoxicity after Concurrent Whole Brain Radiation Therapy and Checkpoint Blockade Immunotherapy for Patients with Brain Metastases
Volume: 102 Page(s): E340 - E340
11/01/2018 Authors: Press RH; Buchwald ZS; Steuer C; Pillai R; Owonikoko TK; Ramalingam S; Curran WJ; Higgins KA
Reduced-Volume Tumor Bed Boost is Not Associated with Inferior Local Control and Survival Outcomes in High-Risk Medulloblastoma
Volume: 102 Page(s): E468 - E469
11/01/2018 Authors: Sudmeier LJ; Tian S; Zhang C; Madden NA; Buchwald ZS; Eaton BR; Shu HKG; Crocker IR; Curran WJ; Esiashvili N
CLINICAL AND DOSIMETRIC FACTORS RELATED TO RADIATION NECROSIS AFTER FIVE FRACTION RADIOSURGERY FOR RESECTED BRAIN METASTASES
Volume: 20 Page(s): 54 - 54
11/01/2018 Authors: Buchwald Z; Jhaveri J; Schreibmann E; Switchenko J; Prabhu R; Chowdhary M; Abugideiri M; Eaton B; Olson J; Shu H-K
LARGE SCALE TRANSCRIPTOMIC ANALYSIS OF MELANOMA BRAIN METASTASES
Volume: 20 Page(s): 68 - 68
11/01/2018 Authors: Kowalski J; Krummel DP; Rupji M; Dwivedi B; Keskin H; Kallay L; Xu M; Ross A; Press R; Rosen H
MRI-based pseudo CT synthesis using anatomical signature and alternating random forest with iterative refinement model.
J Med Imaging (Bellingham) Volume: 5 Page(s): 043504
10/01/2018 Authors: Lei Y; Jeong JJ; Wang T; Shu H-K; Patel P; Tian S; Liu T; Shim H; Mao H; Jani AB
Radiomic Signatures Linked to Genetic Alterations as Detected by Next-Generation Sequencing: A Radiogenomics Analysis of Early-Stage NSCLC
Volume: 13 Page(s): S718 - S719
10/01/2018 Authors: Tian S; Schreibmann E; Goyal S; Rupii M; Cassidy R; Escott C; Ferris M; Patel P; Curran W; Higgins K
Photon-Based Cardiac Sparing Via Volumetric Modulated Arc Therapy in Thoracic Radiation Therapy for Locally Advanced Non-Small Cell Lung Cancer
Volume: 13 Page(s): S371 - S372
10/01/2018 Authors: Ferris M; Sykes K; Kayode O; Wolf J; Press R; Switchenko J; Curran W; Higgins K
Radiation Therapy Is Associated With an Increased Incidence of Cardiac Events in Patients with Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys Volume: 102 Page(s): 383 - 390
10/01/2018 Authors: Ferris MJ; Jiang R; Behera M; Ramalingam SS; Curran WJ; Higgins KA
Post-treatment neutrophil-to-lymphocyte ratio predicts for overall survival in brain metastases treated with stereotactic radiosurgery.
J Neurooncol Volume: 139 Page(s): 689 - 697
09/01/2018 Authors: Chowdhary M; Switchenko JM; Press RH; Jhaveri J; Buchwald ZS; Blumenfeld PA; Marwaha G; Diaz A; Wang D; Abrams RA
Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
Cancer Volume: 124 Page(s): 3586 - 3595
09/01/2018 Authors: Press RH; Zhang C; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Kahn S; Ramalingam SS
Attrition in NRG Oncology's Radiation-Based Clinical Trials.
Int J Radiat Oncol Biol Phys Volume: 102 Page(s): 26 - 33
09/01/2018 Authors: Ulrich CM; Deshmukh S; Pugh SL; Hanlon A; Grady C; Watkins Bruner D; Curran W
Pseudo CT Estimation using Patch-based Joint Dictionary Learning.
Volume: 2018 Page(s): 5150 - 5153
07/01/2018 Authors: Lei Y; Shu HK; Tian S; Wang T; Liu T; Mao H; Shim H; Curran WJ; Yang X
Targeting Mcl-1 enhances DNA replication stress sensitivity for cancer therapy
Volume: 78
07/01/2018 Authors: Chen G; Magis A; Xu K; Park D; Yu D; Owonikoko T; Sica G; Satola S; Ramalingam S; Curran W
Magnetic resonance imaging-based pseudo computed tomography using anatomic signature and joint dictionary learning.
J Med Imaging (Bellingham) Volume: 5 Page(s): 034001
07/01/2018 Authors: Lei Y; Shu H-K; Tian S; Jeong JJ; Liu T; Shim H; Mao H; Wang T; Jani AB; Curran WJ
An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy.
J Radiat Oncol Volume: 7 Page(s): 195 - 201
06/01/2018 Authors: Konski A; Bhargavan M; Owen J; Komaki R; Langer CJ; Gore E; Paulus R; Choy H; Bruner D-W; Curran WJ
3D Ultrasound Prostate Segmentation Using 3D Deeply Supervised V-Net
Volume: 45 Page(s): E473 - E473
06/01/2018 Authors: Yang X; Lei Y; Tian S; Wang T; Jani A; Curran W; Patel P; Liu T
Dosimetric Study of Cone-Beam CT in Adaptive Proton Therapy for Brain Cancer
Volume: 45 Page(s): E259 - E259
06/01/2018 Authors: Wang T; Hedrick S; Lei Y; Liu T; Jiang X; Dhabaan A; Tang X; Curran W; McDonald M; Yang X
Learning-Based Cone-Beans CT Correction: Dosimetric Calculation Accuracy in Prostate Cancer Radiation Therapy
Volume: 45 Page(s): E169 - E170
06/01/2018 Authors: Wang T; Lei Y; Jani A; Patel P; Dhabaan A; Liu T; Dong X; Jiang X; Tang X; Curran W
MRI-Based Synthetic CT for MRI-Only Proton Radiotherapy Treatment Planning
Volume: 45 Page(s): E360 - E360
06/01/2018 Authors: Yang X; Hedrick S; Wang T; Lei Y; Jiang X; Mao H; Curran W; McDonald M; Liu T
A Learning-Based MRI Classification for MRI-Only Radiotherapy Treatment Planning
Volume: 45 Page(s): E524 - E524
06/01/2018 Authors: Lei Y; Shu H; Tian S; Wang T; Dhabaan A; Liu T; Shim H; Mao H; Curran W; Yang X
Optimal Virtual Monoenergetic Image in TwinBeam Dual-Energy CT for Head-And-Neck Radiotherapy
Volume: 45 Page(s): E589 - E589
06/01/2018 Authors: Wang T; Ghavidel J; Beitler J; Tang X; Curran W; Liu T; Yang X
Machine-Learning-Based Classification of Glioblastoma Using Dynamic Susceptibility Enhanced MR Image Derived Delta-Radiomic Features
Volume: 45 Page(s): E584 - E584
06/01/2018 Authors: Jeong J; Wang L; Bing J; Lei Y; Liu T; Ali A; Curran W; Mao H; Yang X
Patient-Specific Synthetic CT Generation for MRI-Only Prostate Radiotherapy Treatment Planning
Volume: 45 Page(s): E701 - E702
06/01/2018 Authors: Yang X; Lei Y; Wang T; Patel P; Dhabaan A; Jiang X; Shim H; Mao H; Curran W; Jani A
Multiparametric MRI-Guided High-Dose-Rate Brachytherapy Boost to the Dominant Intraprostatic Lesion Based On Deformable Registration: A Prospective Study
Volume: 45 Page(s): E443 - E443
06/01/2018 Authors: Giles M; Press R; Wang T; Schreibmann E; Jani A; Liu T; Rossi P; Curran W; Patel P; Yang X
Dosimetric Evaluation of MRI-Based Synthetic CT for Stereotactic Radiosurgery of Brain Cancer
Volume: 45 Page(s): E701 - E701
06/01/2018 Authors: Wang T; Manohar N; Lei Y; Shu H; Tian S; Higgins K; Dhabaan A; Dong X; Liu T; Curran W
Med-A-Nets: Segmentation of Multiple Organs in Chest CT Image with Deep Adversarial Networks
Volume: 45 Page(s): E154 - E154
06/01/2018 Authors: Yang X; Huang J; Lei Y; Higgins K; Beitler J; Yu D; Jiang X; Liu T; Curran W; Fang Y
Patient-Specific Pseudo-CT Generation Using Semantic and Contextual Information-Based Random Forest for MRI-Only Radiation Treatment Planning
Volume: 45 Page(s): E702 - E702
06/01/2018 Authors: Yang X; Lei Y; Higgins K; Wang T; Tian S; Dhabaan A; Shim H; Mao H; Curran W; Shu H
Machine-Learning-Based Classification of Low-Grade and High-Grade Glioblastoma Using Radiomic Features in Multiparametric MRI
Volume: 45 Page(s): E617 - E617
06/01/2018 Authors: Cui G; Jeong J; Lei Y; Wang T; Dong X; Liu T; Curran W; Mao H; Yang X
Multi-Scale V-Net: A Deep Learning Framework for Brain Tumor Segmentation in Multiparametric MRI
Volume: 45 Page(s): E568 - E568
06/01/2018 Authors: Liu Y; Shi X; Xia Y; Lei Y; Tang L; Liu T; Curran W; Mao H; Yang X
Correlation of genomic copy number variation with survival outcomes in high-grade glioma patients
Volume: 36
05/20/2018 Authors: Buchwald Z; Rossi MR; Smith G; Switchenko JM; Hauenstein J; Zhong J; Press RH; Tian S; Saxe D; Neill S
MRI-based Attenuation Correction for PET/MRI: A Novel Approach Combining Anatomic Signature and Machine Learning
Volume: 59
05/01/2018 Authors: Yang X; Lei Y; Higgins K; Mao H; Liu T; Shim H; Curran W; Nye J
Safety Evaluation of Nivolumab Concomitant With Platinum-Based Chemoradiation therapy for Intermediate and High-Risk Local-Regionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504
Volume: 100 Page(s): 1307 - 1308
04/01/2018 Authors: Gillison M; Ferris RL; Zhang Q; Colevas AD; Mell LK; Kirsch C; Moore KL; Truong MT; Kong CS; Jordan R
Neutrophil-to-lymphocyte ratio as a predictor of overall survival in brain metastases following SRS
Volume: 127 Page(s): S370 - S371
04/01/2018 Authors: Chowdhary M; Switchenko J; Abrams R; Wang D; Marwaha G; Blumenfeld P; Press R; Jhaveri J; Olson J; Shu HK
Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high-risk grade 2 glioma: An analysis of the National Cancer Data Base.
Cancer Volume: 124 Page(s): 1169 - 1178
03/15/2018 Authors: Jhaveri J; Liu Y; Chowdhary M; Buchwald ZS; Gillespie TW; Olson JJ; Voloschin AD; Eaton BR; Shu H-KG; Crocker IR
NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
J Neurooncol Volume: 137 Page(s): 39 - 47
03/01/2018 Authors: Ali AN; Zhang P; Yung WKA; Chen Y; Movsas B; Urtasun RC; Jones CU; Choi KN; Michalski JM; Fischbach AJ
Stereotactic body radiation therapy vs. surgery in early-stage non-small cell lung cancer: lessons learned, current recommendations, future directions.
J Thorac Dis Volume: 10 Page(s): 1201 - 1204
03/01/2018 Authors: Tian S; Higgins KA; Curran WJ; Cassidy RJ
External validity of two nomograms for predicting distant brain failure after radiosurgery for brain metastases in a bi-institutional independent patient cohort.
J Neurooncol Volume: 137 Page(s): 147 - 154
03/01/2018 Authors: Prabhu RS; Press RH; Boselli DM; Miller KR; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Patel KR
A Denoising Algorithm for CT Image Using Low-rank Sparse Coding.
Volume: 10574
03/01/2018 Authors: Lei Y; Xu D; Zhou Z; Wang T; Dong X; Liu T; Dhabaan A; Curran WJ; Yang X
Health care disparities among octogenarians and nonagenarians with stage III lung cancer.
Cancer Volume: 124 Page(s): 775 - 784
02/15/2018 Authors: Cassidy RJ; Zhang X; Switchenko JM; Patel PR; Shelton JW; Tian S; Nanda RH; Steuer CE; Pillai RN; Owonikoko TK
High-resolution CT Image Retrieval Using Sparse Convolutional Neural Network.
Volume: 10573
02/01/2018 Authors: Lei Y; Xu D; Zhou Z; Higgins K; Dong X; Liu T; Shim H; Mao H; Curran WJ; Yang X
Improving Image Quality of Cone-Beam CT Using Alternating Regression Forest.
Volume: 10573
02/01/2018 Authors: Lei Y; Tang X; Higgins K; Wang T; Liu T; Dhabaan A; Shim H; Curran WJ; Yang X
Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.
J Clin Invest Volume: 128 Page(s): 500 - 516
01/02/2018 Authors: Chen G; Magis AT; Xu K; Park D; Yu DS; Owonikoko TK; Sica GL; Satola SW; Ramalingam SS; Curran WJ
Angiotensin receptor blockade: a novel approach for symptomatic radiation necrosis after stereotactic radiosurgery.
J Neurooncol Volume: 136 Page(s): 289 - 298
01/01/2018 Authors: Chowdhary M; Okwan-Duodu D; Switchenko JM; Press RH; Jhaveri J; Buchwald ZS; Zhong J; Chapman BV; Bindra RS; Contessa JN
Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.
Front Oncol Volume: 8 Page(s): 440
01/01/2018 Authors: Jhaveri J; Cheng E; Tian S; Buchwald Z; Chowdhary M; Liu Y; Gillespie TW; Olson JJ; Diaz AZ; Voloschin A
Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable, Stage III Non-Small Cell Lung Cancer: A Phase I Study
Volume: 12 Page(s): S2013 - S2014
11/01/2017 Authors: Higgins K; Pillai R; Chen Z; Zhang C; Patel P; Pakkala S; Shelton J; Force S; Fernandez F; Steuer C
Utilization of PET Scan in Advanced Stage Non-Small Cell Lung Cancer in the United States
Volume: 12 Page(s): S2325 - S2326
11/01/2017 Authors: Behera M; Jiang R; Higgins K; Pillai R; Owonikoko T; Belani C; Khuri F; Ward K; Curran W; Ramalingam S
CONCORDANCE OF EGFR AND MGMT ANALYSES BETWEEN LOCAL AND CENTRAL LABORATORIES: IMPLICATIONS FOR CLINICAL TRIAL DESIGN AND PRECISION MEDICINE FOR DEPATUXIZUMAB-MAFODOTIN (ABT-414) IN GLIOBLASTOMA (GBM)
Volume: 19 Page(s): 15 - 15
11/01/2017 Authors: Lassman A; Dimino C; Mansukhani M; Murty V; Ansell PJ; Bain E; Holen KD; Roberts-Rapp LA; Lee J; Curran W
HEMORRHAGIC BRAIN METASTASES UNDERGOING SURGICAL RESECTION ARE ASSOCIATED WITH INCREASED RISK OF LEPTOMENINGEAL DISSEMINATION
Volume: 19 Page(s): 47 - 47
11/01/2017 Authors: Press R; Zhang C; Chowdhary M; Xu K; Prabhu R; Ferris M; Olson JJ; Eaton BR; Shu H-K; Curran W
Guideline-concordant Care Improves Overall Survival for Locally Advanced Non-Small-cell Lung Carcinoma Patients: A National Cancer Database Analysis.
Clin Lung Cancer Volume: 18 Page(s): 706 - 718
11/01/2017 Authors: Ahmed HZ; Liu Y; O'Connell K; Ahmed MZ; Cassidy RJ; Gillespie TW; Patel P; Pillai RN; Behera M; Steuer CE
PATIENT OUTCOMES AND FACTORS ASSOCIATED WITH RECEIPT OF PROTON RADIATION THERAPY FOR ADULTS WITH PRIMARY GLIOMAS: ANALYSIS OF THE NATIONAL CANCER DATA BASE
Volume: 19 Page(s): 223 - 224
11/01/2017 Authors: Jhaveri J; Cheng E; Liu Y; Ferris M; Chowdhary M; Morgan T; Gillespie T; Olson JJ; Voloschin A; Eaton B
Concomitant Chemotherapy and Radiotherapy with SBRT Boost for Unresectable Stage III Non-Small Cell Lung Cancer: A Phase I Study.
J Thorac Oncol Volume: 12 Page(s): 1687 - 1695
11/01/2017 Authors: Higgins KA; Pillai RN; Chen Z; Tian S; Zhang C; Patel P; Pakkala S; Shelton J; Force SD; Fernandez FG
Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.
Cancer Volume: 123 Page(s): 3681 - 3690
10/01/2017 Authors: Cassidy RJ; Zhang X; Patel PR; Shelton JW; Escott CE; Sica GL; Rossi MR; Hill CE; Steuer CE; Pillai RN
A Quantitative Analysis of the Current Radiation Oncologist Job Market
Volume: 99 Page(s): E392 - E393
10/01/2017 Authors: Chowdhary M; Chhabra AM; Switchenko J; Jhaveri J; Sen N; Curran WJ; Abrams RA; Patel K; Marwaha G
External Validity of a Nomogram Predicting Risk of 6-Month and 9-Month Distant Brain Failure After Initial Stereotactic Radiosurgery Alone for Brain Metastases in an Independent Multi-institutional Patient Cohort
Volume: 99 Page(s): E525 - E526
10/01/2017 Authors: Prabhu RS; Press RH; Boselli DM; Patel K; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola C
External Validity of a Nomogram and Recursive Partitioning Analysis to Predict for Distant Brain Failure After Stereotactic Radiosurgery Alone for Brain Metastases: Multi-institutional Analysis
Volume: 99 Page(s): E101 - E101
10/01/2017 Authors: Press RH; Boselli DM; Patel K; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola C; Asher A
KRAS Mutant Non-small Cell Lung Cancer is Associated With Increased Risk of Salvage Whole Brain Radiation after Stereotactic Radiosurgery for Brain Metastases
Volume: 99 Page(s): E100 - E101
10/01/2017 Authors: Press RH; Zhang X; Cassidy RJ; Ferris MJ; Zhong J; Steuer C; Pillai R; Owonikoko TK; Ramalingam S; Patel PR
Next Generation Sequencing and Clinical Outcomes of Lung Adenocarcinomas Treated With Stereotactic Body Radiation Therapy
Volume: 99 Page(s): S241 - S241
10/01/2017 Authors: Cassidy RJ; Zhang X; Patel PR; Shelton JW; Escott CE; Sica GL; Rossi MR; Hill CE; Steuer C; Pillai R
Post-treatment Neutrophil-to-Lymphocyte Ratio as a Predictor of Overall Survival in Melanoma Brain Metastases treated with Stereotactic Radiosurgery
Volume: 99 Page(s): S169 - S169
10/01/2017 Authors: Chowdhary M; Switchenko J; Marwaha G; Abrams RA; Jhaveri J; Olson JJ; Shu HKG; Curran WJ; Khan MK; Patel K
Optimal Treatment Phase Selection Based on a 4DCT Deformable Registration for Stereotactic Body Radiation Therapy in Pancreatic Cancer
Volume: 99 Page(s): E743 - E743
10/01/2017 Authors: Yang X; Wang T; Liu T; Zhu L; Khan MK; El-Rayes B; Curran WJ; Landry JC
Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Int J Radiat Oncol Biol Phys Volume: 99 Page(s): 459 - 467
10/01/2017 Authors: Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE
Stereotactic Body Radiotherapy for Early-stage Non-small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis.
Clin Lung Cancer Volume: 18 Page(s): 551 - 558.e6
09/01/2017 Authors: Cassidy RJ; Patel PR; Zhang X; Press RH; Switchenko JM; Pillai RN; Owonikoko TK; Ramalingam SS; Fernandez FG; Force SD
Pooled Analysis of Individual Patient Data on Concurrent Chemoradiotherapy for Stage III Non-Small-Cell Lung Cancer in Elderly Patients Compared With Younger Patients Who Participated in US National Cancer Institute Cooperative Group Studies.
J Clin Oncol Volume: 35 Page(s): 2885 - 2892
09/01/2017 Authors: Stinchcombe TE; Zhang Y; Vokes EE; Schiller JH; Bradley JD; Kelly K; Curran WJ; Schild SE; Movsas B; Clamon G
Domestic Job Shortage or Job Maldistribution? AGeographic Analysis of the Current RadiationOncology Job Market.
Int J Radiat Oncol Biol Phys Volume: 99 Page(s): 9 - 15
09/01/2017 Authors: Chowdhary M; Chhabra AM; Switchenko JM; Jhaveri J; Sen N; Patel PR; Curran WJ; Abrams RA; Patel KR; Marwaha G
Comparison of Concurrent Use of Thoracic Radiation With Either Carboplatin-Paclitaxel or Cisplatin-Etoposide for Patients With Stage III Non-Small-Cell Lung Cancer: A Systematic Review.
JAMA Oncol Volume: 3 Page(s): 1120 - 1129
08/01/2017 Authors: Steuer CE; Behera M; Ernani V; Higgins KA; Saba NF; Shin DM; Pakkala S; Pillai RN; Owonikoko TK; Curran WJ
External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
Int J Radiat Oncol Biol Phys Volume: 98 Page(s): 632 - 638
07/01/2017 Authors: Press RH; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Burri SH; Patel KR
Modulation of Bax and mTOR for cancer therapeutics
Volume: 77
07/01/2017 Authors: Li R; Ding C; Zhang J; Xie M; Park D; Ding Y; Chen G; Zhang G; Gilbert-Ross M; Zhou W
High-Resolution CT Image Reconstruction Using Sparse-Coding-Based Deep Learning
Volume: 44 Page(s): 3011 - 3011
06/01/2017 Authors: Yang X; Lei Y; Higgins K; Zhou Z; Jiang X; Curran W
A Leaning-Based Approach to Generate Patient-Specific Pseudo-CT for MRI-Based Radiation Therapy Treatment Planning
Volume: 44 Page(s): 3159 - 3159
06/01/2017 Authors: Yang X; Lei Y; Liu T; Rossi P; Mao H; Shim H; Tian S; Curran W; Shu H
Improving CBCT Image Quality Using Machine Learning and Auto-Context Model
Volume: 44
06/01/2017 Authors: Yang X; Lei Y; Higgins K; Dong X; Dhabaan A; Elder E; Jiang X; Curran W; Tang X
Does Size Matter? Investigating the Optimal Planning Target Volume Margin for Post-Operative Stereotactic Radiosurgery Alone to Resected Brain Metastases
Volume: 44 Page(s): 2973 - 2973
06/01/2017 Authors: Jhaveri J; Zhang X; Chowdhary M; Switchenko J; Press R; Cassidy R; Morgan T; Roper J; Dhabaan A; Elder E
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525.
JAMA Oncol Volume: 3 Page(s): 784 - 792
06/01/2017 Authors: Bell EH; Pugh SL; McElroy JP; Gilbert MR; Mehta M; Klimowicz AC; Magliocco A; Bredel M; Robe P; Grosu A-L
Modulation of Bax and mTOR for Cancer Therapeutics.
Cancer Res Volume: 77 Page(s): 3001 - 3012
06/01/2017 Authors: Li R; Ding C; Zhang J; Xie M; Park D; Ding Y; Chen G; Zhang G; Gilbert-Ross M; Zhou W
A randomized phase II study of chemoradiation (CRT) plus /- nivolumab (Nivo) with sequential safety evaluations of Nivo plus /- lirilumab (Liri) or ipilumumab (Ipi) concomitant with (C) RI in intermediate (IR) and high-risk (HR) head and neck squamous cell carcinoma (HNSCC) (RTOG 3504, NCT02764593).
Volume: 35
05/20/2017 Authors: Gillison ML; Ferris RL; Zhang Q; Colevas AD; Mell LK; Kong C; Jordan R; Moore K; Truong MT; Kirsch C
Randomized phase III trial of concurrent chemoradiation followed by nivolumab or placebo for locally advanced non-small cell lung cancer (NSCLC) (RTOG 3505).
Volume: 35
05/20/2017 Authors: Gerber DE; Urbanic JJ; Langer CJ; Hu C; Chang I-F; Lu B; Movsas B; Jeraj R; Curran WJ; Bradley JD
Is less more? Comparing chemotherapy alone to chemotherapy and radiation for high risk, grade II glioma-An analysis of the National Cancer Data Base.
Volume: 35
05/20/2017 Authors: Jhaveri J; Liu Y; Gillespie TW; Chowdhary M; Buchwald Z; Olson JJ; Voloschin AD; Shu H-KG; Crocker IR; Curran WJ
Enrollment into molecular selection trials and impact on patient disposition.
Volume: 35
05/20/2017 Authors: Harvey RD; Steuer CE; Judson EC; Lewis CM; Collins HH; Saba NF; El-Rayes BF; Curran WJ; Rannalingam SS; Pentz RD
Survival outcomes in extensive stage small cell lung cancer patients treated with thoracic radiation.
Volume: 35
05/20/2017 Authors: Higgins KA; Zhang X; Jiang R; Pillai RN; Owonikoko TK; Steuer CE; Saba NF; Pakkala S; Patel PR; Belani CP
Optimal thoracic radiation dose in limited stage small cell lung cancer.
Volume: 35
05/20/2017 Authors: Behera M; Zhang X; Jiang R; Pillai RN; Patel PR; Pakkala S; Steuer CE; Saba NF; Owonikoko TK; Belani C
Presence of genetic aberrations in patients with brain metastases from non-small cell lung cancer (NSCLC) and clinical outcomes
Volume: 35
05/20/2017 Authors: Press RH; Zhang X; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Patel PR
Stereotactic Body Radiation Therapy for Early Stage Non-Small Cell Lung Cancer in Patients 80 Years and Older: A Multi-Center Analysis.
Int J Radiat Oncol Biol Phys Volume: 98 Page(s): 229 - 230
05/01/2017 Authors: Cassidy RJ; Patel PR; Zhang X; Press RH; Switchenko J; Pillai R; Owonikoko TK; Ramalingam S; Fernandez F; Force S
Treatment Design and Rationale for a Randomized Trial of Cisplatin and Etoposide Plus Thoracic Radiotherapy Followed by Nivolumab or Placebo for Locally Advanced Non-Small-Cell Lung Cancer (RTOG 3505).
Clin Lung Cancer Volume: 18 Page(s): 333 - 339
05/01/2017 Authors: Gerber DE; Urbanic JJ; Langer C; Hu C; Chang I-F; Lu B; Movsas B; Jeraj R; Curran WJ; Bradley JD
NRG oncology/NSABP B-51/RTOG 1304: A phase III superiority clinical trial designed to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes and convert to ypN0 after neoadjuvant chemotherapy (NC)
Volume: 77
02/01/2017 Authors: Mamounas EP; Bandos H; White JR; Julian TB; Khan AJ; Shaitelman SF; Torres MA; Vicini FA; Ganz PA; McCloskey SA
Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis.
J Neurooncol Volume: 131 Page(s): 611 - 618
02/01/2017 Authors: Patel KR; Burri SH; Boselli D; Symanowski JT; Asher AL; Sumrall A; Fraser RW; Press RH; Zhong J; Cassidy RJ
A Patch-based CBCT Scatter Artifact Correction Using Prior CT.
Volume: 10132
02/01/2017 Authors: Yang X; Liu T; Dong X; Tang X; Elder E; Curran WJ; Dhabaan A
Pseudo CT Estimation from MRI Using Patch-based Random Forest.
Volume: 10133
02/01/2017 Authors: Yang X; Lei Y; Shu H-K; Rossi P; Mao H; Shim H; Curran WJ; Liu T
Lung cancer: current therapies and new targeted treatments.
Lancet Volume: 389 Page(s): 299 - 311
01/21/2017 Authors: Hirsch FR; Scagliotti GV; Mulshine JL; Kwon R; Curran WJ; Wu Y-L; Paz-Ares L
Ultrasound 2D strain measurement for arm lymphedema using deformable registration: A feasibility study.
PLoS One Volume: 12 Page(s): e0181250
01/01/2017 Authors: Yang X; Torres M; Kirkpatrick S; Curran WJ; Liu T
Postoperative stereotactic radiosurgery for resected brain metastases: A comparison of outcomes for large resection cavities.
Pract Radiat Oncol Volume: 7 Page(s): e419 - e425
01/01/2017 Authors: Zhong J; Ferris MJ; Switchenko J; Press RH; Buchwald Z; Olson JJ; Eaton BR; Curran WJ; Shu H-KG; Crocker IR
Guideline Concordant Care is Associated with Better Survival for Patients with Stage III Non-Small Cell Lung Cancer
Volume: 12 Page(s): S855 - S856
01/01/2017 Authors: Ahmed H; Liu Y; O'Conne K; Gillespie T; Ahmed M; Pate P; Pillai R; Behera M; Steuer C; Owonikoko T
Trends, Patterns of Treatment and Outcomes in Non-Small Cell Lung Cancer (NSCLC) as a Second Primary: A National Cancer Data Base (NCDB) Analysis
Volume: 12 Page(s): S470 - S470
01/01/2017 Authors: Behera M; Gillespie T; Liu Y; Jia Y; Higgins K; Steuer C; Saba N; Shin D; Pakkala S; Pillai R
A Pooled Analysis Comparing the Outcomes of Elderly to Younger Patients on NCTN Trials of Concurrent CCRT for Stage 3 NSCLC
Volume: 12 Page(s): S374 - S375
01/01/2017 Authors: Stinchcombe T; Zhang Y; Vokes E; Schiller J; Bradley J; Kelly K; Curran W; Schild S; Movsas B; Clamon G
Improved prostate delineation in prostate HDR brachytherapy with TRUS-CT deformable registration technology: A pilot study with MRI validation.
J Appl Clin Med Phys Volume: 18 Page(s): 202 - 210
01/01/2017 Authors: Yang X; Rossi PJ; Jani AB; Mao H; Zhou Z; Curran WJ; Liu T
Adaptive Estimation of Personalized Maximum Tolerated Dose in Cancer Phase I Clinical Trials Based on All Toxicities and Individual Genomic Profile.
PLoS One Volume: 12 Page(s): e0170187
01/01/2017 Authors: Chen Z; Li Z; Zhuang R; Yuan Y; Kutner M; Owonikoko T; Curran WJ; Kowalski J
National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer.
Int J Radiat Oncol Biol Phys Volume: 97 Page(s): 128 - 137
01/01/2017 Authors: Higgins KA; O'Connell K; Liu Y; Gillespie TW; McDonald MW; Pillai RN; Patel KR; Patel PR; Robinson CG; Simone CB
Overview of Thoracic Oncology Trials in Cooperative Groups Around the Globe.
Clin Lung Cancer Volume: 18 Page(s): 5 - 12
01/01/2017 Authors: Salahudeen AA; Patel MI; Baas P; Curran WJ; Bradley JD; Gandara DR; Goss GD; Mok TS; Ramalingam SS; Vokes EE
Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth.
Mol Cell Volume: 64 Page(s): 859 - 874
12/01/2016 Authors: Fan J; Lin R; Xia S; Chen D; Elf SE; Liu S; Pan Y; Xu H; Qian Z; Wang M
Multiparametric Magnetic Resonance Imaging Guided Radiation Therapy for Prostate Cancer Using Learning-Based Magnetic Resonance Imaging-Computed Tomography Registration
Volume: 96 Page(s): E601 - E601
10/01/2016 Authors: Yang X; Jani A; Rossi PJ; Mao H; Curran WJ; Liu T
Computed Tomographic Texture Associations With Histology and Outcomes Following Lung Stereotactic Body Radiation Therapy
Volume: 96 Page(s): E475 - E475
10/01/2016 Authors: Patel PR; Schreibmann E; Sutter AI; Whitaker D; Switchenko J; Curran WJ; Higgins KA
Better Overall Survival with Advanced Radiation Treatment Modalities in Stage II and III Non-Small Cell Lung Cancer (NSCLC): A National Cancer Data Base Analysis
Volume: 96 Page(s): E438 - E439
10/01/2016 Authors: Higgins KA; O'Connell K; Liu Y; Patel PR; Pillai RN; Owonikoko TK; Simone CB; Robinson CG; McDonald MW; Gillespie TW
Lung Stereotactic Body Radiation Therapy (SBRT) Versus Pneumonectomy in Patients With Non-Small Cell Lung Cancer (NSCLC) Ages 70 or Older
Volume: 96 Page(s): E468 - E468
10/01/2016 Authors: Higgins KA; Jia Y; Liu Y; Force S; Fernandez F; Ramalingam S; Behera M; Owonikoko TK; Pillai RN; Simone CB
External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole-Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases
Volume: 96 Page(s): E122 - E122
10/01/2016 Authors: Press RH; Burri SH; Boselli D; Symanowski J; Patel K; Lankford S; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola C
Multiparametric Magnetic Resonance Imaging Guided Radiation Therapy for Prostate Cancer Using Learning-Based Magnetic Resonance Imaging-Computed Tomography Registration
Volume: 96 Page(s): E601 - E601
10/01/2016 Authors: Yang X; Jani A; Rossi PJ; Mao H; Curran WJ; Liu T
Computed Tomographic Texture Associations With Histology and Outcomes Following Lung Stereotactic Body Radiation Therapy
Volume: 96 Page(s): E475 - E475
10/01/2016 Authors: Patel PR; Schreibmann E; Sutter AI; Whitaker D; Switchenko J; Curran WJ; Higgins KA
Better Overall Survival with Advanced Radiation Treatment Modalities in Stage II and III Non-Small Cell Lung Cancer (NSCLC): A National Cancer Data Base Analysis
Volume: 96 Page(s): E438 - E439
10/01/2016 Authors: Higgins KA; O'Connell K; Liu Y; Patel PR; Pillai RN; Owonikoko TK; Simone CB; Robinson CG; McDonald MW; Gillespie TW
Lung Stereotactic Body Radiation Therapy (SBRT) Versus Pneumonectomy in Patients With Non-Small Cell Lung Cancer (NSCLC) Ages 70 or Older
Volume: 96 Page(s): E468 - E468
10/01/2016 Authors: Higgins KA; Jia Y; Liu Y; Force S; Fernandez F; Ramalingam S; Behera M; Owonikoko TK; Pillai RN; Simone CB
External Validity of a Risk Stratification Score Predicting Early Distant Brain Failure and Salvage Whole-Brain Radiation Therapy After Stereotactic Radiosurgery for Brain Metastases.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E122
10/01/2016 Authors: Press RH; Burri SH; Boselli D; Symanowski J; Patel K; Lankford S; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola C
Multiparametric Magnetic Resonance Imaging Guided Radiation Therapy for Prostate Cancer Using Learning-Based Magnetic Resonance Imaging-Computed Tomography Registration.
Volume: 96 Page(s): E601
10/01/2016 Authors: Yang X; Jani A; Rossi PJ; Mao H; Curran WJ; Liu T
Comparing Preoperative Stereotactic Radiosurgery (SRS) to Postoperative Whole-Brain Radiation Therapy (WBRT) for Resectable Brain Metastases: A Multi-Institutional Analysis.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E85 - E86
10/01/2016 Authors: Patel K; Burri SH; Symanowski J; Boselli D; Sumrall A; Press RH; Fraser RW; Zhong J; Olson JJ; Curran WJ
Computed Tomographic Texture Associations With Histology and Outcomes Following Lung Stereotactic Body Radiation Therapy.
Volume: 96 Page(s): E475
10/01/2016 Authors: Patel PR; Schreibmann E; Sutter AI; Whitaker D; Switchenko J; Curran WJ; Higgins KA
Better Overall Survival with Advanced Radiation Treatment Modalities in Stage II and III Non-Small Cell Lung Cancer (NSCLC): A National Cancer Data Base Analysis.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E438 - E439
10/01/2016 Authors: Higgins KA; O'Connell K; Liu Y; Patel PR; Pillai RN; Owonikoko TK; Simone CB; Robinson CG; McDonald MW; Gillespie TW
Lung Stereotactic Body Radiation Therapy (SBRT) Versus Pneumonectomy in Patients With Non-Small Cell Lung Cancer (NSCLC) Ages 70 or Older.
Int J Radiat Oncol Biol Phys Volume: 96 Page(s): E468
10/01/2016 Authors: Higgins KA; Jia Y; Liu Y; Force S; Fernandez F; Ramalingam S; Behera M; Owonikoko TK; Pillai RN; Simone CB
Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non-Small-Cell Lung Cancer: Results From the National CancerData Base.
Clin Lung Cancer Volume: 17 Page(s): 398 - 405
09/01/2016 Authors: Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Ramalingam S; Mikell J; Lipscomb J; Curran WJ; Higgins KA
Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.
J Natl Cancer Inst Volume: 108
09/01/2016 Authors: Eaton BR; Pugh SL; Bradley JD; Masters G; Kavadi VS; Narayan S; Nedzi L; Robinson C; Wynn RB; Koprowski C
Radiation plus Chemotherapy in Low-Grade Glioma.
N Engl J Med Volume: 375 Page(s): 490 - 491
08/04/2016 Authors: Buckner JC; Chakravarti A; Curran WJ
Comparing Preoperative With Postoperative Stereotactic Radiosurgery for Resectable Brain Metastases: A Multi-institutional Analysis.
Neurosurgery Volume: 79 Page(s): 279 - 285
08/01/2016 Authors: Patel KR; Burri SH; Asher AL; Crocker IR; Fraser RW; Zhang C; Chen Z; Kandula S; Zhong J; Press RH
WE-AB-207A-07: A Planning CT-Guided Scatter Artifact Correction Method for CBCT Images.
Volume: 43 Page(s): 3799
06/01/2016 Authors: Yang X; Liu T; Dong X; Elder E; Curran W; Dhabaan A
TH-CD-206-09: Learning-Based MRI-CT Prostate Registration Using Spare Patch-Deformation Dictionary.
Volume: 43 Page(s): 3884 - 3885
06/01/2016 Authors: Yang X; Jani A; Rossi P; Mao H; Curran W; Liu T
TH-CD-206-02: BEST IN PHYSICS (IMAGING): 3D Prostate Segmentation in MR Images Using Patch-Based Anatomical Signature.
Volume: 43 Page(s): 3883
06/01/2016 Authors: Yang X; Jani A; Rossi P; Mao H; Curran W; Liu T
Changing Landscape of Radiotherapy for Melanoma Brain Metastases, in Light of Newer Targeted Agents and Immune Checkpoint Inhibitors.
J Oncol Pract Volume: 12 Page(s): 543 - 544
06/01/2016 Authors: Khan MK; Curran WJ
National Cancer Data Base analysis of proton versus photon radiotherapy in non-small cell lung cancer(NSCLC).
Volume: 34
05/20/2016 Authors: Behera M; OConnell KA; Liu Y; Gillespie TW; Pillai RN; Patel P; Simone CB; Robinson CG; Owonikoko TK; Belani CP
Non-small cell lung cancer (NSCLC) as a second primary: Analysis of the National Cancer Data Base (NCDB).
Volume: 34
05/20/2016 Authors: Behera M; Gillespie TW; Liu Y; Jia Y; Higgins KA; Steuer CE; Saba NF; Shin DM; Pakkala S; Pillai RN
A pooled analysis of concurrent chemoradiotherapy (CCRT) for patients with stage III non-small cell lung cancer (NSCLC) who participated in US cooperative group trials: Comparing the outcomes of elderly to younger patients (pts).
Volume: 34
05/20/2016 Authors: Stinchcombe T; Zhang YJ; Vokes EE; Schiller JH; Bradley JD; Curran WJ; Movsas B; Schild SE; Clamon GH; Govindan R
NRG Oncology/NSABP B-51/RTOG 1304: Phase III trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) reduces invasive breast cancer recurrence free interval (IBCRFI) in patients (pts) with positive axillary (PAx) nodes who are ypN0 after neoadjuvant chemotherapy (NC).
Volume: 34
05/20/2016 Authors: Mamounas EP; Bandos H; White JR; Julian TB; Khan AJ; Shaitelman SF; Torres MA; Vicini F; Ganz PA; McCloskey SA
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.
N Engl J Med Volume: 374 Page(s): 1344 - 1355
04/07/2016 Authors: Buckner JC; Shaw EG; Pugh SL; Chakravarti A; Gilbert MR; Barger GR; Coons S; Ricci P; Bullard D; Brown PD
Angiotensin Blockade Reduces Quantitative and Qualitative Radiation-Induced Neck Fibrosis: Interim Analysis of Prospective Trial
Volume: 94 Page(s): 956 - 957
03/15/2016 Authors: Okwan-Duodu D; Yang X; Yu DS; Patel K; Switchenko J; Beitler JJ; Curran WJ; Liu T
Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
JAMA Oncol Volume: 2 Page(s): 359 - 367
03/01/2016 Authors: Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW
NRG Oncology/NSABP B-51/RTOG 1304: A phase Ill clinical trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypNO after neoadjuvant chemotherapy (NC)
Volume: 76
02/15/2016 Authors: Mamounas EP; Bandos H; White JR; Julian TB; Khan AJ; Shaitelman SF; Torres MA; Vicini FA; Ganz PA; McCloskey SA
NRG Oncology/NSABP B-51/RTOG 1304: A phase Ill clinical trial to determine if chest wall and regional nodal radiotherapy (CWRNRT) post mastectomy (Mx) or the addition of RNRT to breast RT post breast-conserving surgery (BCS) will reduce invasive cancer events in patients (pts) with positive axillary (Ax) nodes who are ypNO after neoadjuvant chemotherapy (NC)
Volume: 76
02/15/2016 Authors: Mamounas EP; Bandos H; White JR; Julian TB; Khan AJ; Shaitelman SF; Torres MA; Vicini FA; Ganz PA; McCloskey SA
Progesterone to improve neurocognitive outcomes following cranial irradiation.
Volume: 34 Page(s): 128
01/20/2016 Authors: Atif F; Yu DS; Yousuf S; Bruner D; Curran WJ; Stein DG
Patch-Based Label Fusion for Automatic Multi-Atlas-Based Prostate Segmentation in MR Images.
Volume: 9786
01/01/2016 Authors: Yang X; Jani AB; Rossi PJ; Mao H; Curran WJ; Liu T
3D Transrectal Ultrasound (TRUS) Prostate Segmentation Based on Optimal Feature Learning Framework.
Volume: 9784
01/01/2016 Authors: Yang X; Rossi PJ; Jani AB; Mao H; Curran WJ; Liu T
Seeking New Approaches to Patients With Small Cell Lung Cancer.
Am Soc Clin Oncol Educ Book Volume: 35 Page(s): e477 - e482
01/01/2016 Authors: Pietanza MC; Zimmerman S; Peters S; Curran WJ
Stereotactic body radiation therapy versus no treatment for early stage non-small cell lung cancer in medically inoperable elderly patients: A National Cancer Data Base analysis.
Cancer Volume: 121 Page(s): 4222 - 4230
12/01/2015 Authors: Nanda RH; Liu Y; Gillespie TW; Mikell JL; Ramalingam SS; Fernandez FG; Curran WJ; Lipscomb J; Higgins KA
Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance).
Neurooncol Pract Volume: 2 Page(s): 199 - 204
12/01/2015 Authors: Brown PD; Anderson SK; Carrero XW; O'Neill BP; Giannini C; Galanis E; Shah SA; Abrams RA; Curran WJ; Buckner JC
Evaluation of the Prognostic Performance of a 12-gene Glioblastoma Signature Among Low-Grade Glioma Patients in the Cancer Genome Atlas Database
Volume: 93 Page(s): S140 - S140
11/01/2015 Authors: Huff B; Crocker IR; Curran WJ; Shu HKG
Intensity Modulated Radiation Therapy is Associated With Improved Survival in Non-Small Cell Lung Cancer With Advanced T Stage: Results From the National Cancer Data Base
Volume: 93 Page(s): S163 - S163
11/01/2015 Authors: Jegadeesh N; Liu Y; Gillespie T; Fernandez F; Suresh R; Mikell JL; Lipscomb J; Curran WJ; Higgins KA
Bevacizumab Use in Patients With Subtotal Resection of Newly Diagnosed Glioblastoma (GBM): A Secondary Analysis of NRG Oncology/RTOG 0825
Volume: 93 Page(s): S110 - S110
11/01/2015 Authors: Hall WA; Pugh SL; Gilbert MR; Wefel JS; Armstrong T; Wendland MM; Brachman DG; Roof KS; Brown PD; Crocker IR
An Update of the Credentialing Process for the NRG Oncology NSABP B-51 / RTOG 1304 Phase 3 Randomized Clinical Trial
Volume: 93 Page(s): E570 - E570
11/01/2015 Authors: Leif JL; Nguyen H; Tailor AT; Galvin JM; Followill DS; Kiniry D; Julian TB; Mamounas E; White JR; Khan AJ
Comparing Preoperative Stereotactic Radiosurgery (SRS) to Postoperative SRS for Resectable Brain Metastases
Volume: 93 Page(s): S38 - S39
11/01/2015 Authors: Patel K; Asher A; Burri SH; Fraser RW; Kandula S; Press RH; Chen Z; Zhang C; Hadjipanayis CG; Olson J
BRCA1 Protein Expression Predicts Survival in Glioblastoma Multiforme (GBM) Patients From a RTOG Cohort
Volume: 93 Page(s): S141 - S141
11/01/2015 Authors: Vassilakopoulou M; Won M; Curran WJ; Souhami L; Prados M; Langer C; Rimm D; Hanna JA; Neumeister VN; Melian E
Impact of Angiotensin Blockade on Symptomatic Radiation Necrosis Following Stereotactic Radiosurgery
Volume: 93 Page(s): E360 - E360
11/01/2015 Authors: Okwan-Duodu D; Patel K; Zhong J; Prabhu RS; Eaton BR; Olson J; Shu HKG; Curran WJ; Crocker IR
Novel risk stratification score for predicting early distant brain failure and salvage whole-brain radiotherapy after stereotactic radiosurgery for brain metastases.
Cancer Volume: 121 Page(s): 3836 - 3843
11/01/2015 Authors: Press RH; Prabhu RS; Nickleach DC; Liu Y; Shu H-KG; Kandula S; Patel KR; Curran WJ; Crocker I
Cartographic Mapping and Travel Burden to Assess and Develop Strategies to Improve Minority Access to National Cancer Clinical Trials.
Int J Radiat Oncol Biol Phys Volume: 93 Page(s): 702 - 709
11/01/2015 Authors: Bruner DW; Pugh SL; Yeager KA; Bruner J; Curran W
Progress and Infrastructure for Improved Patient Outcomes of the National Cancer Institute Network Groups.
Semin Oncol Volume: 42 Page(s): 679 - 680
10/01/2015 Authors: Blanke CD; Curran WJ
Automated population-based planning for whole brain radiation therapy.
Volume: 16 Page(s): 76 - 86
09/08/2015 Authors: Schreibmann E; Fox T; Curran W; Shu H-K; Crocker I
Stereotactic Body Radiation vs. Observation for Early-Stage NSCLC in Elderly Patients
JOURNAL OF THORACIC ONCOLOGY Volume: 10 Page(s): S326 - S326
09/01/2015 Authors: Nanda RH; Gillespie TW; Mikell JL; Liu Y; Libscomb J; Ramalingam SS; Fernandez F; Curran WJ; Higgins KA
A Systematic Review of Carboplatin-Paclitaxel versus Cisplatin-Etoposide Concurrent with Thoracic Radiation for Stage III NSCLC Patients
JOURNAL OF THORACIC ONCOLOGY Volume: 10 Page(s): S212 - S212
09/01/2015 Authors: Steuer C; Behera M; Higgins KA; Saba N; Shin D; Pakkala S; Pillai R; Owonikoko TK; Curran WJ; Belani CP
Automated population-based planning for whole brain radiation therapy.
J Appl Clin Med Phys Volume: 16 Page(s): 76 - 86
09/01/2015 Authors: Schreibmann E; Fox T; Curran W; Shu H-K; Crocker I
Development of Bcl2 BH4 antagonist for cancer therapy
Volume: 75
08/01/2015 Authors: Han B; Park D; Li R; Xie M; Owonikoko T; Sica G; Ding C; Zhou J; Magis A; Ramalingam S
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs.
Mayo Clin Proc Volume: 90 Page(s): 996 - 1000
08/01/2015 Authors: Tefferi A; Kantarjian H; Rajkumar SV; Baker LH; Abkowitz JL; Adamson JW; Advani RH; Allison J; Antman KH; Bast RC
Dose escalation with over-dose and under-dose controls in Phase I/II clinical trials.
Contemp Clin Trials Volume: 43 Page(s): 133 - 141
07/01/2015 Authors: Chen Z; Yuan Y; Li Z; Kutner M; Owonikoko T; Curran WJ; Khuri F; Kowalski J
Variation over time and interdependence between disease progression and death among patients with glioblastoma on RTOG 0525.
Neuro Oncol Volume: 17 Page(s): 999 - 1006
07/01/2015 Authors: Wang M; Dignam JJ; Won M; Curran W; Mehta M; Gilbert MR
Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.
Cancer Cell Volume: 27 Page(s): 852 - 863
06/08/2015 Authors: Han B; Park D; Li R; Xie M; Owonikoko TK; Zhang G; Sica GL; Ding C; Zhou J; Magis AT
Radiotherapy patterns of care in gastric adenocarcinoma: a single institution experience.
J Gastrointest Oncol Volume: 6 Page(s): 247 - 253
06/01/2015 Authors: Cheng J; Squires MH; Mikell JL; Fisher SB; Staley CA; Kooby DA; El-Rayes BF; Curran WJ; Hall WA; Colbert LE
Ultrasound 2D Strain Measurement of Radiation-Induced Toxicity: Phantom and Ex Vivo Experiments
Volume: 42 Page(s): 3684 - 3684
06/01/2015 Authors: Liu T; Torres M; Rossi P; Jani A; Curran W; Yang X
Quantitative Ultrasonic Nakagami Imaging ofNeck Fibrosis After Head and Neck Radiation Therapy.
Int J Radiat Oncol Biol Phys Volume: 92 Page(s): 407 - 414
06/01/2015 Authors: Yang X; Yoshida E; Cassidy RJ; Beitler JJ; Yu DS; Curran WJ; Liu T
BEST IN PHYSICS (IMAGING): 3D Prostate Segmentation in Ultrasound Images Using Patch-Based Anatomical Feature
Volume: 42 Page(s): 3685 - 3685
06/01/2015 Authors: Yang X; Rossi P; Jani A; Ogunleye T; Curran W; Liu T
Trimodality therapy in the treatment of stage IIIA non-small cell lung cancer (NSCLC): Analysis of the National Cancer Database.
Volume: 33
05/20/2015 Authors: Behera M; Steuer CE; Fernandez F; Liu Y; Fu C; Gillespie TW; Higgins KA; Saba NF; Pillai RN; Force S
Utilization and outcomes of low dose versus high dose cisplatin in head and neck cancer patients receiving concurrent radiation.
Volume: 33
05/20/2015 Authors: Wong SJ; Li L; Hess LM; Chen AY; Curran WJ; Harari PM; Kimple RJ; Murphy BA; Opincar LLM; Garden AS
Erratum to: Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases.
J Neurooncol Volume: 123 Page(s): 113
05/01/2015 Authors: Eaton BR; LaRiviere MJ; Kim S; Prabhu RS; Patel K; Kandula S; Oyesiku N; Olson J; Curran W; Shu H-K
Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases.
J Neurooncol Volume: 123 Page(s): 103 - 111
05/01/2015 Authors: Eaton BR; LaRiviere MJ; Kim S; Prabhu RS; Patel K; Kandula S; Oyesiku N; Olson J; Curran W; Shu H-K
Bevacizumab-induced hypertension is a predictive marker for improved outcomes in patients with recurrent glioblastoma treated with bevacizumab.
Cancer Volume: 121 Page(s): 1456 - 1462
05/01/2015 Authors: Zhong J; Ali AN; Voloschin AD; Liu Y; Curran WJ; Crocker IR; Shu H-KG
Phase 1/2 trials of Temozolomide, Motexafin Gadolinium, and 60-Gy fractionated radiation for newly diagnosed supratentorial glioblastoma multiforme: final results of RTOG 0513.
Int J Radiat Oncol Biol Phys Volume: 91 Page(s): 961 - 967
04/01/2015 Authors: Brachman DG; Pugh SL; Ashby LS; Thomas TA; Dunbar EM; Narayan S; Robins HI; Bovi JA; Rockhill JK; Won M
Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study.
J Neurooncol Volume: 122 Page(s): 409 - 417
04/01/2015 Authors: Mehta MP; Wang D; Wang F; Kleinberg L; Brade A; Robins HI; Turaka A; Leahy T; Medina D; Xiong H
Postoperative radiotherapy is associated with better survival in non-small cell lung cancer with involved N2 lymph nodes: results of an analysis of the National Cancer Data Base.
J Thorac Oncol Volume: 10 Page(s): 462 - 471
03/01/2015 Authors: Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG
High nuclear hypoxia-inducible factor 1 alpha expression is a predictor of distant recurrence in patients with resected pancreatic adenocarcinoma.
Int J Radiat Oncol Biol Phys Volume: 91 Page(s): 631 - 639
03/01/2015 Authors: Colbert LE; Fisher SB; Balci S; Saka B; Chen Z; Kim S; El-Rayes BF; Adsay NV; Maithel SK; Landry JC
A 3D Neurovascular Bundles Segmentation Method based on MR-TRUS Deformable Registration.
Volume: 9413
02/01/2015 Authors: Yang X; Rossi P; Jani AB; Mao H; Ogunleye T; Curran WJ; Liu T
A MR-TRUS Registration Method for Ultrasound-Guided Prostate Interventions.
Volume: 9415
02/01/2015 Authors: Yang X; Rossi P; Mao H; Jani AB; Ogunleye T; Curran WJ; Liu T
Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
Lancet Oncol Volume: 16 Page(s): 187 - 199
02/01/2015 Authors: Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A
Definitive radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.
Pract Radiat Oncol Volume: 5 Page(s): 141 - 148
01/01/2015 Authors: Rodrigues G; Choy H; Bradley J; Rosenzweig KE; Bogart J; Curran WJ; Gore E; Langer C; Louie AV; Lutz S
Adjuvant radiation therapy in locally advanced non-small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline.
Pract Radiat Oncol Volume: 5 Page(s): 149 - 155
01/01/2015 Authors: Rodrigues G; Choy H; Bradley J; Rosenzweig KE; Bogart J; Curran WJ; Gore E; Langer C; Louie AV; Lutz S
Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone.
J Neurooncol Volume: 120 Page(s): 657 - 663
12/01/2014 Authors: Patel KR; Prabhu RS; Kandula S; Oliver DE; Kim S; Hadjipanayis C; Olson JJ; Oyesiku N; Curran WJ; Khan MK
Four-dimensional (4D) motion detection to correct respiratory effects in treatment response assessment using molecular imaging biomarkers.
Technol Cancer Res Treat Volume: 13 Page(s): 571 - 582
12/01/2014 Authors: Schreibmann E; Crocker I; Schuster DM; Curran WJ; Fox T
Automated segmentation of the parotid gland based on atlas registration and machine learning: a longitudinal MRI study in head-and-neck radiation therapy.
Int J Radiat Oncol Biol Phys Volume: 90 Page(s): 1225 - 1233
12/01/2014 Authors: Yang X; Wu N; Cheng G; Zhou Z; Yu DS; Beitler JJ; Curran WJ; Liu T
Low CHD5 expression activates the DNA damage response and predicts poor outcome in patients undergoing adjuvant therapy for resected pancreatic cancer.
Oncogene Volume: 33 Page(s): 5450 - 5456
11/20/2014 Authors: Hall WA; Petrova AV; Colbert LE; Hardy CW; Fisher SB; Saka B; Shelton JW; Warren MD; Pantazides BG; Gandhi K
Higher Dose of Palliative Thoracic Radiation Is Associated With Improved Survival for Patients With Stage IV Non-Small Cell Lung Cancer
Volume: 90 Page(s): S48 - S48
11/15/2014 Authors: Rajpara RS; Gillespie TW; Nickleach DC; Liu Y; Lipscomb J; Fernandez FG; Mikell JL; Ramalingam SS; Owonikoko TK; Pillai RN
A Comparison of Palliative Inpatient Management Strategies for Cancer-Related Superior Vena Cava Obstruction
Volume: 90 Page(s): S68 - S69
11/15/2014 Authors: Hall WA; Steuer CE; Nickleach DC; Behera M; Owonikoko TK; Higgins KA; Khuri FR; Curran WJ; Ramalingam SS
Postoperative Radiation Therapy (PORT) Is Associated With Better Survival in Non-Small Cell Lung Cancer With Involved N2 Lymph Nodes
Volume: 90 Page(s): S18 - S18
11/15/2014 Authors: Mikell JL; Gillespie TW; Hall WA; Nickleach DC; Liu Y; Lipscomb J; Ramalingam SS; Rajpara RS; Force SD; Fernandez FG
R9802: PHASE III STUDY OF RADIATION THERAPY (RT) WITH OR WITHOUT PROCARBAZINE, CCNU, AND VINCRISTINE (PCV) IN LOW-GRADE QLIOMA: RESULTS BY HISTOLOGIC TYPE
NEURO-ONCOLOGY Volume: 16
11/01/2014 Authors: Buckner J; Shaw E; Pugh S; Gilbert M; Barger G; Coons S; Ricci P; Bullard D; Brown P; Stelzer K
RTOG 0525 RECURSIVE PARTITIONING ANALYSIS BASED ON CLINICAL AND PROTEIN BIOMARKER PARAMETERS
NEURO-ONCOLOGY Volume: 16
11/01/2014 Authors: Bell EH; Pugh S; Gilbert M; Mehta M; Klimowicz A; Magliocco A; Bredel M; Robe P; Grosu A; Stupp R
Combining targeted agents with modern radiotherapy in soft tissue sarcomas.
J Natl Cancer Inst Volume: 106
11/01/2014 Authors: Wong P; Houghton P; Kirsch DG; Finkelstein SE; Monjazeb AM; Xu-Welliver M; Dicker AP; Ahmed M; Vikram B; Teicher BA
Clinical trials in thoracic radiation oncology: as easy as 1, 2, 3.
Int J Radiat Oncol Biol Phys Volume: 90 Page(s): 490 - 492
11/01/2014 Authors: Machtay M; Bradley JD; Curran WJ
Prostate CT segmentation method based on nonrigid registration in ultrasound-guided CT-based HDR prostate brachytherapy.
Med Phys Volume: 41 Page(s): 111915
11/01/2014 Authors: Yang X; Rossi P; Ogunleye T; Marcus DM; Jani AB; Mao H; Curran WJ; Liu T
BEVACIZUMAB-INDUCED HYPERTENSION IS A PREDICTIVE MARKER FOR IMPROVED OUTCOMES IN RECURRENT GLIOBLASTOMA
NEURO-ONCOLOGY Volume: 16
11/01/2014 Authors: Zhong J; Ali A; Voloschin A; Liu Y; Curran W; Crocker I; Shu H-K
Exercise-induced lung cancer regression: mechanistic findings from a mouse model.
Cancer Volume: 120 Page(s): 3302 - 3310
11/01/2014 Authors: Higgins KA; Park D; Lee GY; Curran WJ; Deng X
ASSOCIATION OF NEUROCOGNITIVE AND PATIENT REPORTED OUTCOMES WITH THE PRESENCE OF RESIDUAL DISEASE FOLLOWING SURGICAL RESECTION IN GLIOBLASTOMA (GBM)
NEURO-ONCOLOGY Volume: 16
11/01/2014 Authors: Hall WA; Pugh SL; Wefel JS; Armstrong TS; Gilbert MR; Brachman DG; Werner-Wasik M; Wendland M; Brown PD; Chao ST
Development of small molecule Bax agonists for lung cancer treatment
Volume: 74
10/01/2014 Authors: Xin M; Li R; Park D; Owonikoko TK; Sica GL; Corsino PE; Ding JZC; Magis AT; Ramalingam SS; Curran WJ
NRG Oncology research opportunities within the new National Clinical Trials Network.
Semin Oncol Volume: 41 Page(s): 553 - 555
10/01/2014 Authors: Curran WJ; DiSaia PJ; Wolmark N
A pilot study of hypofractionated stereotactic radiation therapy and sunitinib in previously irradiated patients with recurrent high-grade glioma.
Int J Radiat Oncol Biol Phys Volume: 90 Page(s): 369 - 375
10/01/2014 Authors: Wuthrick EJ; Curran WJ; Camphausen K; Lin A; Glass J; Evans J; Andrews DW; Axelrod R; Shi W; Werner-Wasik M
Diagnostic accuracy of ultrasonic histogram features to evaluate radiation toxicity of the parotid glands: a clinical study of xerostomia following head-and-neck cancer radiotherapy.
Acad Radiol Volume: 21 Page(s): 1304 - 1313
10/01/2014 Authors: Yang X; Tridandapani S; Beitler JJ; Yu DS; Chen Z; Kim S; Bruner DW; Curran WJ; Liu T
Small-molecule Bax agonists for cancer therapy.
Nat Commun Volume: 5 Page(s): 4935
09/17/2014 Authors: Xin M; Li R; Xie M; Park D; Owonikoko TK; Sica GL; Corsino PE; Zhou J; Ding C; White MA
Automated Population-Based Planning for Whole Brain Radiation Therapy
Volume: 90 Page(s): S324 - S324
09/01/2014 Authors: Schreibmann E; Fox T; Curran W; Shu H; Crocker I
The Credentialing Process for the NSABP B-51/RTOG 1304 Phase 3 Randomized Clinical Trial
Volume: 90 Page(s): S940 - S940
09/01/2014 Authors: Leif J; Nguyen H; Hollan A; Followil D; Galvin J; Kiniry D; Julian TB; Mamounas EP; White J; Kahn AJ
Patterns of presentation and failure in patients with gliomatosis cerebri treated with partial-brain radiation therapy.
Cancer Volume: 120 Page(s): 2713 - 2720
09/01/2014 Authors: Kandula S; Saindane AM; Prabhu RS; Hanasoge S; Patel KR; Shu H-K; Curran WJ; Crocker IR
Identification of a 12-gene Expression Signature from the Cancer Genome Atlas Prognostic for Survival in Glioblastoma
Volume: 90 Page(s): S38 - S39
09/01/2014 Authors: Huff B; Switchenko J; Dwivedi B; Curran WJ; Crocker I; Shu HK
Single Fraction Radiosurgery Versus Hypofractionated Radiosurgery for the Treatment of Resected Large Brain Metastases: A Comparison of Complications and Local Tumor Control
Volume: 90 Page(s): S324 - S325
09/01/2014 Authors: Eaton BR; Patel K; Prabhu RS; Kandula S; Curran WJ; Shu H; Crocker I
Ultrasound Texture Features as Potential Early Imaging Biomarkers for Normal-Tissue Toxicity in Breast Cancer Radiation Therapy
Volume: 90 Page(s): S242 - S243
09/01/2014 Authors: Yang X; Torres M; Curran WJ; Liu T
Mature Survival Data from RTOG 9802: A Phase III Study of Radiation Therapy (RT) With or Without Procarbazine, CCNU, and Vincristine (PCV) for Adult Patients with High-Risk Low-Grade Glioma (LGG)
Volume: 90 Page(s): S37 - S38
09/01/2014 Authors: Mehta MP; Won M; Shaw EG; Buckner J; Gilbert M; Barger G; Coons S; Ricci P; Bullard D; Brown PD
Inter- and Intraoperator Reproducibility of Cutaneous Toxicity Measurements Using Quantitative Ultrasound
Volume: 90 Page(s): S265 - S266
09/01/2014 Authors: Lee A; Johnson JA; Yang X; Torres MA; Curran WJ; Liu T
A Comparison of Palliative Inpatient Management Strategies for Cancer-Related Superior Vena Cava Obstruction
Volume: 90 Page(s): S80 - S81
09/01/2014 Authors: Hall WA; Steuer CE; Nickleach DC; Behera M; Owonikoko TK; Higgins KA; Khuri FR; Curran WJ; Ramalingam SS
A Phase 1 Study Examining a Stereotactic Boost in Combination With Chemoradiation for Patients With Stage III Non-Small Cell Lung Cancer
Volume: 90 Page(s): S626 - S627
09/01/2014 Authors: Higgins KA; Shelton JW; Landry JC; Beitler JJ; Curran WJ
Integration of MR Images Into Ultrasound for 3D Doppler Imaging of the Neurovascular Bundle in Prostate Radiation Therapy: A Pilot Study
Volume: 90 Page(s): S440 - S440
09/01/2014 Authors: Yang X; Rossi PJ; Ogunleye TB; Wang Y; Curran WJ; Liu T
The Use of MRI for GTV Delineation in Borderline and Locally Advanced Pancreatic Cancer Increases Local Control in Patients Treated With Intensity Modulated Radiation Therapy
Volume: 90 Page(s): S354 - S355
09/01/2014 Authors: Colbert L; Hall WA; Mosley C; Seldon C; Mittal P; Switchenko J; Mikell J; Mavraj G; Yu DS; Landry JC
Radiation Therapy Patterns of Care in Gastric Adenocarcinoma: A Single-Institution Experience
Volume: 90 Page(s): S352 - S352
09/01/2014 Authors: Cheng J; Squires MH; Mikell JL; Fisher SB; Hall WA; Colbert LE; Shelton JW; Staley CA; Kooby DA; El-Reyes BF
Comparison of Linear Accelerator (Linac) and Cobalt-60 Based SRS Dosimetric Indices in the Radiosurgical Treatment of Cerebral AVM Patients
Volume: 90 Page(s): S910 - S910
09/01/2014 Authors: Ogunleye TB; Rahnema SN; Crocker IR; Curran WJ; Marchan EM; Rossi PJ
Clinical Predictors of Distant Brain Failure and Early Salvage Whole Brain Radiation Therapy After LINAC-Based Stereotactic Radiosurgery for Brain Metastases
Volume: 90 Page(s): S330 - S331
09/01/2014 Authors: Press RH; Prabhu RS; Nickleach D; Liu Y; Shu H; Curran WJ; Crocker IR
Nuclear Hypoxia-Inducible Factor 1 Alpha is a Predictor of Distant Failure in Patients With Resected Pancreatic Adenocarcinoma
Volume: 90 Page(s): S49 - S49
09/01/2014 Authors: Colbert L; Fisher SB; Balci S; Chen Z; Kim S; Adsay NV; Maithel SK; El-Rayes BF; Landry JC; Curran WJ
Locoregional tumor failure after definitive radiation for patients with stage III non-small cell lung cancer.
Radiat Oncol Volume: 9 Page(s): 187
08/26/2014 Authors: Rajpara RS; Schreibmann E; Fox T; Stapleford LJ; Beitler JJ; Curran WJ; Higgins KA
EGFR expression and survival in patients given cetuximab and chemoradiation for stage III non-small cell lung cancer: a secondary analysis of RTOG 0324.
Radiother Oncol Volume: 112 Page(s): 30 - 36
07/01/2014 Authors: Komaki R; Paulus R; Blumenschein GR; Curran WJ; Robert F; Thariat J; Werner-Wasik M; Choy H; Hirsch FR; Ang KK
Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis.
Cell Death Differ Volume: 21 Page(s): 1160 - 1169
07/01/2014 Authors: Wang B; Xie M; Li R; Owonikoko TK; Ramalingam SS; Khuri FR; Curran WJ; Wang Y; Deng X
TH-E-BRF-09: Gaussian Mixture Model Analysis of Radiation-Induced Parotid-Gland Injury: An Ultrasound Study of Acute and Late Xerostomia in Head-And-Neck Radiotherapy.
Volume: 41 Page(s): 571
06/01/2014 Authors: Liu T; Yu D; Beitler J; Tridandapani S; Bruner D; Curran W; Yang X
SU-E-T-513: Probabilistic Approach to Plan Evaluation in Linac-Based Stereotactic Radiosurgery: A Patient Specific Uncertainty Analysis.
Volume: 41 Page(s): 345
06/01/2014 Authors: Park P; Roper J; Fox T; Schreibmann E; Elder E; Tejani M; Curran W; Crocker I; Dhabaan A
TH-C-BRD-06: A Novel MRI Based CT Artifact Correction Method for Improving Proton Range Calculation in the Presence of Severe CT Artifacts.
Volume: 41 Page(s): 551
06/01/2014 Authors: Park P; Schreibmann E; Fox T; Roper J; Elder E; Tejani M; Crocker I; Curran W; Dhabaan A
TH-A-BRF-09: Integration of High-Resolution MRSI Into Glioblastoma Treatment Planning.
Volume: 41 Page(s): 538
06/01/2014 Authors: Schreibmann E; Cordova J; Shu H; Crocker I; Curran W; Holder C; Shim H
TU-F-12A-09: GLCM Texture Analysis for Normal-Tissue Toxicity: A Prospective Ultrasound Study of Acute Toxicity in Breast-Cancer Radiotherapy.
Volume: 41 Page(s): 482
06/01/2014 Authors: Liu T; Yang X; Curran W; Torres M
TU-F-BRF-02: MR-US Prostate Registration Using Patient-Specific Tissue Elasticity Property Prior for MR-Targeted, TRUS-Guided HDR Brachytherapy.
Volume: 41 Page(s): 470 - 471
06/01/2014 Authors: Yang X; Rossi P; Ogunleye T; Jani A; Curran W; Liu T
SU-D-9A-06: 3D Localization of Neurovascular Bundles Through MR-TRUS Registration in Prostate Radiotherapy.
Volume: 41 Page(s): 123
06/01/2014 Authors: Yang X; Rossi P; Ogunleye T; Jani A; Curran W; Liu T
3D Localization of Neurovascular Bundles Through MR-TRUS Registration in Prostate Radiotherapy
Volume: 41 Page(s): 123 - 123
06/01/2014 Authors: Yang X; Rossi P; Ogunleye T; Jani A; Curran W; Liu T
The effect of institutional clinical trial enrollment volume on survival of patients with stage III non-small cell lung cancer treated with chemoradiation: A report of the Radiation Therapy Oncology Group (RTOG) 0617.
Volume: 32
05/20/2014 Authors: Eaton BR; Pugh SL; Bradley JD; Kavadi V; Narayan S; Nedzi LA; Robinson CG; Deutsch M; Koprowski CD; Johnson DW
NSABP B-51/RTOG 1304: Randomized phase III clinical trial evaluating the role of postmastectomy chest wall and regional nodal XRT (CWRNRT) and post-lumpectomy RNRT in patients (pts) with documented positive axillary (Ax) nodes before neoadjuvant chemotherapy (NC) who convert to pathologically negative Ax nodes after NC.
Volume: 32
05/20/2014 Authors: Mamounas EP; White JR; Bandos H; Julian TB; Kahn AJ; Shaitelman SF; Torres MA; McCloskey SA; Vicini FA; Ganz PA
Reply to M.C. Chamberlain.
J Clin Oncol Volume: 32 Page(s): 1634 - 1635
05/20/2014 Authors: Gilbert MR; Dignam J; Pugh S; Armstrong TS; Wefel JS; Aldape K; Stupp R; Hegi M; Won M; Curran WJ
CHD7 expression predicts survival outcomes in patients with resected pancreatic cancer.
Cancer Res Volume: 74 Page(s): 2677 - 2687
05/15/2014 Authors: Colbert LE; Petrova AV; Fisher SB; Pantazides BG; Madden MZ; Hardy CW; Warren MD; Pan Y; Nagaraju GP; Liu EA
Identification of a tumor-suppressive human-specific microRNA within the FHIT tumor-suppressor gene.
Cancer Res Volume: 74 Page(s): 2283 - 2294
04/15/2014 Authors: Hu B; Ying X; Wang J; Piriyapongsa J; Jordan IK; Sheng J; Yu F; Zhao P; Li Y; Wang H
Outcomes and patterns of failure for grade 2 meningioma treated with reduced-margin intensity modulated radiation therapy.
Int J Radiat Oncol Biol Phys Volume: 88 Page(s): 1004 - 1010
04/01/2014 Authors: Press RH; Prabhu RS; Appin CL; Brat DJ; Shu H-KG; Hadjipanayis C; Olson JJ; Oyesiku NM; Curran WJ; Crocker I
Ultrasound 2D Strain Estimator Based on Image Registration for Ultrasound Elastography.
Volume: 9040
03/20/2014 Authors: Yang X; Torres M; Kirkpatrick S; Curran WJ; Liu T
Benefit from procarbazine, lomustine, and vincristine in oligodendroglial tumors is associated with mutation of IDH.
J Clin Oncol Volume: 32 Page(s): 783 - 790
03/10/2014 Authors: Cairncross JG; Wang M; Jenkins RB; Shaw EG; Giannini C; Brachman DG; Buckner JC; Fink KL; Souhami L; Laperriere NJ
A randomized trial of bevacizumab for newly diagnosed glioblastoma.
N Engl J Med Volume: 370 Page(s): 699 - 708
02/20/2014 Authors: Gilbert MR; Dignam JJ; Armstrong TS; Wefel JS; Blumenthal DT; Vogelbaum MA; Colman H; Chakravarti A; Pugh S; Won M
Ultrasonic Nakagami-parameter characterization of parotid-gland injury following head-and-neck radiotherapy: a feasibility study of late toxicity.
Med Phys Volume: 41 Page(s): 022903
02/01/2014 Authors: Yang X; Tridandapani S; Beitler JJ; Yu DS; Wu N; Wang Y; Bruner DW; Curran WJ; Liu T
Improved hippocampal dose with reduced margin radiotherapy for glioblastoma multiforme.
Radiat Oncol Volume: 9 Page(s): 20
01/10/2014 Authors: Ali AN; Ogunleye T; Hardy CW; Shu H-K; Curran WJ; Crocker IR
A New CT Prostate Segmentation for CT-Based HDR Brachytherapy.
Volume: 9036 Page(s): 90362K
01/01/2014 Authors: Yang X; Rossi P; Ogunleye T; Jani AB; Curran WJ; Liu T
Bcl2 induces DNA replication stress by inhibiting ribonucleotide reductase.
Cancer Res Volume: 74 Page(s): 212 - 223
01/01/2014 Authors: Xie M; Yen Y; Owonikoko TK; Ramalingam SS; Khuri FR; Curran WJ; Doetsch PW; Deng X
Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.
J Clin Oncol Volume: 31 Page(s): 4085 - 4091
11/10/2013 Authors: Gilbert MR; Wang M; Aldape KD; Stupp R; Hegi ME; Jaeckle KA; Armstrong TS; Wefel JS; Won M; Blumenthal DT
Automated skin segmentation in ultrasonic evaluation of skin toxicity in breast cancer radiotherapy.
Ultrasound Med Biol Volume: 39 Page(s): 2166 - 2175
11/01/2013 Authors: Gao Y; Tannenbaum A; Chen H; Torres M; Yoshida E; Yang X; Wang Y; Curran W; Liu T
Effect of prophylactic cranial irradiation on survival in elderly patients with limited-stage small cell lung cancer.
Cancer Volume: 119 Page(s): 3753 - 3760
11/01/2013 Authors: Eaton BR; Kim S; Marcus DM; Prabhu R; Chen Z; Ramalingam SS; Curran WJ; Higgins KA
EXERCISE INDUCED LUNG CANCER TUMOR GROWTH SUPPRESSION VIA ACTIVATION OF P53: MECHANISTIC FINDINGS FROM A MOUSE MODEL
JOURNAL OF THORACIC ONCOLOGY Volume: 8 Page(s): S277 - S277
11/01/2013 Authors: Higgins KA; Park D; Curran WJ; Deng X
AN INTERGROUP RANDOMIZED PHASE III COMPARISON OF STANDARD-DOSE (60 GY) VERSUS HIGH-DOSE (74 GY) CHEMORADIOTHERAPY (CRT) +/- CETUXIMAB (CETUX) FOR STAGE III NON-SMALL CELL LUNG CANCER (NSCLC): RESULTS ON CETUX FROM RTOG 0617
JOURNAL OF THORACIC ONCOLOGY Volume: 8 Page(s): S3 - S3
11/01/2013 Authors: Bradley J; Masters G; Hu C; Blumenschein G; Bogart J; Schild S; Michalski JM; Kavadi V; Garces YI; Narayan S
Integration of Intraoperative Ultrasound Volume Into CT-Based Treatment Planning in Prostate HDR Brachytherapy: A Pilot Study
Volume: 87 Page(s): S372 - S372
10/01/2013 Authors: Yang X; Rossi P; Ogunleye T; Curran WJ; Liu T
Postradiation Diffusion MRIs May Distinguish True Progression from Pseudoprogression in GBM Patients
Volume: 87 Page(s): S19 - S19
10/01/2013 Authors: Danish H; Schreibmann E; Holder C; Vincentelli C; Hao C; Curran W; Fox T; Crocker I; Shu HG
Quantitative Ultrasound Evaluation of Post-Radiation Therapy Sialadenitis and Fibrosis of the Parotid Glands in Patients Following Head-and-Neck Radiation Therapy
Volume: 87 Page(s): S459 - S459
10/01/2013 Authors: Yang X; Beitler JJ; Yu DS; Tridandapani S; Bruner DW; Curran WJ; Liu T
Dosimetric Evaluation of Single Versus Multi-isocenter Frameless Radiosurgery for Multiple Brain Metastases
Volume: 87 Page(s): S758 - S758
10/01/2013 Authors: Camarata AS; Siddiqi AS; Prabhu RS; Ogunleye T; Koontz-Raisig WG; Tejani M; Curran WJ; Crocker IR; Shu HG
Hypofractionated Breast Cancer Radiation Therapy Does Not Increase Cutaneous Toxicity: A Prospective Comparative Study Between Standard and Hypofractionated Radiation Therapy Using Quantitative Ultrasound Imaging
Volume: 87 Page(s): S48 - S48
10/01/2013 Authors: Yang X; Liu T; Curran WJ; Torres MA
Impact of FACBC PET in Imaging and GTV Design of Cerebral Gliomas
Volume: 87 Page(s): S250 - S250
10/01/2013 Authors: Marchan EM; Goodman MM; Schuster DM; Vakili J; Olson JJ; Hadjipanayis CG; Brat DJ; Curran WJ; Shu HG; Crocker IR
Intracranial Control for Adjuvant Whole Brain Radiation Therapy Versus Stereotactic Radiosurgery Alone for Resected Brain Metastases
Volume: 87 Page(s): S565 - S565
10/01/2013 Authors: Patel K; Prabhu R; Hadjipanayis C; Olson J; Oyesiku N; Curran W; Shu H; Crocker I
Increasing Pretreatment Tumor SUVmean Is Associated With Local Regional Failure After Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer
Volume: 87 Page(s): S525 - S526
10/01/2013 Authors: Rajpara RS; Wang X; Chen Z; Schreibmann E; Fox T; Stapleford LJ; Beitler JJ; Curran WJ; Higgins KA
Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.
Mol Cancer Ther Volume: 12 Page(s): 2200 - 2212
10/01/2013 Authors: Li R; Hu Z; Sun S-Y; Chen ZG; Owonikoko TK; Sica GL; Ramalingam SS; Curran WJ; Khuri FR; Deng X
Patterns of Failure for Grade 2/3 Meningioma Treated With Reduced Margin Intensity Modulated Radiation Therapy
Volume: 87 Page(s): S158 - S158
10/01/2013 Authors: Press RH; Prabhu RS; Appin CL; Brat DJ; Shu HG; Hadjipanayis C; Olson JJ; Oyesiku NM; Curran WJ; Crocker I
Acute Toxicity Can Be Used to Predict Late Toxicity in Breast-Cancer Radiation Therapy: A Prospective Longitudinal Study With Quantitative Ultrasound Imaging
Volume: 87 Page(s): S237 - S238
10/01/2013 Authors: Liu T; Yang X; Liu Y; Wang Y; Curran WJ; Torres MA
Consolidation chemotherapy after chemoradiation? Not the right answer to not the right question?
J Thorac Oncol Volume: 8 Page(s): 1116 - 1117
09/01/2013 Authors: Curran WJ
Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
Cancer Res Volume: 73 Page(s): 5485 - 5496
09/01/2013 Authors: Park D; Magis AT; Li R; Owonikoko TK; Sica GL; Sun S-Y; Ramalingam SS; Khuri FR; Curran WJ; Deng X
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma.
Cancer Volume: 119 Page(s): 3148 - 3155
09/01/2013 Authors: Colbert LE; Fisher SB; Hardy CW; Hall WA; Saka B; Shelton JW; Petrova AV; Warren MD; Pantazides BG; Gandhi K
Hypofractionated radiosurgery for intact or resected brain metastases: defining the optimal dose and fractionation.
Radiat Oncol Volume: 8 Page(s): 135
06/07/2013 Authors: Eaton BR; Gebhardt B; Prabhu R; Shu H-K; Curran WJ; Crocker I
WE-E-134-03: Ultrasonic Tissue Characterization of Parotid-Gland Injury Following Head-And-Neck Radiotherapy Using Nakagami-Parameter Imaging: A Feasibility Study.
Volume: 40 Page(s): 495
06/01/2013 Authors: Liu T; Yu D; Beitler J; Tridandapani S; Bruner D; Curran W; Yang X
TU-A-WAB-04: A Prospective Longitudinal Study with Ultrasound Nakagami Imaging to Evaluate the Relationship Between Acute and Late Normal-Tissue Toxicity in Breast-Cancer Radiotherapy.
Volume: 40 Page(s): 423
06/01/2013 Authors: Liu T; Yang X; Liu Y; Wang Y; Curran W; Torres M
WE-C-WAB-11: Improved the Accuracy of Prostate Delineation for Ultrasound-Guided CT-Based Treatment Planning in Prostate HDR Brachytherapy: A Pilot Study with MRI Validation.
Volume: 40 Page(s): 480
06/01/2013 Authors: Yang X; Rossi P; Ogunleye T; Curran W; Liu T
WE-C-116-04: Development of Automatic Segmentation Algorithm to Assess Parotid-Gland Volume Changes Following Radiotherapy for Head-And-Neck Malignancies: A Longitudinal Study.
Volume: 40 Page(s): 484
06/01/2013 Authors: Yang X; Cheng G; Wu N; Curran W; Liu T
Patterns of failure in advanced-stage diffuse large B-cell lymphoma (DLBCL) patients treated with R-CHOP chemotherapy and the emerging role of consolidative radiotherapy
Volume: 31
05/20/2013 Authors: Shi ZJ; Das S; Okwan-Duodu D; Esiashvili N; Flowers C; Jiang K; Chen Z; Wang X; Curran WJ; Khan MK
Clinical outcomes for a novel 6 degrees of freedom image guided localization method for frameless radiosurgery for intracranial brain metastases.
J Neurooncol Volume: 113 Page(s): 93 - 99
05/01/2013 Authors: Prabhu RS; Dhabaan A; Hall WA; Ogunleye T; Crocker I; Curran WJ; Shu H-KG
Development of small molecule BcI-XL inhibitors for treatment of lung cancer
Volume: 73
04/15/2013 Authors: Park D; Magis AT; Li R; Owonikoko TKK; Sica GL; Sun S-Y; Ramalingam SS; Khuri FR; Curran WJ; Deng X
RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.
Int J Radiat Oncol Biol Phys Volume: 85 Page(s): 1206 - 1211
04/01/2013 Authors: Chakravarti A; Wang M; Robins HI; Lautenschlaeger T; Curran WJ; Brachman DG; Schultz CJ; Choucair A; Dolled-Filhart M; Christiansen J
Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.
J Clin Oncol Volume: 31 Page(s): 337 - 343
01/20/2013 Authors: Cairncross G; Wang M; Shaw E; Jenkins R; Brachman D; Buckner J; Fink K; Souhami L; Laperriere N; Curran W
NCI-RTOG translational program strategic guidelines for the early-stage development of radiosensitizers.
J Natl Cancer Inst Volume: 105 Page(s): 11 - 24
01/02/2013 Authors: Lawrence YR; Vikram B; Dignam JJ; Chakravarti A; Machtay M; Freidlin B; Takebe N; Curran WJ; Bentzen SM; Okunieff P
Voxel clustering for quantifying PET-based treatment response assessment.
Med Phys Volume: 40 Page(s): 012401
01/01/2013 Authors: Schreibmann E; Waller AF; Crocker I; Curran W; Fox T
A phase II study of conventional radiation therapy and thalidomide for supratentorial, newly-diagnosed glioblastoma (RTOG 9806).
J Neurooncol Volume: 111 Page(s): 33 - 39
01/01/2013 Authors: Alexander BM; Wang M; Yung WKA; Fine HA; Donahue BA; Tremont IW; Richards RS; Kerlin KJ; Hartford AC; Curran WJ
Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.
PLoS One Volume: 8 Page(s): e74670
01/01/2013 Authors: Li R; You S; Hu Z; Chen ZG; Sica GL; Khuri FR; Curran WJ; Shin DM; Deng X
Fractionated stereotactic radiation therapy improves cranial neuropathies in patients with skull base meningiomas: a retrospective cohort study.
Radiat Oncol Volume: 7 Page(s): 225
12/28/2012 Authors: Shen X; Andrews DW; Sergott RC; Evans JJ; Curran WJ; Machtay M; Fragoso R; Eldredge H; Champ CE; Witek M
Head and neck carcinoma in the United States: first comprehensive report of the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN).
Cancer Volume: 118 Page(s): 5783 - 5792
12/01/2012 Authors: Ang KK; Chen A; Curran WJ; Garden AS; Harari PM; Murphy BA; Wong SJ; Bellm LA; Schwartz M; Newman J
c-Myc suppression of DNA double-strand break repair.
Neoplasia Volume: 14 Page(s): 1190 - 1202
12/01/2012 Authors: Li Z; Owonikoko TK; Sun S-Y; Ramalingam SS; Doetsch PW; Xiao Z-Q; Khuri FR; Curran WJ; Deng X
Six degrees of freedom CBCT-based positioning for intracranial targets treated with frameless stereotactic radiosurgery.
J Appl Clin Med Phys Volume: 13 Page(s): 3916
11/08/2012 Authors: Dhabaan A; Schreibmann E; Siddiqi A; Elder E; Fox T; Ogunleye T; Esiashvili N; Curran W; Crocker I; Shu H-K
Short Course Radiation Therapy for Acoustic Neuromas
Volume: 84 Page(s): S276 - S277
11/01/2012 Authors: Johnson A; Ali AN; Dhabbaan A; Jiang X; Shu H; Curran W; Crocker I
Comparing central nervous system (CNS) and extra-CNS hemangiopericytomas in the Surveillance, Epidemiology, and End Results program: analysis of 655 patients and review of current literature.
Cancer Volume: 118 Page(s): 5331 - 5338
11/01/2012 Authors: Hall WA; Ali AN; Gullett N; Crocker I; Landry JC; Shu H-K; Prabhu R; Curran W
A Revised RTOG Recursive Partitioning Analysis (RPA) Model for Gliobtastoma Based Upon Multiplatform Biomarker Profiles
Volume: 84 Page(s): S4 - S5
11/01/2012 Authors: Chakravarti A; Wang M; Aldape K; Sulman E; Bredel M; Hegi M; Gilbert M; Curran W; Werner-Wasik M; Mehta M
IDH Status Predicts Benefit From PCV With Radiation Therapy in Anaplastic Oligodendroglioma (RTOG 9402)
Volume: 84 Page(s): S5 - S5
11/01/2012 Authors: Cairncross G; Wang M; Jenkins R; Shaw E; Giannini C; Brachman D; Buckner J; Fink K; Mehta M; Curran W
Multileaf Collimator-based LINAC Radiosurgery for Arteriovenous Malformations
Volume: 84 Page(s): S296 - S297
11/01/2012 Authors: Marchan E; Hanfelt J; Oyesiku NM; Dhabban A; Hsieh S; Khan MK; Curran WJ; Shu HK; Crocker IR
Ultrasound Nakagami Imaging to Evaluate Neck Fibrosis Following Head and Neck Radiation Therapy: A Feasibility and Reproducibility Study
Volume: 84 Page(s): S31 - S31
11/01/2012 Authors: Yang X; Beitler JJ; Yu D; Tridandapani S; Curran WJ; Liu T
A Revised RTOG Recursive Partitioning Analysis (RPA) Model for Glioblastoma Based Upon Multi-Platform Biomarker Profiles
Volume: 48 Page(s): 134 - 134
11/01/2012 Authors: Chakravarti A; Wang M; Aldape K; Sulman E; Bredel M; Hegi M; Gilbert M; Curran W; Werner-Wasik M; Mehta M
Clinical Outcomes for a Novel 6 Degrees of Freedom Image Guided Immobilization and Localization Method for Frameless Radiosurgery for Brain Metastases
Volume: 84 Page(s): S294 - S294
11/01/2012 Authors: Prabhu RS; Dhabaan A; Crocker I; Hall W; Ogunleye T; Curran W; Shu HK
PHASE I STUDY OF VELIPARIB IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY IN PATIENTS WITH BRAIN METASTASES
Volume: 7 Page(s): S479 - S479
11/01/2012 Authors: Mehta M; Curran W; Wang D; Wang F; Kleinberg L; Brade A; Mostafa N; Qian J; Leahy T; Desai B
Ultrasound Histogram Assessment of Acute and Late Parotid Gland Injury Following Head-and-Neck Radiation Therapy
Volume: 84 Page(s): S500 - S500
11/01/2012 Authors: Yang X; Beitler JJ; Yu D; Tridandapani S; Curran WJ; Liu T
NCI-RTOG Translational-Program Strategic Guidelines for the Early Stage Development of Radiosensitizers
Volume: 84 Page(s): S708 - S708
11/01/2012 Authors: Lawrence Y; Vikram B; Dignam JJ; Chakravarti A; Freidlin B; Curran W; Bentzen SM; Okunieff P; Coleman CN
Automated Quality Assurance for IGRT-based Patient Positioning
Volume: 84 Page(s): S733 - S734
11/01/2012 Authors: Schreibmann E; Beitler J; Curran WJ; Fox T
Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases
Volume: 84 Page(s): S285 - S286
11/01/2012 Authors: Eaton BR; Gebhardt B; Prabhu R; Shu H; Curran W; Crocker I
Analyzing Locoregional Tumor Failure in Association With Pretreatment FDG PET Parameters and Radiation Dose Among Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
Volume: 84 Page(s): S582 - S583
11/01/2012 Authors: Rajpara RS; Schreibmann E; Fox T; Stapleford LJ; Beitler JJ; Curran WJ; Higgins KA
Phase I Safety and Pharmacokinetic (PK) Study of Veliparib in Combination With Whole Brain Radiation Therapy (WBRT) in Patients (pts) With Brain Metastases
Volume: 84 Page(s): S269 - S270
11/01/2012 Authors: Mehta MP; Curran WJ; Wang D; Wang F; Kleinberg L; Brade A; Mostafa N; Qian J; Leahy T; Desai B
A REVISED RECURSIVE PARTITIONING ANALYSIS MODEL FOR GLIOBLASTOMA BASED UPON MULTI-PLATFORM BIOMARKER PROFILES
Volume: 14 Page(s): 56 - 56
10/01/2012 Authors: Charkravarti A; Wang M; Aldape K; Sulman E; Bredel M; Hegi M; Gilbert M; Curran W; Werner-Wasik M; Mehta M
In reply to Zagar and Marks.
Int J Radiat Oncol Biol Phys Volume: 84 Page(s): 305 - 306
10/01/2012 Authors: Kong FMS; Ritter T; Quint D; Marsh L; Senan S; Gaspar L; Komaki R; Hurkmans C; Timmerman R; Choy H
Compliance with therapeutic guidelines in Radiation Therapy Oncology Group prospective gastrointestinal clinical trials.
Radiother Oncol Volume: 105 Page(s): 9 - 13
10/01/2012 Authors: Willett CG; Moughan J; O'Meara E; Galvin JM; Crane CH; Winter K; Manfredi D; Rich TA; Rabinovitch R; Lustig R
Analyzing Locoregional Tumor Failure in Association with Pre-treatment FDG PET Parameters and Radiation Dose among Patients with Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
Volume: 7 Page(s): S235 - S236
09/01/2012 Authors: Rajpara RS; Schreibmann E; Fox T; Stapleford LJ; Beitler JJ; Curran WJ; Higgins KA
PHASE 1 STUDY OF VELIPARIB WITH CONCURRENT WHOLE BRAIN RADIATION THERAPY (WBRT) IN PATIENTS (PTS) WITH BRAIN METASTASES (METS)
Volume: 23 Page(s): 148 - 149
09/01/2012 Authors: Mehta MP; Curran WJ; Wang D; Wang F; Kleinberg L; Brade A; Qian J; Leahy T; Desai B; Giranda VL
A Systematic Analysis Of High-dose Radiation In The Treatment Of Surgically Unresectable, Locally Advanced Non-small Cell Lung Cancer.
JOURNAL OF THORACIC ONCOLOGY Volume: 7 Page(s): S212 - S213
09/01/2012 Authors: Behera M; Beitler JJ; Bhimani C; Higgins K; Chen Z; Deng X; Curran WJ; Khuri FR; Ramalingam SS; Owonikoko TK
Parp Enzyme Inhibitor, Veliparib (ABT-888), Potentiates the Efficacy Of Chemotherapy And Radiation In Small Cell Lung Cancer (SCLC)
Volume: 7 Page(s): S278 - S278
09/01/2012 Authors: Owonikoko TK; Zhang G; Deng X; Li C; Beumer JH; Rossi MR; Ramalingam SS; Curran WJ; Sun S; Khuri FR
Ultrasound histogram assessment of parotid gland injury following head-and-neck radiotherapy: a feasibility study.
Ultrasound Med Biol Volume: 38 Page(s): 1514 - 1521
09/01/2012 Authors: Yang X; Tridandapani S; Beitler JJ; Yu DS; Yoshida EJ; Curran WJ; Liu T
Ultrasound GLCM texture analysis of radiation-induced parotid-gland injury in head-and-neck cancer radiotherapy: an in vivo study of late toxicity.
Med Phys Volume: 39 Page(s): 5732 - 5739
09/01/2012 Authors: Yang X; Tridandapani S; Beitler JJ; Yu DS; Yoshida EJ; Curran WJ; Liu T
Phase I trial using the proteasome inhibitor bortezomib and concurrent chemoradiotherapy for head-and-neck malignancies.
Int J Radiat Oncol Biol Phys Volume: 83 Page(s): 1192 - 1197
07/15/2012 Authors: Kubicek GJ; Axelrod RS; Machtay M; Ahn PH; Anne PR; Fogh S; Cognetti D; Myers TJ; Curran WJ; Dicker AP
Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.
Int J Radiat Oncol Biol Phys Volume: 83 Page(s): e531 - e536
07/15/2012 Authors: Komaki R; Paulus R; Ettinger DS; Videtic GMM; Bradley JD; Glisson BS; Langer CJ; Sause WT; Curran WJ; Choy H
Redesigning radiotherapy quality assurance: opportunities to develop an efficient, evidence-based system to support clinical trials--report of the National Cancer Institute Work Group on Radiotherapy Quality Assurance.
Int J Radiat Oncol Biol Phys Volume: 83 Page(s): 782 - 790
07/01/2012 Authors: Bekelman JE; Deye JA; Vikram B; Bentzen SM; Bruner D; Curran WJ; Dignam J; Efstathiou JA; FitzGerald TJ; Hurkmans C
PHASE 1 SAFETY AND PHARMACOKINETIC (PK) STUDY OF VELIPARIB IN COMBINATION WITH WHOLE BRAIN RADIATION THERAPY (WBRT) IN PATIENTS (PTS) WITH BRAIN METASTASES
JOURNAL OF THORACIC ONCOLOGY Volume: 7 Page(s): S120 - S120
07/01/2012 Authors: Mehta MP; Curran WJ; Wang D; Wang F; Kleinberg L; Brade A; Mostafa N; Zhou X; Qian J; Leahy T
SU-E-J-189: The Kullback-Leiber Divergence for Quantifying Changes in Radiotherapy Treatment Response.
Volume: 39 Page(s): 3696
06/01/2012 Authors: Schreibmann E; Crocker I; Shu H; Curran W; Fox T
SU-E-J-191: A Multivariate Framework for N-Tissue Classification in Treatment Assessment of Glioblastomas.
Volume: 39 Page(s): 3696
06/01/2012 Authors: Schreibmann E; Crocker I; Shu H; Curran W; Fox T
The Kullback-Leiber Divergence for Quantifying Changes in Radiotherapy Treatment Response
Volume: 39 Page(s): 3696 - 3696
06/01/2012 Authors: Schreibmann E; Crocker I; Shu H; Curran W; Fox T
Ultrasound Texture Analysis of Radiation-Induced Parotid-Gland Injury in Post-Radiotherapy Head-And-Neck Patients: Feasibility Study
Volume: 39 Page(s): 4003 - 4003
06/01/2012 Authors: Yang X; Tridandapani S; Beitler J; Yu D; Henry S; Chen H; Curran W; Liu T
A Multivariate Framework for N-Tissue Classification in Treatment Assessment of Glioblastomas
Volume: 39 Page(s): 3696 - 3696
06/01/2012 Authors: Schreibmann E; Crocker I; Shu H; Curran W; Fox T
Chemotherapy plus radiotherapy (CT-RT) versus RT alone for patients with anaplastic oligodendroglioma: Long-term results of the RTOG 9402 phase III study
Volume: 30
05/20/2012 Authors: Cairncross JG; Wang M; Shaw EG; Jenkins RB; Scheithauer BW; Brachman D; Buckner JC; Fink KL; Souhami L; Laperriere N
A systematic analysis of high-dose radiation in the treatment of surgically unresectable, locally advanced non-small cell lung cancer
Volume: 30
05/20/2012 Authors: Behera M; Beitler JJ; Bhimani C; Higgins K; Chen Z; Kim S; Deng X; Curran WJ; Khuri FR; Ramalingam SS
A revised RTOG recursive partitioning analysis (RPA) model for glioblastoma based upon multiplatform biomarker profiles
Volume: 30
05/20/2012 Authors: Chakravarti A; Wang M; Aldape KD; Sulman EP; Bredel M; Magliocco AM; Klimowicz AC; Hegi M; Stupp R; Gilbert MR
Expression pattern and biologic relevance of Bcl-2 and Mcl-1 in pulmonary neuroendocrine tumors.
Volume: 30
05/20/2012 Authors: Chowdry RP; Sica G; Chen Z; Goodman A; Kim S; Deng X; Curran WJ; Gal AA; Khuri FR; Ramalingam SS
Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases
Volume: 30
05/20/2012 Authors: Mehta MP; Curran WJ; Wang D; Wang F; Kleinberg L; Brade AM; Mostafa N; Zhou X; Qian J; Leahy T
Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
Int J Radiat Oncol Biol Phys Volume: 83 Page(s): e61 - e66
05/01/2012 Authors: Prabhu R; Shu H-K; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
A systematic analysis of efficacy of second-line chemotherapy in sensitive and refractory small-cell lung cancer.
J Thorac Oncol Volume: 7 Page(s): 866 - 872
05/01/2012 Authors: Owonikoko TK; Behera M; Chen Z; Bhimani C; Curran WJ; Khuri FR; Ramalingam SS
NNK promotes migration and invasion of lung cancer cells through activation of c-Src/PKC/FAK loop.
Cancer Lett Volume: 318 Page(s): 106 - 113
05/01/2012 Authors: Shen J; Xu L; Owonikoko TK; Sun S-Y; Khuri FR; Curran WJ; Deng X
c-Myc suppresses DNA double-strand break repair
CANCER RESEARCH Volume: 72
04/15/2012 Authors: Li Z; Owonikoko TK; Sun S-Y; Xiao Z-Q; Doetsch PW; Khuri FR; Curran WJ; Deng X
Defining local-regional control and its importance in locally advanced non-small cell lung carcinoma.
J Thorac Oncol Volume: 7 Page(s): 716 - 722
04/01/2012 Authors: Machtay M; Paulus R; Moughan J; Komaki R; Bradley JE; Choy H; Albain K; Movsas B; Sause WT; Curran WJ
RNAi-mediated targeting of noncoding and coding sequences in DNA repair gene messages efficiently radiosensitizes human tumor cells.
Cancer Res Volume: 72 Page(s): 1221 - 1228
03/01/2012 Authors: Zheng Z; Ng WL; Zhang X; Olson JJ; Hao C; Curran WJ; Wang Y
Reliability of quantitative ultrasonic assessment of normal-tissue toxicity in breast cancer radiotherapy.
Int J Radiat Oncol Biol Phys Volume: 82 Page(s): 724 - 731
02/01/2012 Authors: Yoshida EJ; Chen H; Torres M; Andic F; Liu H-Y; Chen Z; Sun X; Curran WJ; Liu T
Thromboembolic Events Associated with Thalidomide and Multimodality Therapy for Soft Tissue Sarcomas: Results of RTOG 0330.
Sarcoma Volume: 2012 Page(s): 659485
01/01/2012 Authors: Kane JM; Harris J; Kraybill WG; Harmon DC; Ettinger DS; Lucas DR; Delaney TF; Wang D; Curran WJ; Eisenberg BL
Higher biologically effective dose of radiotherapy is associated with improved outcomes for locally advanced non-small cell lung carcinoma treated with chemoradiation: an analysis of the Radiation Therapy Oncology Group.
Int J Radiat Oncol Biol Phys Volume: 82 Page(s): 425 - 434
01/01/2012 Authors: Machtay M; Bae K; Movsas B; Paulus R; Gore EM; Komaki R; Albain K; Sause WT; Curran WJ
Human immunodeficiency virus-associated lung cancer in the era of highly active antiretroviral therapy.
Cancer Volume: 118 Page(s): 164 - 172
01/01/2012 Authors: Pakkala S; Chen Z; Rimland D; Owonikoko TK; Gunthel C; Brandes JR; Saba NR; Shin DM; Curran WJ; Khuri FR
Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cells.
Mol Cancer Ther Volume: 11 Page(s): 45 - 56
01/01/2012 Authors: Liu Y; Sun S-Y; Owonikoko TK; Sica GL; Curran WJ; Khuri FR; Deng X
A Randomized Phase III Study of Conventional Whole Breast Irradiation (WBI) vs Partial Breast Irradiation (PBI) for Women with Stage 0, 1, or 2 Breast Cancer: NSABP B-39/RTOG 0413.
CANCER RESEARCH Volume: 71
12/15/2011 Authors: Julian TB; Costantino JP; Vicini FA; White JR; Cecchini RS; Winter KA; Arthur DW; Kuske R; Rabinovitch R; Parda DS
A phase 1b trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies.
Cancer Volume: 117 Page(s): 5548 - 5559
12/15/2011 Authors: Wuthrick EJ; Kamrava M; Curran WJ; Werner-Wasik M; Camphausen KA; Hyslop T; Axelrod R; Andrews DW; Glass J; Machtay M
Radiosensitizing effects of ectopic miR-101 on non-small-cell lung cancer cells depend on the endogenous miR-101 level.
Int J Radiat Oncol Biol Phys Volume: 81 Page(s): 1524 - 1529
12/01/2011 Authors: Chen S; Wang H; Ng WL; Curran WJ; Wang Y
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus.
Int J Radiat Oncol Biol Phys Volume: 81 Page(s): 1442 - 1457
12/01/2011 Authors: Kong F-MS; Ritter T; Quint DJ; Senan S; Gaspar LE; Komaki RU; Hurkmans CW; Timmerman R; Bezjak A; Bradley JD
VARIATION OVER TIME AND INTERDEPENDENCE BETWEEN DISEASE PROGRESSION AND DEATH AMONG PATIENTS WITH GLIOBLASTOMA (GBM) ON RTOG 0525
NEURO-ONCOLOGY Volume: 13 Page(s): 28 - 28
11/01/2011 Authors: Wang M; Dignam J; Won M; Curran W; Mehta M; Gilbert M
Validation and simplification of the Radiation Therapy Oncology Group recursive partitioning analysis classification for glioblastoma.
Int J Radiat Oncol Biol Phys Volume: 81 Page(s): 623 - 630
11/01/2011 Authors: Li J; Wang M; Won M; Shaw EG; Coughlin C; Curran WJ; Mehta MP
RTOG 0525: A RANDOMIZED PHASE III TRIAL COMPARING STANDARD ADJUVANT TEMOZOLOMIDE (TMZ) WITH A DOSE-DENSE (DD) SCHEDULE IN NEWLY DIAGNOSED GLIOBLASTOMA (GBM)
NEURO-ONCOLOGY Volume: 13 Page(s): 51 - 51
11/01/2011 Authors: Gilbert MR; Wang M; Aldape KD; Stupp R; Hegi M; Jaeckle KA; Armstrong TS; Wefel JS; Won M; Blumenthal DT
Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.
J Natl Cancer Inst Volume: 103 Page(s): 1452 - 1460
10/05/2011 Authors: Curran WJ; Paulus R; Langer CJ; Komaki R; Lee JS; Hauser S; Movsas B; Wasserman T; Rosenthal SA; Gore E
Spectrophotometer and ultrasound evaluation of late toxicity following breast-cancer radiotherapy.
Med Phys Volume: 38 Page(s): 5747 - 5755
10/01/2011 Authors: Yoshida EJ; Chen H; Torres MA; Curran WJ; Liu T
Clinical, Molecular, and Molecular-Clinical Profile (MCP) Exploratory Subset Analysis of RTOG 0525: a Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)
EUROPEAN JOURNAL OF CANCER Volume: 47 Page(s): 10 - 10
09/01/2011 Authors: Mehta M; Wang M; Aldape K; Sulman E; Stupp R; Jaeckle K; Blumenthal D; Erridge S; Curran W; Gilbert M
Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51.
Int J Radiat Oncol Biol Phys Volume: 81 Page(s): 218 - 224
09/01/2011 Authors: Daniels TB; Brown PD; Felten SJ; Wu W; Buckner JC; Arusell RM; Curran WJ; Abrams RA; Schiff D; Shaw EG
Age as an independent prognostic factor in patients with glioblastoma: a Radiation Therapy Oncology Group and American College of Surgeons National Cancer Data Base comparison.
J Neurooncol Volume: 104 Page(s): 351 - 356
08/01/2011 Authors: Siker ML; Wang M; Porter K; Nelson DF; Curran WJ; Michalski JM; Souhami L; Chakravarti A; Yung WKA; Delrowe J
Acute esophagitis and late lung toxicity in concurrent chemoradiotherapy trials in patients with locally advanced non-small-cell lung cancer: analysis of the radiation therapy oncology group (RTOG) database.
Clin Lung Cancer Volume: 12 Page(s): 245 - 251
07/01/2011 Authors: Werner-Wasik M; Paulus R; Curran WJ; Byhardt R
Phase II study of cetuximab in combination with chemoradiation in patients with stage IIIA/B non-small-cell lung cancer: RTOG 0324.
J Clin Oncol Volume: 29 Page(s): 2312 - 2318
06/10/2011 Authors: Blumenschein GR; Paulus R; Curran WJ; Robert F; Fossella F; Werner-Wasik M; Herbst RS; Doescher PO; Choy H; Komaki R
Prognostic value of H-MLH1 after adjusting for RPA class in GBM patients.
Front Biosci (Elite Ed) Volume: 3 Page(s): 1182 - 1191
06/01/2011 Authors: Choucair A; Moughan J; Schultz C; Schulsinger A; Mehta M; Curran W
Early toxicity results with 3D conformal external beam therapy (CEBT) from the NSABP B-39/RTOG 0413 accelerated partial breast irradiation (APBI) trial.
JOURNAL OF CLINICAL ONCOLOGY Volume: 29
05/20/2011 Authors: Julian TB; Costantino JP; Vicini FA; White JR; Winter KA; Arthur DW; Kuske RR; Rabinovitch R; Parda DS; Mamounas EP
Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Analysis of disparities in care.
JOURNAL OF CLINICAL ONCOLOGY Volume: 29
05/20/2011 Authors: Murphy BA; Chen AY; Curran WJ; Garden AS; Harari PM; Wong SJ; Bellm LA; Schwartz M; Newman J; Adkins D
Variation over time and interdependence between disease progression and death among patients with glioblastoma (GBM) on RTOG 0525.
JOURNAL OF CLINICAL ONCOLOGY Volume: 29
05/20/2011 Authors: Wang M; Dignam J; Won M; Curran WJ; Mehta MP; Gilbert MR
Early toxicity predicts long-term survival in high-grade glioma.
Br J Cancer Volume: 104 Page(s): 1365 - 1371
04/26/2011 Authors: Lawrence YR; Wang M; Dicker AP; Andrews D; Curran WJ; Michalski JM; Souhami L; Yung W-K; Mehta M
Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States.
Cancer Volume: 117 Page(s): 1679 - 1686
04/15/2011 Authors: Wong SJ; Harari PM; Garden AS; Schwartz M; Bellm L; Chen A; Curran WJ; Murphy BA; Ang KK
Phase i study of 'dose-dense' pemetrexed plus carboplatin/radiotherapy for locally advanced non-small cell lung carcinoma.
Radiat Oncol Volume: 6 Page(s): 17
02/16/2011 Authors: Shen X; Denittis A; Werner-Wasik M; Axelrod R; Gilman P; Meyer T; Treat J; Curran WJ; Machtay M
A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
Breast Cancer Res Treat Volume: 125 Page(s): 893 - 902
02/01/2011 Authors: Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D
A noninvasive integrative method for analyzing radiation-induced lung injury.
Clin Adv Hematol Oncol Volume: 9 Page(s): 157 - 160
02/01/2011 Authors: Korah MP; Waller AF; Schreibmann E; Curran WJ; Crocker IR
Comparing CNS and Extra-CNS Hemangiopericytomas in the Surveillance, Epidemiology, and End Results Program (SEER): An Analysis of 655 Patients
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 81 Page(s): S120 - S120
01/01/2011 Authors: Hall WA; Ali A; Crocker I; Landry JC; Shu H; Curran WJ
RTOG 0525: Exploratory Subset Analysis from a Randomized Phase III Trial Comparing Standard (std) Adjuvant Temozolomide (TMZ) with a Dose-dense (dd) Schedule for Glioblastoma (GBM)
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 81 Page(s): S128 - S129
01/01/2011 Authors: Mehta MP; Wang M; Aldape K; Stupp R; Jaeckle KA; Blumenthal D; Brown P; Erridge S; Curran W; Gilbert M
Current Dosing Paradigm For Stereotactic Radiosurgery Alone Following Surgical Resection of Brain Metastases Needs To Be Optimized For Improved Local Control
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 81 Page(s): S652 - S653
01/01/2011 Authors: Prabhu RS; Hadjipanayis C; Shu H; Hall W; Raore B; Olson JJ; Curran W; Oyesiku N; Crocker I
United States Patterns of Radiation Oncology Practice in the Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN) Study
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 81 Page(s): S138 - S138
01/01/2011 Authors: Kimple RJ; Garden AS; Yang RZ; Wong SJ; Schwartz M; Curran WJ; Murphy BA; Chen AY; Ang KK; Harari PM
Pattern of failure after limited margin radiotherapy and temozolomide for glioblastoma.
Int J Radiat Oncol Biol Phys Volume: 79 Page(s): 130 - 136
01/01/2011 Authors: McDonald MW; Shu H-KG; Curran WJ; Crocker IR
High-Resolution Ultrasonic Assessment of Parotid Gland in Post-Radiotherapy Head and Neck Cancer Patients
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 81 Page(s): S535 - S535
01/01/2011 Authors: Shi Z; Chen H; Beitler JJ; Tridandapani S; Curran WJ; Liu T
Stereotactic body radiosurgery for spinal metastatic disease: an evidence-based review.
Int J Surg Oncol Volume: 2011 Page(s): 979214
01/01/2011 Authors: Hall WA; Stapleford LJ; Hadjipanayis CG; Curran WJ; Crocker I; Shu H-KG
Mono- or double-site phosphorylation distinctly regulates the proapoptotic function of Bax.
PLoS One Volume: 5 Page(s): e13393
10/14/2010 Authors: Wang Q; Sun S-Y; Khuri F; Curran WJ; Deng X
DETERMINANTS OF THERAPEUTIC RESISTANCE IN GLIOBLASTOMAS: LESSONS LEARNED FROM RTOG 0211 AND BEYOND
Volume: 96 Page(s): S12 - S12
09/01/2010 Authors: Chakravarti A; Wang M; Robins I; Guha A; Curran W; Brachman D; Schultz C; Choucair A; Dolled-Filhart M; Christiansen J
DETERMINANTS OF THERAPEUTIC RESISTANCE IN GLIOBLASTOMAS: LESSONS LEARNED FROM RTOG 0211 AND BEYOND
Volume: 96 Page(s): S38 - S38
09/01/2010 Authors: Chakravarti A; Wang M; Robins I; Guha A; Curran W; Brachman D; Schultz C; Choucair A; Dolled-Filhart M; Christiansen J
Phase I trial using patupilone (epothilone B) and concurrent radiotherapy for central nervous system malignancies.
Int J Radiat Oncol Biol Phys Volume: 77 Page(s): 1009 - 1016
07/15/2010 Authors: Fogh S; Machtay M; Werner-Wasik M; Curran WJ; Bonanni R; Axelrod R; Andrews D; Dicker AP
Combined modality therapy for stage III non-small-cell lung cancer.
Semin Radiat Oncol Volume: 20 Page(s): 186 - 191
07/01/2010 Authors: Anderson CS; Curran WJ
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: radiation therapy oncology group trial 9402.
Int J Radiat Oncol Biol Phys Volume: 77 Page(s): 662 - 669
07/01/2010 Authors: Wang M; Cairncross G; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Laperriere N
Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation.
PLoS One Volume: 5 Page(s): e11397
07/01/2010 Authors: Yan D; Ng WL; Zhang X; Wang P; Zhang Z; Mo Y-Y; Mao H; Hao C; Olson JJ; Curran WJ
Dosimetric performance of the new high-definition multileaf collimator for intracranial stereotactic radiosurgery.
Volume: 11 Page(s): 3040
06/21/2010 Authors: Dhabaan A; Elder E; Schreibmann E; Crocker I; Curran WJ; Oyesiku NM; Shu H-K; Fox T
Hypofractionated stereotactic radiation therapy: an effective therapy for recurrent high-grade gliomas.
J Clin Oncol Volume: 28 Page(s): 3048 - 3053
06/20/2010 Authors: Fogh SE; Andrews DW; Glass J; Curran W; Glass C; Champ C; Evans JJ; Hyslop T; Pequignot E; Downes B
Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN): Findings related to the oropharynx
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Wong SJ; Chen AY; Curran WJ; Garden AS; Harari PM; Murphy BA; Bellm LA; Schwartz M; Ang K
Longitudinal Oncology-Registry of Head and Neck Carcinoma (LORHAN): First Overview of complete data set
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Harari PM; Chen AY; Curran WJ; Garden AS; Murphy BA; Wong SJ; Bellm LA; Schwartz M; Schneider C; Ang K
HIV-associated lung cancer in the era of highly active antiretroviral therapy (HAART): Correlation between CD4 count and outcome.
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Pakkala S; Chen Z; Rimland D; Owonikoko TK; Gunthel C; Brandes JC; Saba NF; Curran WJ; Khuri FR; Ramalingam SS
Acute neurological toxicity (NT) and long-term outcomes in high-grade glioma RTOG trials.
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Lawrence YR; Wang M; Dicker A; Andrews DW; Curran WJ; Michalski JM; Souhami L; Yung WA; Mehta MP
Determinants of therapeutic resistance in glioblastomas: Lessons learned from RTOG 0211 and beyond
JOURNAL OF CLINICAL ONCOLOGY Volume: 28
05/20/2010 Authors: Chakravarti A; Wang M; Robins H; Guha A; Curran WJ; Brachman D; Choucair AK; Dolled-Filhart M; Lautenschlaeger T; Mehta MP
The influence of gender, race, and marital status on survival in lung cancer patients: analysis of Radiation Therapy Oncology Group trials.
J Thorac Oncol Volume: 5 Page(s): 631 - 639
05/01/2010 Authors: Siddiqui F; Bae K; Langer CJ; Coyne JC; Gamerman V; Komaki R; Choy H; Curran WJ; Watkins-Bruner D; Movsas B
Whole-brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small-cell lung cancer: a randomized, open-label phase II study.
Clin Lung Cancer Volume: 11 Page(s): 176 - 181
05/01/2010 Authors: Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez JI; Gottfried M; Curran W; Throuvalas N
Response to "Unacceptable cosmesis in a protocol investigating intensity-modulated radiotherapy with active breathing control for accelerated partial-breast irradiation" (Int J Radiat Oncol Biol Phys 2010;76:71-78) and "Toxicity of three-dimensional conformal radiotherapy for accelerated partial breast irradiation" Int J Radiat Oncol Biol Phys 2009;75:1290-1296).
Int J Radiat Oncol Biol Phys Volume: 77 Page(s): 317
05/01/2010 Authors: Wolmark N; Curran WJ; Vicini F; White J; Costantino JP; Arthur D; Kuske R; Rabinovitch R; Julian TB; Parda DS
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.
J Clin Oncol Volume: 28 Page(s): 2181 - 2190
05/01/2010 Authors: Auprin A; Le Pchoux C; Rolland E; Curran WJ; Furuse K; Fournel P; Belderbos J; Clamon G; Ulutin HC; Paulus R
Incidence, risks, and sequelae of posterior fossa syndrome in pediatric medulloblastoma.
Int J Radiat Oncol Biol Phys Volume: 77 Page(s): 106 - 112
05/01/2010 Authors: Korah MP; Esiashvili N; Mazewski CM; Hudgins RJ; Tighiouart M; Janss AJ; Schwaibold FP; Crocker IR; Curran WJ; Marcus RB
Mono- or double-site phosphorylation distinctly regulates the proapoptotic function of Bax
Volume: 70
04/01/2010 Authors: Wang Q; Wang T; Gao F; Sun S-Y; Khuri FR; Curran WJ; Deng X
Biomarkers and surrogate endpoints for normal-tissue effects of radiation therapy: the importance of dose-volume effects.
Int J Radiat Oncol Biol Phys Volume: 76 Page(s): S145 - S150
03/01/2010 Authors: Bentzen SM; Parliament M; Deasy JO; Dicker A; Curran WJ; Williams JP; Rosenstein BS
Radiotherapy for Limited Stage Small Cell Lung Cancer
Volume: 1 Page(s): 39 - 58
01/01/2010 Authors: Schild SE; Curran WJ
Postoperative Radiotherapy for Patients with Stage II or III Non-small Cell Lung Cancer Treated with Sublobar Resections: A SEER Registry Analysis
Volume: 78 Page(s): S518 - S518
01/01/2010 Authors: Edelman S; Riffenburgh RH; Curran WJ
Six DOF CBCT-based Positioning for Intracranial Targets Treated with Frameless Stereotactic Radiosurgery (SRS)
Volume: 78 Page(s): S793 - S794
01/01/2010 Authors: Dhabaan A; Schreibmann E; Elder E; Fox T; Waller A; Ogunleye T; Esiashvili N; Crocker I; Curran W; Shu H
Safety and Efficacy of Fractionated Stereotactic Radiotherapy (FSR) and Stereotactic Radiosurgery (SRS) in the Treatment of Functioning and Non-functioning Pituitary Tumors
Volume: 78 Page(s): S289 - S289
01/01/2010 Authors: Hall WA; Chen Z; Shu H; Curran WJ; Oyesiku N; Crocker IR
Are the New NCI Operational Efficiency Guidelines Achievable? A Look at the Radiation Therapy Oncology Group Studies Activated in 2009 in Comparison to the New Operational Efficiency Working Group (OEWG) Guidelines
Volume: 78 Page(s): S490 - S490
01/01/2010 Authors: Soto N; Winter K; Machtay M; Walters-Page L; Okrent K; Robinson D; McCarthy B; Hoffman W; Curran WJ
The Role of Radiotherapy for Extensive-Stage and Recurrent Small Cell Lung Cancer
Volume: 1 Page(s): 59 - 65
01/01/2010 Authors: Schild SE; Curran WJ
Longitudinal oncology registry of head and neck carcinoma (LORHAN): initial supportive care findings.
Support Care Cancer Volume: 17 Page(s): 1393 - 1401
11/01/2009 Authors: Murphy BA; Chen A; Curran WJ; Garden AS; Harari PM; Wong SJ; Ang KK
Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03.
J Neurooncol Volume: 95 Page(s): 247 - 257
11/01/2009 Authors: Corn BW; Wang M; Fox S; Michalski J; Purdy J; Simpson J; Kresl J; Curran WJ; Diaz A; Mehta M
PATTERNS OF CARE FOR RADIOTHERAPY IN CHILDREN AND YOUNG ADULTS WITH HODGKIN'S LYMPHOMA BASED ON DATA FROM SURVILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER) REGISTRY
PEDIATRIC BLOOD & CANCER Volume: 53 Page(s): 758 - 759
11/01/2009 Authors: Esiashvili N; Goodman M; Curran WJ; Mertens A
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411.
Volume: 27 Page(s): 4096 - 4102
09/01/2009 Authors: Crane CH; Winter K; Regine WF; Safran H; Rich TA; Curran W; Wolff RA; Willett CG
Whole brain radiation therapy plus concomitant temozolomide for the treatment of brain metastases from non-small cell lung cancer: a randomized, open-label, phase II study
JOURNAL OF THORACIC ONCOLOGY Volume: 4 Page(s): S544 - S544
09/01/2009 Authors: Chua D; Krzakowski M; Chouaid C; Pallotta MG; Martinez J; Gottfried M; Curran W; Throuvalas N
Gender differences in survival among lung cancer patients treated in radiation therapy oncology group (RTOG) trials
JOURNAL OF THORACIC ONCOLOGY Volume: 4 Page(s): S524 - S524
09/01/2009 Authors: Siddiqui F; Langer CJ; Bae K; Coyne J; Gamerman V; Bryan C; Komaki R; Choy H; Curran WJ; Watkins-Bruner D
For whom the Bell's Palsy tolls?
Am J Clin Oncol Volume: 32 Page(s): 450 - 451
08/01/2009 Authors: Kaushal A; Curran WJ
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials.
Int J Radiat Oncol Biol Phys Volume: 74 Page(s): 1580 - 1591
08/01/2009 Authors: Woodward WA; Bristow RG; Clarke MF; Coppes RP; Cristofanilli M; Duda DG; Fike JR; Hambardzumyan D; Hill RP; Jordan CT
Economic analysis of radiation therapy oncology group 97-14: multiple versus single fraction radiation treatment of patients with bone metastases.
Am J Clin Oncol Volume: 32 Page(s): 423 - 428
08/01/2009 Authors: Konski A; James J; Hartsell W; Leibenhaut MH; Janjan N; Curran W; Roach M; Watkins-Bruner D
Phase I trial using proteasome inhibitor bortezomib and concurrent temozolomide and radiotherapy for central nervous system malignancies.
Int J Radiat Oncol Biol Phys Volume: 74 Page(s): 433 - 439
06/01/2009 Authors: Kubicek GJ; Werner-Wasik M; Machtay M; Mallon G; Myers T; Ramirez M; Andrews D; Curran WJ; Dicker AP
Toward dose optimization for fractionated stereotactic radiotherapy for acoustic neuromas: comparison of two dose cohorts.
Int J Radiat Oncol Biol Phys Volume: 74 Page(s): 419 - 426
06/01/2009 Authors: Andrews DW; Werner-Wasik M; Den RB; Paek SH; Downes-Phillips B; Willcox TO; Bednarz G; Maltenfort M; Evans JJ; Curran WJ
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: Radiation therapy oncology group trial 9402
Volume: 27
05/20/2009 Authors: Wang M; Cairncross G; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Souhami L; Laperriere N; Mehta M
Cognition and quality of life after chemotherapy plus radiotherapy (RT) vs. RT for pure and mixed anaplastic oligodendrogliomas: Radiation therapy oncology group trial 9402.
J Clin Oncol Volume: 27 Page(s): e20519
05/20/2009 Authors: Wang M; Cairncross G; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Souhami L; Laperriere N; Mehta M
A phase I trial using patupilone (epothilone B) and concurrent radiotherapy for CNS malignancies.
J Clin Oncol Volume: 27 Page(s): e14504
05/20/2009 Authors: Fogh SE; Machtay M; Werner-Wasik M; Curran W; Bonanni R; Mallon G; Axelrod R; Andrews D; Dicker A
Longitudinal oncology registry of head and neck carcinoma (LORHAN): First report of outcomes
Volume: 27
05/20/2009 Authors: Curran WJ; Chen AY; Garden AS; Harari P; Murphy BA; Wong S; Bellm LA; Schwartz M; Dawson D; Ang KK
Longitudinal oncology registry of head and neck carcinoma (LORHAN): First report of outcomes.
J Clin Oncol Volume: 27 Page(s): 6071
05/20/2009 Authors: Curran WJ; Chen AY; Garden AS; Harari P; Murphy BA; Wong S; Bellm LA; Schwartz M; Dawson D; Ang KK
A phase I trial using patupilone (epothilone B) and concurrent radiotherapy for CNS malignancies
Volume: 27
05/20/2009 Authors: Fogh SE; Machtay M; Werner-Wasik M; Curran W; Bonanni R; Mallon G; Axelrod R; Andrews D; Dicker A
Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.
Int J Radiat Oncol Biol Phys Volume: 73 Page(s): 699 - 708
03/01/2009 Authors: Tsien C; Moughan J; Michalski JM; Gilbert MR; Purdy J; Simpson J; Kresel JJ; Curran WJ; Diaz A; Mehta MP
Short delay in initiation of radiotherapy may not affect outcome of patients with glioblastoma: a secondary analysis from the radiation therapy oncology group database.
J Clin Oncol Volume: 27 Page(s): 733 - 739
02/10/2009 Authors: Blumenthal DT; Won M; Mehta MP; Curran WJ; Souhami L; Michalski JM; Rogers CL; Corn BW
Fractionated Stereotactic Radiotherapy for the Management of Optic Nerve Sheath Meningiomas
Volume: 75 Page(s): S486 - S486
01/01/2009 Authors: Den RB; Tjoumakaris S; Werner-Wasik M; Evans J; Curran WJ; Andrews DW
RTOG 0017: a phase I trial of concurrent gemcitabine/carboplatin or gemcitabine/paclitaxel and radiation therapy ("ping-pong trial") followed by adjuvant chemotherapy for patients with favorable prognosis inoperable stage IIIA/B non-small cell lung cancer.
J Thorac Oncol Volume: 4 Page(s): 80 - 86
01/01/2009 Authors: Choy H; Jain AK; Moughan J; Curran W; Whipple G; Demas WF; Ettinger DS
Preliminary Demonstration of a Radiation-dose Response via Ultrasound-based Skin Measurements in Breast Cancer Radiotherapy
Volume: 75 Page(s): S192 - S192
01/01/2009 Authors: Liu T; Woodhouse SA; Shaitelman SF; Zhou J; Wong TJ; Yoshida EJ; Kutcher GJ; Curran WJ
Prognostic Factors for Lung Cancer Tumor Recurrence after Thoracic Radiotherapy Based on Sequential Post-treatment PET Scans
Volume: 75 Page(s): S456 - S456
01/01/2009 Authors: Werner-Wasik M; Pequignot E; Hyslop T; Shulli B; Xiao Y; Machtay M; Taylor A; Curran W; Axelrod R
Final Report of a Pilot Study of Carboplatin Plus Dose Dense Pemetrexed and Radiotherapy for Locally-advanced Non-small-cell Lung Carcinoma
Volume: 75 Page(s): S162 - S163
01/01/2009 Authors: Shen X; Wemer-Wasik M; DeNittis A; Axelrod R; Gilman P; Meyer T; Treat J; Curran W; Machtay M
Factors Associated with Attrition in RTOG Clinical Trials
Volume: 75 Page(s): S89 - S90
01/01/2009 Authors: Ulrich CM; James J; Grady C; Byron C; Hanlon A; Watkins-Bruner D; Curran W
Pattern or Failure after Limited Margin Radiotherapy and Temozolomide for Glioblastoma
Volume: 75 Page(s): S227 - S227
01/01/2009 Authors: McDonald MW; Shu HG; Curran WJ; Crocker IR
The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Meta-analysis of Radiation Therapy Oncology Group (RTOG) Trials
Volume: 75 Page(s): S163 - S163
01/01/2009 Authors: Bruner DW; Bae K; Siddiqui F; Langer CJ; Coyne J; Gamerman V; Komaki R; Choy H; Curran WJ; Movsas B
Correlation of Pulmonary and Cardiac Dose-volume Histogram (DVH) Data with the Development of Radiation Adverse Events following Chemoradiation: Secondary Analysis of Radiation Therapy Oncology Group (RTOG) 0324
Volume: 75 Page(s): S161 - S162
01/01/2009 Authors: Grosshans DR; Bae K; Blumenschein G; Curran W; Robert F; Fossella F; Wemer-Wasik M; Doescher P; Choy H; Komaki R
Report on a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy.
Med Phys Volume: 36 Page(s): 12 - 17
01/01/2009 Authors: Bednarz G; Machtay M; Werner-Wasik M; Downes B; Bogner J; Hyslop T; Galvin J; Evans J; Curran W; Andrews D
PHOTON-BASED FRACTIONATED RADIOTHERAPY AND RADIOSURGERY FOR THE TREATMENT OF CHORDOMAS AND CHONDROSARCOMAS: A MULTI-INSTITUTIONAL REVIEW
Volume: 10 Page(s): 884 - 884
10/01/2008 Authors: Den R; Goldberg Y; Werner-Wasik M; Corn B; Daniels S; Andrews D; Evans J; Breneman R; Warnick R; Curran W
A PHASE I TRIAL OF HYPOFRACTIONATED STEREOTACTIC RADIATION THERAPY WITH SUNITINIB IN RECURRENT HIGH-GRADE GLIOMA
Volume: 10 Page(s): 885 - 885
10/01/2008 Authors: Wuthrick E; Curran W; Lin A; Glass J; Evans J; Andrews D; Axelrod R; Pereira-Rico A; Murphy H; Werner-Wasik M
PREDICTIVE VALUE OF HMLH1 AFTER ADJUSTING FOR RPA CLASS IN PATIENTS WITH GBMS TREATED ON RTOG PROTOCOLS
Volume: 10 Page(s): 855 - 855
10/01/2008 Authors: Choueair A; Moughan J; Ford C; Hansen J; Schultz C; Schulsinger A; Hammond E; Mehta M; Curran W
AN UPDATE ON CORRELATIVE MOLECULAR ENDPOINTS FROM RTOG 0211: PHASE I/II STUDY OF GEFITINIB plus RADIATION FOR NEWLY DIAGNOSED GLIOBLASTOMA
Volume: 10 Page(s): 785 - 785
10/01/2008 Authors: Chakravartti A; Wang M; Mischel P; Robins HI; Guha A; Machray M; Curran W; Roach M; Mehta M; Dicker A
Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of nonacoustic cranial nerve schwannomas.
Neurosurgery Volume: 63 Page(s): 734 - 740
10/01/2008 Authors: Showalter TN; Werner-Wasik M; Curran WJ; Friedman DP; Xu X; Andrews DW
TOXICITY RESULTS OF RTOG 9813-A PHASE III RANDOMIZED STUDY OF RADIATION THERAPY (RT) AND TEMOZOLOMIDE (TMZ) VERSUS RT AND NITROSOUREA (NU) FOR ANAPLASTIC ASTROCYTOMA (AA) AND MIXED ANAPLASTIC OLIGOASTROCYTOMA (MAOA)
Volume: 10 Page(s): 826 - 826
10/01/2008 Authors: Chang S; Wang M; Cairncross G; Gilbert M; Bahary JP; Dolinskas C; Aldape K; Chakravarti A; Curran W; Schift D
The prognostic value of nestin expression in newly diagnosed glioblastoma: report from the Radiation Therapy Oncology Group.
Radiat Oncol Volume: 3 Page(s): 32
09/25/2008 Authors: Chinnaiyan P; Wang M; Rojiani AM; Tofilon PJ; Chakravarti A; Ang KK; Zhang H-Z; Hammond E; Curran W; Mehta MP
Re: Intensity-modulated radiation therapy dose prescription, recording, and delivery: patterns of variability among institutions and treatment planning systems.
J Natl Cancer Inst Volume: 100 Page(s): 1264
09/03/2008 Authors: Galvin JM; Xiao Y; Curran WJ
Addressing the current challenges of non-small-cell lung cancer clinical trial accrual.
Clin Lung Cancer Volume: 9 Page(s): 222 - 226
07/01/2008 Authors: Curran WJ; Schiller JH; Wolkin AC; Comis RL; Scientific Leadership Council in Lung Cancer of the Coalition of Cancer Cooperative Groups
Anaplastic oligodendroglial tumors: refining the correlation among histopathology, 1p 19q deletion and clinical outcome in Intergroup Radiation Therapy Oncology Group Trial 9402.
Brain Pathol Volume: 18 Page(s): 360 - 369
07/01/2008 Authors: Giannini C; Burger PC; Berkey BA; Cairncross JG; Jenkins RB; Mehta M; Curran WJ; Aldape K
Celebrating 40 years of clinical inquiry: The RTOG'S ruby anniversary.
Int J Radiat Oncol Biol Phys Volume: 71 Page(s): 321 - 323
06/01/2008 Authors: Curran WJ; Machtay M; Wasserman T; Shipley WU
Pilot study of carboplatin/radiotherapy plus 'dose-dense' pemetrexed for locally advanced non-small cell lung carcinoma
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Machtay M; Werner-Wasik M; DeNittis A; Axelrod RA; Gilman P; Lavarino J; Meyer T; Treat J; Curran WJ
Longitudinal oncology registry of head and neck carcinoma (LORHAN): Initial treatment findings
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Curran WJ; Chen A; Garden A; Harari P; Murphy BA; Wong SJ; Bellm L; Schwartz M; Dawson D; Ang K
A phase I trial of the combination of the antiangiogenic agent sunitinib and radiation therapy for patients with primary and metastatic central nervous system malignancies
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Wuthrick EJ; Curran WJ; Werner-Wasik M; Lin A; Axelrod RA; Pereira-Rico A; Murphy H; Machtay M; Dicker AP
RTOG 0324: A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients with stage IIIA/B non-small cell lung cancer (NSCLC)-Association between EGFR gene copy number and patients' outcome
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Olsen CC; Paulus R; Komaki R; Varella-Garcia M; Dziadziuszko R; Curran WJ; Robert F; Choy H; Blumenschein GR; Hirsch FR
Phase I trial of bortezomib (VELCADE), cisplatin and radiotherapy for advanced head and neck cancer
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Kubicek GJ; Machtay M; Axelrod RA; Curran WJ; Keane WM; Anne R; Mallon G; Myers T; Dicker AP
RTOG 0330: A pilot phase II study of preoperative radiation therapy/thalidomide for low-grade primary soft tissue sarcoma or preoperative MAID/thalidomide/radiation therapy for high/intermediate grade primary soft tissue sarcoma of the extremity or body wall
JOURNAL OF CLINICAL ONCOLOGY Volume: 26
05/20/2008 Authors: Kane JM; Harris J; Kraybill WG; Harmon DC; Ettinger DS; Lucas DR; DeLaney TF; Wang D; Curran WJ; Eisenberg BL
Prospective evaluation of quality of life and neurocognitive effects in patients with multiple brain metastases receiving whole-brain radiotherapy with or without thalidomide on Radiation Therapy Oncology Group (RTOG) trial 0118.
Int J Radiat Oncol Biol Phys Volume: 71 Page(s): 71 - 78
05/01/2008 Authors: Corn BW; Moughan J; Knisely JPS; Fox SW; Chakravarti A; Yung WKA; Curran WJ; Robins HI; Brachman DG; Henderson RH
A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
Int J Radiat Oncol Biol Phys Volume: 71 Page(s): 79 - 86
05/01/2008 Authors: Knisely JPS; Berkey B; Chakravarti A; Yung AWK; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
Globalization of the Radiation Therapy Oncology Group: implementation of a model for service expansion and public health improvement.
J Clin Oncol Volume: 26 Page(s): 1160 - 1166
03/01/2008 Authors: Corn BW; Wexler ID; Suntharalingam M; Inbar M; Curran WJ; Radiation Therapy Oncology Group
A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
Volume: 70 Page(s): 510 - 514
02/01/2008 Authors: Sperduto PW; Berkey B; Gaspar LE; Mehta M; Curran W
Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.
Neurosurgery Volume: 62 Suppl 2 Page(s): 763 - 775
02/01/2008 Authors: Veznedaroglu E; Andrews DW; Benitez RP; Downes MB; Werner-Wasik M; Rosenstock J; Curran WJ; Rosenwasser RH
Clinical cancer advances 2007: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
Volume: 26 Page(s): 313 - 325
01/10/2008 Authors: Gralow J; Ozols RF; Bajorin DF; Cheson BD; Sandler HM; Winer EP; Bonner J; Demetri GD; Curran W; Ganz PA
Role of FDG-PET in definition of involved-field radiation therapy for pediatric patients with Hodgkin's lymphoma
Volume: 72 Page(s): S78 - S78
01/01/2008 Authors: Esiashvili N; Halkar R; Keller F; Robertson VL; Fox TH; Waller AF; Curran WJ; Marcus RB
A randomized trial or chemotherapy plus radiotherapy (RT) versus RT alone for anaplastic oligodendroglioma (RTOG 9402): The perspective of longer follow-up
Volume: 72 Page(s): S7 - S8
01/01/2008 Authors: Cairncross G; Wang M; Chang S; Shaw E; Jenkins R; Scheithauer B; Buckner J; Fink K; Mehta M; Curran W
Expression of epidermal growth factor receptor (EGFR) in human meningioma and preliminary clinical results
Volume: 72 Page(s): S200 - S200
01/01/2008 Authors: Whiton MA; Champ C; Kenyon L; Hyslop T; Perry A; Andrews DW; Curran WJ; Dicker AP; Wemicke AG
An analysis of consent form modification of RTOG healthcare institutions consent forms: A readability impact study
Volume: 72 Page(s): S479 - S479
01/01/2008 Authors: Chin LJ; Allegrante JP; Sage WM; Marks R; James JL; Curran W
Incidence, risk, and sequelae of posterior fossa syndrome in pediatric medulloblastoma
Volume: 72 Page(s): S81 - S81
01/01/2008 Authors: Korah M; Esiashvili N; Mazewski C; Hudgins R; Tighiouart M; Janss A; Schwaibold F; Crocker I; Curran W; Marcus R
Longitudinal oncology registry of head and neck carcinoma (LORHAN): Preliminary report regarding radiation patterns of care
Volume: 72 Page(s): S409 - S410
01/01/2008 Authors: Garden AS; Chen A; Curran W; Harari P; Murphy B; Wong S; Schwartz M; Dawson D; Dempsey C; Ang K
Photon based fractionated radiotherapy and radiosurgery for the treatment of chordomas and chondrosarcomas: A multi-institutional review
Volume: 72 Page(s): S204 - S204
01/01/2008 Authors: Den RB; Goldberg Y; Werner-Wasik M; Corn BW; Daniel SR; Andrews DW; Evans J; Breneman R; Warnick R; Curran WJ
Phase I trial using the proteasome inhibitor bortezomib (velcade) and concurrent chemoradiotherapy for head and neck malignancies
Volume: 72 Page(s): S376 - S377
01/01/2008 Authors: Fogh SE; Kubicek GJ; Machtay M; Axelrod R; Anne R; Mallon G; Keane WM; Myers T; Curran WJ; Dicker AP
A phase I trial of hypofractionated stereotactic radiation therapy with sunitinib in recurrent high grade glioma
Volume: 72 Page(s): S205 - S205
01/01/2008 Authors: Wuthrick EJ; Curran WJ; Lin A; Glass J; Evans J; Andrews D; Axelrod R; Murphy H; Werner-Wasik M; Dicker AP
Correlation of EGFR expression by IHC and FISH to predict patient outcome: A phase II RTOG 0324 study for patients with stage III NSCLC treated by chemoradiotherapy and cetuximab (C225)
Volume: 72 Page(s): S115 - S115
01/01/2008 Authors: Komaki RU; Paulus R; Olsen C; Conway P; Ang K; Trotti A; Blumenschein G; Curran W; Choy H; Hirsch F
Metabolic response to thoracic radiation therapy in patients with non-small cell lung cancer: Long term results obtained with semiautomatic contouring software
Volume: 72 Page(s): S114 - S115
01/01/2008 Authors: Werner-Wasik M; Shulli B; Pequignot E; Xiao Y; Machtay M; Taylor A; Curran WJ; Axelrod R
The prognostic value of nestin expression in newly diagnosed GBM: Report from the RTOG
Volume: 72 Page(s): S206 - S206
01/01/2008 Authors: Chinnaiyan P; Wang M; Rojiani AM; Tofilon PJ; Chakravarti A; Ang K; Zhang H; Hammond E; Curran W; Mehta MP
An update on correlative molecular Endpoints from RTOG 0211: Phase I/II study of gefitinib plus radiation for newly diagnosed glioblastoma patients
Volume: 72 Page(s): S9 - S10
01/01/2008 Authors: Chakravarti A; Wang M; Mischel P; Robins HI; Guha A; Machtay M; Curran W; Roach M; Mehta M; Dicker A
Multifocal glioblastoma multiforme: prognostic factors and patterns of progression.
Int J Radiat Oncol Biol Phys Volume: 69 Page(s): 820 - 824
11/01/2007 Authors: Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M
Results of the phase I dose-escalating study of motexafin gadolinium with standard radiotherapy in patients with glioblastoma multiforme.
Int J Radiat Oncol Biol Phys Volume: 69 Page(s): 831 - 838
11/01/2007 Authors: Ford JM; Seiferheld W; Alger JR; Wu G; Endicott TJ; Mehta M; Curran W; Phan S-C
Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911.
J Clin Oncol Volume: 25 Page(s): 4800 - 4805
10/20/2007 Authors: Langer CJ; Harris J; Horwitz EM; Nicolaou N; Kies M; Curran W; Wong S; Ang K
Anaplastic oligodendroglial tumors: Refining the correlation among histopathology, 1p 19q deletion, and clinical outcome in intergroup radiation therapy oncology group trial 9402
Volume: 9 Page(s): 548 - 548
10/01/2007 Authors: Giannini C; Burger P; Won M; Cairncross G; Jenkins RB; Mehta M; Curran W; Aldape K
Phase II trial of concomitant low-dose temozolomide with radiation therapy (RT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Updated results of RTOG 04-20
Volume: 9 Page(s): 528 - 528
10/01/2007 Authors: Lieberman F; Moughan J; Tsein C; Curran W; Werner-Wasik M; Smith R; Grossheim L; Hug E; Robins I; Mehta M
Report of a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy
Volume: 84 Page(s): S294 - S295
09/01/2007 Authors: Bednarz G; Machtay M; Werner-Wasik M; Downes B; Bogner J; White J; Evans J; Li Y; Hyslop T; Galvin J
Rethinking prognostic factors in the era of combined modality therapy for Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC): a retrospective analysis of RTOG Protocols 9410 and 9801
JOURNAL OF THORACIC ONCOLOGY Volume: 2 Page(s): S309 - S309
08/01/2007 Authors: Langer CJ; Paulus R; Curran W; Movsas B; Werner-Wasik M; Komaki R; Lee JS; Choy H
A phase II study of cetuximab (C225) in combination with chemoradiation
JOURNAL OF THORACIC ONCOLOGY Volume: 2 Page(s): S342 - S343
08/01/2007 Authors: Blumenschein JGR; Moughan J; Curran W; Robert F; Fossella F; Werner-Wasik M; Doescher P; Choy H; Komaki R
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group.
Lancet Oncol Volume: 8 Page(s): 613 - 624
07/01/2007 Authors: Trotti A; Pajak TF; Gwede CK; Paulus R; Cooper J; Forastiere A; Ridge JA; Watkins-Bruner D; Garden AS; Ang KK
A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (pts) with stage III A/B non-small cell lung cancer (NSCLC): An interim report of the RTOG 0324 trial
Volume: 25
06/20/2007 Authors: Blumenschein G; Moughan J; Curran W; Robert F; Fossella F; Werner-Wasik M; Doescher P; Choy H; Komaki R
The modifier of Min 2 (Mom2) locus: embryonic lethality of a mutation in the Atp5a1 gene suggests a novel mechanism of polyp suppression.
Genome Res Volume: 17 Page(s): 566 - 576
05/01/2007 Authors: Baran AA; Silverman KA; Zeskand J; Koratkar R; Palmer A; McCullen K; Curran WJ; Edmonston TB; Siracusa LD; Buchberg AM
Imaging response in malignant glioma, RTOG 90-06.
Am J Clin Oncol Volume: 30 Page(s): 32 - 37
02/01/2007 Authors: Lustig RA; Seiferheld W; Berkey B; Yung AWK; Scarantino C; Movsas B; Jones CU; Simpson JR; Fishbach J; Curran WJ
A Phase II trial of subcutaneous amifostine and radiation therapy in patients with head-and-neck cancer.
Int J Radiat Oncol Biol Phys Volume: 67 Page(s): 445 - 452
02/01/2007 Authors: Ann PR; Machtay M; Rosenthal DI; Brizel DM; Morrison WH; Irwin DH; Chougule PB; Estopinal NC; Berson A; Curran WJ
Integration of surgery with fractionated stereotactic radiotherapy (FSR) for the treatment of residual or recurrent craniopharyngiomas: Minimizing treatment-related morbidities
Volume: 69 Page(s): S246 - S247
01/01/2007 Authors: Kaushal A; Evans JJ; Pack SH; Rosen M; Heron DE; Gilbert M; Savino PJ; Downes MB; Bednarz G; Werner-Wasik I
Longitudinal oncology registry of head and neck carcinoma (LORHAN), a new national cancer registry
Volume: 69 Page(s): S138 - S139
01/01/2007 Authors: Murphy B; Chen A; Harari P; Curran W; Wong S; Bellm L; Gamber D; Dawson D; Garden A; Ang K
Clinical cancer advances 2006: major research advances in cancer treatment, prevention, and screening--a report from the American Society of Clinical Oncology.
J Clin Oncol Volume: 25 Page(s): 146 - 162
01/01/2007 Authors: Ozols RF; Herbst RS; Colson YL; Gralow J; Bonner J; Curran WJ; Eisenberg BL; Ganz PA; Kramer BS; Kris MG
Fractionated stereotactic radiotherapy (FSR) and stereotactic radiosurgery (SRS) for the treatment of nonacoustic cranial nerve schwannomas
Volume: 69 Page(s): S164 - S164
01/01/2007 Authors: Showalter TN; Werner-Wasik M; Curran WJ; Friedman DP; Machtay M; Evans J; Andrews DW
Concomitant radio-chemotherapy (CT-RT) versus sequential CT-RT in locally advanced Non-Small-Cell Lung Cancer (NSCLC): A meta-analysis using Individual Patient Data (IPD) from Randomised Clinical Trials (RCTs)
Volume: 69 Page(s): S5 - S5
01/01/2007 Authors: Rolland E; Le Pechoux C; Curran WJ; Furuse K; Fournel P; Uitterhoeve L; Clamon G; Ulutin HC; Stewart L; Auperin A
A phase I trial of patupilone (Epothilone B) and concurrent radiotherapy for CNS malignancies
Volume: 69 Page(s): S244 - S245
01/01/2007 Authors: Machtay M; Curran WJ; Werner-Wasik M; Mallon G; Axelrod R; Andrews D; Dicker AP
"Less is not Always more": An economic analysis of radiation therapy oncology group 94-10
Volume: 69 Page(s): S182 - S182
01/01/2007 Authors: Konski AA; Bhargavan M; Owen J; Komaki R; Langer C; Byhardt R; Paulus R; Choy H; Bruner D; Curran W
Tolerance of optic structures: 10-year experience treating 321 patients with fractionated stereotactic radiation therapy
Volume: 69 Page(s): S166 - S166
01/01/2007 Authors: Russo G; Werner-Wasik M; Hyslop T; Bednarz G; Downes B; Andrews D; Evans J; Curran W
RTOG 0324: A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): Correlation between EGFR expression and the patients' outcome
Volume: 69 Page(s): S57 - S58
01/01/2007 Authors: Komaki R; Moughan J; Ang K; Curran W; Robert F; Thariat J; Zhang H; Werner-Wasik M; Choy H; Blumenschein G
A survey of the ITC volumetric treatment planning data archive supporting RTOG advanced technology clinical trials
Volume: 69 Page(s): S195 - S195
01/01/2007 Authors: Bosch WR; Straube WL; Matthews JW; Michalski JM; Deasy JO; Young B; O'Meara E; Curran WJ; Cox JD; Purdy JA
A phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: RTOG PA0411
Volume: 69 Page(s): S77 - S78
01/01/2007 Authors: Crane CH; Winter K; Regine W; Safran H; Rich T; Curran W; Wolff R; Willett C
Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model.
J Clin Oncol Volume: 24 Page(s): 5711 - 5715
12/20/2006 Authors: Abrey LE; Ben-Porat L; Panageas KS; Yahalom J; Berkey B; Curran W; Schultz C; Leibel S; Nelson D; Mehta M
Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04-20
Volume: 8 Page(s): 445 - 445
10/01/2006 Authors: Lieberman FS; Berkey B; Tsien C; Curran W; Werner-Wasik M; Smith R; Grossheirn L; Hugh E; Mehta M
Validation of EORTC prognostic factors for adults with low-grade glioma: A report utilizing intergroup 86-72-51
Volume: 8 Page(s): 483 - 483
10/01/2006 Authors: Brown PD; Daniels TB; Ballman K; Felton S; Buckner JC; Arusell RM; Curran WJ; Abrams R; Earle JD; Shaw EG
'Short' delay in initiation of radiotherapy may not affect the outcome of patients with GBM: A secondary analysis from the RTOG database
Volume: 8 Page(s): 483 - 483
10/01/2006 Authors: Blumenthal DT; Berkey B; Nelson D; Curran W; Leibel S; Souhami L; Michalski J; Corn B; Chakravarti A; Rogers L
Age as an independent prognostic factor in patients with glioblastoma: An RTOG and ACoS national cancer base comparison
Volume: 8 Page(s): 408 - 408
10/01/2006 Authors: Siker ML; Berkey B; Porter K; Nelson D; Curran W; Michalski J; Souhami L; Chakravarti A; Yung W; DelRowe J
Therapy for stage III non-small-cell lung cancer: Bob Beamon or Chemo-Beamo?
Clin Lung Cancer Volume: 8 Page(s): 84
09/01/2006 Authors: Curran WJ
Longitudinal oncology registry of head and neck carcinoma (LORHAN), a new national cancer registry.
Volume: 24 Page(s): 300S - 300S
06/20/2006 Authors: Curran W; Chen A; Harari P; Murphy B; Wong S; Bellm L; Gamber D; Dawson D; Ang K
Combined modality therapy of locally advanced adenocarcinoma of the rectum: Update of a phase I trial of preoperative radiation (RT) with concurrent capecitabine (Cap) and irinotecan (Ir).
J Clin Oncol Volume: 24 Page(s): 13547
06/20/2006 Authors: Mitchell EP; Anne P; Goldstein S; Isenberg G; Fitzgerald J; Palazzo J; Hauck W; Lavarino J; Sanson J; Curran WJ
An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastoma.
J Clin Oncol Volume: 24 Page(s): 1527
06/20/2006 Authors: Chakravarti A; Berkey B; Robins HI; Guha A; Curran WJ; Brachman D; Shultz C; Mehta M
Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04-20.
J Clin Oncol Volume: 24 Page(s): 1510
06/20/2006 Authors: Lieberman FS; Tsien C; Berkey B; Curran W; Werner-Wasik M; Smith R; Grossheim L; Hug E; Mehta M
Phase I study of irinotecan (Ir) and cisplatin (DDP) in combination with thoracic radiotherapy (RT), either twice daily (45 Gy) or once daily (70 Gy), in patients with limited (Ltd) small cell lung carcinoma (SCLC): Early analysis of RTOG 0241.
J Clin Oncol Volume: 24 Page(s): 7058
06/20/2006 Authors: Langer CJ; Swann S; Werner-Wasik M; Lilenbaum R; Curran W; Sandler A; Scidmore N; Samuels M; Choy H
Prospective neurocognitive effects and quality of life (QOL) in patients with multiple brain metastases receiving whole brain radiation (WBRT) thalidomide on radiation therapy oncology group (RTOG) trial 0118.
J Clin Oncol Volume: 24 Page(s): 8589
06/20/2006 Authors: Fox S; Berkey B; Knisely J; Chakravarti A; Yung WA; Curran W; Robins H; Brachmen D; Henderson R; Mehta M
Longitudinal Oncology Registry of Head and Neck Carcinoma (LORHAN), a new national cancer registry.
J Clin Oncol Volume: 24 Page(s): 5583
06/20/2006 Authors: Curran W; Chen A; Harari P; Murphy B; Wong S; Bellm L; Gamber D; Dawson D; Ang K
Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group Trial 9402.
J Clin Oncol Volume: 24 Page(s): 2707 - 2714
06/20/2006 Authors: Intergroup Radiation Therapy Oncology Group Trial 9402; Cairncross G; Berkey B; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L
Phase II trial of concomitant low dose temozolomide with external beam radiation (EBRT) followed by 12 months of temozolomide and irinotecan for newly diagnosed glioblastoma (GBM): Preliminary results of RTOG 04-20.
Volume: 24 Page(s): 60S - 60S
06/20/2006 Authors: Lieberman FS; Tsien C; Berkey B; Curran W; Werner-Wasik M; Smith R; Grossheim L; Hug E; Mehta M
Phase I study of irinotecan (Ir) and cisplatin (DDP) in combination with thoracic radiotherapy (RT), either twice daily (45 Gy) or once daily (70 Gy), in patients with limited (Ltd) small cell lung carcinoma (SCLC): Early analysis of RTOG 0241.
Volume: 24 Page(s): 378S - 378S
06/20/2006 Authors: Langer CJ; Swann S; Werner-Wasik M; Lilenbaum R; Curran W; Sandler A; Scidmore N; Samuels M; Choy H
Prospective neurocognitive effects and quality of life (QOL) in patients with multiple brain metastases receiving whole brain radiation (WBRT) +/- thalidomide on radiation therapy oncology group (RTOG) trial 0118.
Volume: 24 Page(s): 490S - 490S
06/20/2006 Authors: Fox S; Berkey B; Knisely J; Chakravarti A; Yung WA; Curran W; Robins H; Brachmen D; Henderson R; Mehta M
An update of phase II results from RTOG 0211: A phase I/II study of gefitinib with radiotherapy in newly diagnosed glioblastorna.
Volume: 24 Page(s): 64S - 64S
06/20/2006 Authors: Chakravarti A; Berkey B; Robins HI; Guha A; Curran WJ; Brachman D; Shultz C; Mehta M
Spinal cord gliomas: A multi-institutional retrospective analysis.
Int J Radiat Oncol Biol Phys Volume: 64 Page(s): 1060 - 1071
03/15/2006 Authors: Abdel-Wahab M; Etuk B; Palermo J; Shirato H; Kresl J; Yapicier O; Walker G; Scheithauer BW; Shaw E; Lee C
Impact of Her-2 Neu overexpression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer: an exploratory analysis.
Am J Clin Oncol Volume: 29 Page(s): 71 - 79
02/01/2006 Authors: Poltinnikov IM; Rudoler SB; Tymofyeyev Y; Kennedy J; Anne PR; Curran WJ
On the accuracy of cone-beam CT and stereoscopic x-ray image guidance for radiotherapy of vertebral tumors: An intra-institutional comparison
Volume: 66 Page(s): S639 - S639
01/01/2006 Authors: Bogner J; Bednarz G; Downes-Philips B; Galvin J; Georg D; Andrews D; Curran W
Validation of EORTC prognostic factors for adults with low grade glioma: A report utilizing intergroup 86-72-51
Volume: 66 Page(s): S83 - S83
01/01/2006 Authors: Daniels TB; Brown PD; Ballman K; Felton S; Buckner J; Arusell RM; Curran WJ; Earle JD; Shaw EG
Interim report of a randomized trial comparing two forms of immobilization of the head for fractionated stereotactic radiotherapy
Volume: 66 Page(s): S715 - S715
01/01/2006 Authors: Bednarz G; Machtay M; Werner-Wasik M; Downes B; Bogner J; Curran W; Dicker A; Valicenti R; Evans J; Andrews D
A review of the activities of the ITC in support of RTOG advanced technology clinical trials
Volume: 66 Page(s): S134 - S135
01/01/2006 Authors: Purdy JA; Bosch WR; Straube WL; Matthews JW; Haynes RJ; Michalski JM; Martin EA; Winter K; Curran WJ; Cox JD
Expression, prognostic value, and impact of chemotherapy on plasma angiogenic factors VEGF, IL-8, and basic FGF for lung cancer patients receiving radiotherapy
Volume: 66 Page(s): S156 - S157
01/01/2006 Authors: Chen Y; Hyrien O; Okunieff P; Pandya K; Liu W; Smudzin T; Choy H; Curran WJ
An update of phase II results from RTOG 0211: A phase I/II study of Gefitinib plus radiation for newly-diagnosed glioblastoma patients
Volume: 66 Page(s): S83 - S84
01/01/2006 Authors: Chakravarti A; Berkey B; Robins HI; Guha A; Curran W; Brachman D; Shultz C; Mehta M
Sociodemographic factors are significant predictors of toxicity in RTOG non-operative NSCLC trials
Volume: 66 Page(s): S62 - S62
01/01/2006 Authors: Movsas B; Swann S; Curran W; Coyne J; Konski A; Komaki R; Bradley J; Langer C; Choy H; Watkins-Bruner D
Improved hearing preservation with deescalated dose of fractionated stereotactic radiotherapy (SRT) in patients with acoustic schwannomas: 50.4 Gy vs. 46.8 Gy
Volume: 66 Page(s): S241 - S241
01/01/2006 Authors: Werner-Wasik M; Curran WJ; Evans J; Machtay M; Li Y; Andrews DW
Age as an independent prognostic factor in patients with glioblastoma: A radiation therapy oncology group analysis
Volume: 66 Page(s): S196 - S196
01/01/2006 Authors: Siker ML; Berkey BA; Nelson D; Curran WJ; Michalski J; Souhami L; Chakravarti A; Yung WA; DelRowe J; Mehta MP
Adaptive protocol development and trial initiation: RTOG's experience in the current clinical trials environment
Volume: 66 Page(s): S460 - S460
01/01/2006 Authors: Young BK; Martin E; Hoffman W; Wudarski T; King SR; Brasteter H; Galvin J; Curran WJ
Comparison of 5-year survival between RTOG-94-10 and a phase 2 study of induction chemotherapy followed by efaproxiral plus radiotherapy in patients with locally advanced NSCLC
Volume: 66 Page(s): S28 - S29
01/01/2006 Authors: Choy H; Swann S; Nabid A; Stea B; Roa W; Souhami L; Curran W
Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience.
Int J Radiat Oncol Biol Phys Volume: 63 Page(s): 667 - 671
11/01/2005 Authors: Machtay M; Hsu C; Komaki R; Sause WT; Swann RS; Langer CJ; Byhardt RW; Curran WJ
Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol.
J Clin Oncol Volume: 23 Page(s): 5883 - 5891
09/01/2005 Authors: Belani CP; Choy H; Bonomi P; Scott C; Travis P; Haluschak J; Curran WJ
MRI changes due to early-delayed conformal radiotherapy and postsurgical effects in patients with brain tumors.
Int J Radiat Oncol Biol Phys Volume: 63 Page(s): 56 - 63
09/01/2005 Authors: Armstrong CL; Hunter JV; Hackney D; Shabbout M; Lustig RW; Goldstein B; Werner-Wasik M; Curran WJ
Glycerol rhizotomy versus gamma knife radiosurgery for the treatment of trigeminal neuralgia: an analysis of patients treated at one institution.
Int J Radiat Oncol Biol Phys Volume: 63 Page(s): 82 - 90
09/01/2005 Authors: Henson CF; Goldman HW; Rosenwasser RH; Downes MB; Bednarz G; Pequignot EC; Werner-Wasik M; Curran WJ; Andrews DW
Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
J Clin Oncol Volume: 23 Page(s): 5918 - 5928
09/01/2005 Authors: Choy H; Nabid A; Stea B; Scott C; Roa W; Kleinberg L; Ayoub J; Smith C; Souhami L; Hamburg S
Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma.
Volume: 74 Page(s): 201 - 205
09/01/2005 Authors: Fisher B; Seiferheld W; Schultz C; DeAngelis L; Nelson D; Schold SC; Curran W; Mehta M
Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
J Clin Oncol Volume: 23 Page(s): 4991 - 4998
08/01/2005 Authors: Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW; Radiation Therapy Oncology Group 9609
Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame.
Int J Radiat Oncol Biol Phys Volume: 62 Page(s): 652 - 658
07/01/2005 Authors: Poltinnikov IM; Fallon K; Xiao Y; Reiff JE; Curran WJ; Werner-Wasik M
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
Clin Cancer Res Volume: 11 Page(s): 4981s - 4983s
07/01/2005 Authors: Lynch TJ; Bogart JA; Curran WJ; DeCamp MM; Gandara DR; Goss G; Henschke CI; Jett JR; Johnson BE; Kelly KL
What is the meaning of local-regional control after chemoradiation for locally advanced NSCLC? An RTOG analysis
Volume: 49 Page(s): S17 - S17
07/01/2005 Authors: Machtay M; Swann S; Komaki R; Byhardt R; Paulus R; Sause W; Curran W; Albain K; Movas B
Phase I study of combination irinotecan and cisplatin and either twice daily thoracic radiation (45Gy) or once daily thoracic radiotherapy (70Gy) in patients with limited small cell lung carcinoma (SCLC): Early toxicity analysis of RTOG 0241
Volume: 49 Page(s): S323 - S323
07/01/2005 Authors: Langer C; Swann S; Werner-Wasik M; Lillenbaum R; Curran W; Sandler A; Scidmore N; Choy H; Samuels M
Impact of metronomic chemotherapy schedule on circulating VEGF and bFGF during concurrent thoracic radiotherapy
Volume: 49 Page(s): S16 - S16
07/01/2005 Authors: Chen Y; Hyrien O; Okunieff P; Pandya K; Wang W; Liu W; Smudzin T; Choy H; Curran W
Overall treatment time during concurrent chemoradiotherapy and outcomes: An RTOG secondary analysis
Volume: 49 Page(s): S17 - S17
07/01/2005 Authors: Machtay M; Swann S; Komaki R; Sause W; Langer C; Byhardt R; Curran W
A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial
Volume: 49 Page(s): S78 - S78
07/01/2005 Authors: Blumenschein G; Swann S; Curran W; Robert F; Werner-Wasik M; Lee C; Jafar S; Share R; Choy H; Komaki R
Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.
Int J Radiat Oncol Biol Phys Volume: 62 Page(s): 318 - 327
06/01/2005 Authors: Chakravarti A; Seiferheld W; Tu X; Wang H; Zhang HZ; Ang KK; Hammond E; Curran W; Mehta M
Impact of overall treatment time during concurrent chemoradiotherapy for locally advanced NSCLC: An RTOG secondary analysis.
Volume: 23 Page(s): 635S - 635S
06/01/2005 Authors: Swann RS; Machtay M; Komaki R; Sause WT; Langer CJ; Byhardt RW; Curran WJ
In regard to Dr. Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
Int J Radiat Oncol Biol Phys Volume: 62 Page(s): 614 - 615
06/01/2005 Authors: Kondziolka D; Lunsford LD; Flickinger JC
A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 Trial
Volume: 23 Page(s): 654S - 654S
06/01/2005 Authors: Werner-Wasik M; Swann S; Curran W; Robert F; Komaki R; Lee CP; Jafar S; Share R; Choy H; Blumenschein G
Tumor size as a predictor of pathologic complete response (pCR) and survival in a prospective trial of chemoradiation for locally advanced rectal cancer.
Volume: 23 Page(s): 288S - 288S
06/01/2005 Authors: Kim CS; Anne PR; Mitchell EP; Palazzo J; Pequignot E; Fishel R; Goldstein SD; Isenberg GA; Curran W
RTOG 0118: A phase III study of conventional radiation therapy alone vs. conventional radiation therapy plus thalidomide for multiple brain metastases.
Volume: 23 Page(s): 114S - 114S
06/01/2005 Authors: Knisely JPS; Berkey BA; Chakravarti A; Yung WKA; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
Concurrent split course hyperfractionated radiotherapy (Hfx RT), cisplatin (DDP) and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN): Update of RTOG 9911.
Volume: 23 Page(s): 519S - 519S
06/01/2005 Authors: Horwitz EM; Harris J; Langer CJ; Nicolaou N; Kies M; Curran W; Wong SJ; Ang K
Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
J Clin Oncol Volume: 23 Page(s): 3480 - 3487
05/20/2005 Authors: Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ
Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: Report of radiation therapy oncology group 93-05 protocol: In regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004; 60 : 853-860) - Response
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 62 Page(s): 297 - 297
05/01/2005 Authors: Souhami L; Podgorsak EB; Mehta MP; Brachman D; Werner-Wasik M; Curran WJ; Lustig R; Schultz CJ; Sause W; Okunieff P
Lack of survival benefit after stereotactic radiosurgery boost for glioblastoma multiforme: randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of radiation therapy oncology group 93-05 protocol: in regard to Souhami et al. (Int J Radiat Oncol Biol Phys 2004;60:853-860).
Int J Radiat Oncol Biol Phys Volume: 62 Page(s): 296 - 297
05/01/2005 Authors: Vordermark D; Klbl O
Treatment of locally advanced non-small cell lung cancer: what we have and have not learned over the past decade.
Semin Oncol Volume: 32 Page(s): S2 - S5
04/01/2005 Authors: Curran WJ
Integration of surgery with fractionated stereotactic radiotherapy for treatment of nonfunctioning pituitary macroadenomas.
Int J Radiat Oncol Biol Phys Volume: 61 Page(s): 795 - 808
03/01/2005 Authors: Paek SH; Downes MB; Bednarz G; Keane WM; Werner-Wasik M; Curran WJ; Andrews DW
Improvement in vision and cranial neuropathies after stereotactic radiotherapy for the treatment of skull base meningiomas
Volume: 63 Page(s): S157 - S157
01/01/2005 Authors: McElveen TL; Settle K; Downes M; Werner-Wasik M; Curran WJ; Andrews DW
Impact of pretreatment tumor size and lymph nodes on pathologic complete response and survival in a prospective trial of chemoradiation for locally advanced rectal cancer
Volume: 63 Page(s): S164 - S165
01/01/2005 Authors: Kim C; Anne PR; Mitchell E; Pequignot E; Palazzo J; Goldstein S; Isenberg G; Curran W
One-on-one peer support for cancer patients: An evaluation of an alternative to traditional support groups
PSYCHO-ONCOLOGY Volume: 14 Page(s): S28 - S29
01/01/2005 Authors: Rhodes LM; Bontempo MG; Curran WJ
Reassessing prognostic factors in the era of combined modality therapy for locally advanced NSCLC: A retrospective analysis of RTOG 9410 and 9801
Volume: 63 Page(s): S39 - S40
01/01/2005 Authors: Langer CJ; Swann S; Curran W; Movsas B; Werner-Wasik M; Komaki R; Lee J; Choy H
Impact of Her-2 neu over-expression on outcome of elderly women treated with wide local excision and breast irradiation for early stage breast cancer
Volume: 63 Page(s): S241 - S241
01/01/2005 Authors: Poltinnikov IM; Rudoler SR; Tymofyeyev Y; Kennedy J; Anne PR; Curran WJ
A phase I trial of gemcitabine, carboplatin or gemcitabine, paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG 0017 study
Volume: 63 Page(s): S42 - S43
01/01/2005 Authors: Choy H; Swann S; Curran W; Whipple G; Demas W; Ettinger D
Phase II study of paclitaxel and cisplatin in combination with split course concomitant hyperfractionated re-irradiation in patients with recurrent squamous cell cancer of the head and neck: Results of RTOG 99-11
Volume: 63 Page(s): S72 - S73
01/01/2005 Authors: Horwitz EM; Harris J; Langer CJ; Nicolaou N; Kies M; Curran WJ; Wong SJ; Ang KK
A phase II study of Cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial
Volume: 63 Page(s): S44 - S44
01/01/2005 Authors: Komaki R; Swann S; Curran W; Robert F; Maria W; Lee C; Jafar S; Share R; Choy H; Blumenschein G
Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.
Int J Radiat Oncol Biol Phys Volume: 60 Page(s): 853 - 860
11/01/2004 Authors: Souhami L; Seiferheld W; Brachman D; Podgorsak EB; Werner-Wasik M; Lustig R; Schultz CJ; Sause W; Okunieff P; Buckner J
An update of phase I data from RTOG 0211: A phase I/II clinical study of ZD 1839 (Gefitinib) plus radiation for newly diagnosed glioblastoma (GBM) patients
Volume: 6 Page(s): 372 - 372
10/01/2004 Authors: Chakravarti A; Seiferheld W; Robins HI; Guha A; Brachman D; Curran W; Choucair A; Mehta M
Does stereotactic eligibility for the treatment of glioblastoma cause selection bias in randomized studies?
Am J Clin Oncol Volume: 27 Page(s): 516 - 521
10/01/2004 Authors: Lustig RA; Scott CB; Curran WJ
An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiotherapy (RT) versus RT alone for pure and mixed anaplastic oligodendroglioma: Initial report of RTOG 94-02
Volume: 6 Page(s): 371 - 371
10/01/2004 Authors: Cairncross G; Seiferheld W; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Curran W
Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.
Neurosurgery Volume: 55 Page(s): 519 - 530
09/01/2004 Authors: Veznedaroglu E; Andrews DW; Benitez RP; Downes MB; Werner-Wasik M; Rosenstock J; Curran WJ; Rosenwasser RH
Outcomes research in cancer clinical trial cooperative groups: the RTOG model.
Qual Life Res Volume: 13 Page(s): 1025 - 1041
08/01/2004 Authors: Bruner DW; Movsas B; Konski A; Roach M; Bondy M; Scarintino C; Scott C; Curran W
Evaluation of expression of DNA repair molecules as a prognostic factor for long-term survivors with glioblastoma multiforme (GBM) treated on RTOG protocols with irradiation and nitrosoureas.
Volume: 22 Page(s): 109S - 109S
07/15/2004 Authors: Ford C; Seiferheld W; Choucair AK; Hansen J; Dabbas B; Schultz C; Schulsinger A; Mehta M; Curran W
Long term survivors with glioblastoma multiforme (GBM) treated on RTOG protocols with irradiation and nitrosurea have higher initial expression of Ki-67.
Volume: 22 Page(s): 875S - 875S
07/15/2004 Authors: Choucair AK; Seiferheld W; Ford C; Hansen J; Dabbas B; Schultz C; Schulsinger A; Mehta M; Curran W
Phase II trial of concurrent split course hyperfractionated radiotherapy (Hfx RT), cisplatin (DDP) and paclitaxel (P) in patients with recurrent, previously irradiated squamous cell carcinoma of the head and neck (SCCHN). Results of RTOG 9911.
Volume: 22 Page(s): 490S - 490S
07/15/2004 Authors: Langer CJ; Harris J; Horwitz E; Nicolaou N; Kies M; Curran W; Wong S; Ang KK
A phase II trial of preoperative paclitaxel, carboplatin, 5-FU and radiation in patients with resectable esophageal or gastric cancer (Ca)
Volume: 22 Page(s): 321S - 321S
07/15/2004 Authors: Anne PR; Axelrod R; Rosato E; Rosato F; Kairys J; Ramirez M; Cantor R; Chapman A; Curran W; Mitchell E
Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors.
Int J Radiat Oncol Biol Phys Volume: 59 Page(s): 1122 - 1126
07/15/2004 Authors: Chang SM; Seiferheld W; Curran W; Share R; Atkins J; Choucair A; Kresl J; Thoron L; Cairncross G; Gilbert M
An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib plus radiation for newly-diagnosed glioblastoma (GBM) patients.
Volume: 22 Page(s): 124S - 124S
07/15/2004 Authors: Chakravarti A; Seiferheld W; Robins HI; Guha A; Brachman D; Curran W; Choucair A; Mehta M
An intergroup randomized controlled clinical trial (RCT) of chemotherapy plus radiation (RT) versus RT alone for pure and mixed anaplastic oligodendrogliomas: Initial report of RTOG 94-02.
Volume: 22 Page(s): 107S - 107S
07/15/2004 Authors: Cairncross G; Seiferheld W; Shaw E; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Curran W
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
Lancet Volume: 363 Page(s): 1665 - 1672
05/22/2004 Authors: Andrews DW; Scott CB; Sperduto PW; Flanders AE; Gaspar LE; Schell MC; Werner-Wasik M; Demas W; Ryu J; Bahary J-P
Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma.
Int J Radiat Oncol Biol Phys Volume: 59 Page(s): 117 - 125
05/01/2004 Authors: Brown PD; Buckner JC; O'Fallon JR; Iturria NL; O'Neill BP; Brown CA; Scheithauer BW; Dinapoli RP; Arusell RM; Curran WJ
Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.
Neuro Oncol Volume: 6 Page(s): 96 - 103
04/01/2004 Authors: Brat DJ; Seiferheld WF; Perry A; Hammond EH; Murray KJ; Schulsinger AR; Mehta MP; Curran WJ; Radiation Therapy Oncology Group
A comparison of treatment outcomes with Gamma Knife radiosurgery versus Glycerol Rhizotomy in the management of trigeminal neuralgia
Volume: 71 Page(s): S13 - S14
04/01/2004 Authors: Febles C; Goldman G; Rosenwasser R; Werner-Wakik M; Bednarz G; Downes MB; Curran W; Andrews D
Adult patients with supratentorial pilocytic astrocytomas: a prospective multicenter clinical trial.
Int J Radiat Oncol Biol Phys Volume: 58 Page(s): 1153 - 1160
03/15/2004 Authors: Brown PD; Buckner JC; O'Fallon JR; Iturria NL; Brown CA; O'Neill BP; Scheithauer BW; Dinapoli RP; Arusell RM; Abrams RA
Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404.
Int J Radiat Oncol Biol Phys Volume: 58 Page(s): 1147 - 1152
03/15/2004 Authors: Prados MD; Seiferheld W; Sandler HM; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL
Phase I/II conformal three-dimensional radiation therapy dose escalation study in patients with supratentorial glioblastoma multiforme: Report of the radiation therapy oncology group 98-03 protocol
Volume: 60 Page(s): S163 - S164
01/01/2004 Authors: Werner-Wasik M; Seiferheld W; Michalski J; Gilbert M; Purdy J; Simpson J; Kresl J; Curran WJ; Diaz A; Mehta M
Radiation therapy (RT) alone vs intensive procarbazine-CCNU-vincristine (I-PCV) chemotherapy followed by radiation therapy for anaplastic oligodendroglioma (AO) and mixed oligo-astrocytoma (MOA): Results of radiation therapy oncology group (RTOG) - Intergroup protocol 94-02
Volume: 60 Page(s): S163 - S163
01/01/2004 Authors: Shaw EG; Seiferheld W; Cairncross JG; Jenkins R; Scheithauer B; Brachman D; Buckner J; Fink K; Souhami L; Curran W
Dosimetric uncertainties of three-dimensional dose reconstruction from two-dimensional data in a multi-institutional study.
J Appl Clin Med Phys Volume: 5 Page(s): 15 - 28
01/01/2004 Authors: Weinberg R; Kaurin DGL; Choy H; Curran WJ; MacRae R; Kim JS; Kim J; Tucker SL; Bonomi PD; Belani C
Prospective health-related quality of life valuations (utilities) of 8 Gy in 1 fraction vs 30 Gy in 10 fractions for palliation of painful bone metastases: Preliminary results of RTOG 97-14
Volume: 60 Page(s): S142 - S142
01/01/2004 Authors: Bruner DW; Winter K; Hartsell W; Konski A; Curran W; Roach M; Doncals D; Movsas B; Lee D; Scarantino C
Comparison of three IMRT inverse planning techniques that allow for partial esophagus sparing in patients receiving thoracic radiation therapy for lung cancer.
Med Dosim Volume: 29 Page(s): 210 - 216
01/01/2004 Authors: Xiao Y; Werner-Wasik M; Michalski D; Houser C; Bednarz G; Curran W; Galvin J
Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT-11 chemotherapy and radiotherapy.
Anticancer Res Volume: 24 Page(s): 3161 - 3167
01/01/2004 Authors: Charara M; Edmonston TB; Burkholder S; Walters R; Anne P; Mitchell E; Fry R; Boman B; Rose D; Fishel R
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.
Volume: 22 Page(s): 157 - 165
01/01/2004 Authors: Meyers CA; Smith JA; Bezjak A; Mehta MP; Liebmann J; Illidge T; Kunkler I; Caudrelier J-M; Eisenberg PD; Meerwaldt J
Critical factors for patient management.
Volume: 42 Suppl 1 Page(s): S7 - S8
12/01/2003 Authors: Ninane V; Le Pechoux C; Curran W; Furuse K; Liptay M; Meert AP; Paesmans M; Rami-Porta R; Roelandts M; Ruckdeschel JC
The Third International Cytoprotection Investigator's Congress - Introduction
SEMINARS IN ONCOLOGY Volume: 30 Page(s): 1 - 1
12/01/2003 Authors: Curran WJ
Evolving chemoradiation treatment strategies for locally advanced non-small-cell lung cancer.
Oncology (Williston Park) Volume: 17 Page(s): 7 - 14
12/01/2003 Authors: Curran WJ
Management of unresectable non-small cell carcinoma of the lung (NSCLC).
Lung Cancer Volume: 42 Suppl 1 Page(s): S15 - S16
12/01/2003 Authors: Cox JD; Le Chevalier T; Arriagada R; Choy H; Curran WJ; Fukuoka M; Harper P; Komaki R; Le Pechoux C; Lievens Y
Cyclooxygenase-2 (COX-2) and epidermal growth factor receptor (EGFR) expression in human pituitary macroadenomas.
Am J Clin Oncol Volume: 26 Page(s): S75 - S80
08/01/2003 Authors: Bloomer CW; Kenyon L; Hammond E; Hyslop T; Andrews DW; Curran WJ; Dicker AP
Cyclooxygenase-2 (COX-2) expression in human meningioma as a function of tumor grade.
Am J Clin Oncol Volume: 26 Page(s): S98 - 102
08/01/2003 Authors: Lin C-CD; Kenyon L; Hyslop T; Hammond E; Andrews DW; Curran WJ; Dicker AP
Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
J Clin Oncol Volume: 21 Page(s): 2529 - 2536
07/01/2003 Authors: Mehta MP; Rodrigus P; Terhaard CHJ; Rao A; Suh J; Roa W; Souhami L; Bezjak A; Leibenhaut M; Komaki R
Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
J Clin Oncol Volume: 21 Page(s): 2519 - 2524
07/01/2003 Authors: Brown PD; Buckner JC; O'Fallon JR; Iturria NL; Brown CA; O'Neill BP; Scheithauer BW; Dinapoli RP; Arusell RM; Curran WJ
RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.
J Clin Oncol Volume: 21 Page(s): 2364 - 2371
06/15/2003 Authors: Shaw E; Scott C; Suh J; Kadish S; Stea B; Hackman J; Pearlman A; Murray K; Gaspar L; Mehta M
Induction therapy for locally advanced esophageal or gastric cancer: A phase I/II trial of paclitaxel, carboplatinum, 5-FU and radiation therapy followed by surgery.
Volume: 51 Page(s): S131 - S132
02/01/2003 Authors: Whiton MA; Anne PR; Curran WJ
Prognostic and predictive value of microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT11 chemotherapy and radiotherapy
Volume: 16 Page(s): 115A - 115A
01/01/2003 Authors: Charara M; Edmonston TB; Mitchell E; Anne P; Fry R; Burkholder S; Pequignot E; Hauck W; Rose D; Walters R
Prognostic and predictive value of Microsatellite status and cell cycle associated markers in rectal cancer patients undergoing a combined regimen of 5-FU and CPT11 chemotherapy and radiotherapy
Volume: 83 Page(s): 115A - 115A
01/01/2003 Authors: Charara M; Edmonston TB; Mitchell E; Anne P; Fry R; Burkholder S; Pequignot E; Hauck W; Rose D; Walters R
DNA-PKcs subunits in radiosensitization by hyperthermia on hepatocellular carcinoma hepG2 cell line.
World J Gastroenterol Volume: 8 Page(s): 797 - 803
10/01/2002 Authors: Zeng Z-C; Jiang G-L; Wang G-M; Tang Z-Y; Curran WJ; Iliakis G
Fractionated stereotactic radiotherapy for the treatment of optic nerve sheath meningiomas: preliminary observations of 33 optic nerves in 30 patients with historical comparison to observation with or without prior surgery.
Neurosurgery Volume: 51 Page(s): 890 - 902
10/01/2002 Authors: Andrews DW; Faroozan R; Yang BP; Hudes RS; Werner-Wasik M; Kim SM; Sergott RC; Savino PJ; Shields J; Shields C
Lead-in phase to randomized trial of motexafin gadolinium and whole-brain radiation for patients with brain metastases: centralized assessment of magnetic resonance imaging, neurocognitive, and neurologic end points.
Volume: 20 Page(s): 3445 - 3453
08/15/2002 Authors: Mehta MP; Shapiro WR; Glantz MJ; Patchell RA; Weitzner MA; Meyers CA; Schultz CJ; Roa WH; Leibenhaut M; Ford J
Using segmented fields to treat brain tumors
MEDICAL PHYSICS Volume: 29 Page(s): 1209 - 1209
06/01/2002 Authors: Bednarz G; Houser C; Michalski D; Butzbach D; Werner-Wasik M; Galvin J; Curran W
Transformation of shot coordinates for repeated application of Leksell head frame for volume staged treatment of large arteriovenous malformations
MEDICAL PHYSICS Volume: 29 Page(s): 1369 - 1369
06/01/2002 Authors: Michalski D; Bednarz G; Werner-Wasik M; Rosenwasser R; Curran W
Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
J Clin Oncol Volume: 20 Page(s): 2267 - 2276
05/01/2002 Authors: Shaw E; Arusell R; Scheithauer B; O'Fallon J; O'Neill B; Dinapoli R; Nelson D; Earle J; Jones C; Cascino T
Combined-modality therapy for inoperable non-small-cell lung cancer using gemcitabine.
Clin Lung Cancer Volume: 3 Suppl 1 Page(s): S17 - S21
03/01/2002 Authors: Curran WJ
Inoperable localized stage I and stage II non-small-cell lung cancer.
Curr Treat Options Oncol Volume: 3 Page(s): 75 - 83
02/01/2002 Authors: Gressen EL; Curran WJ
New chemotherapeutic agents: update of major chemoradiation trials in solid tumors.
Oncology Volume: 63 Suppl 2 Page(s): 29 - 38
01/01/2002 Authors: Curran WJ
Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy.
Volume: 12 Page(s): 34 - 39
01/01/2002 Authors: Werner-Wasik M; Axelrod RS; Friedland DP; Hauck W; Rose LJ; Chapman AE; Grubbs S; Deshields M; Curran WJ
Chemotherapy for high-grade glioma.
Cochrane Database Syst Rev Volume: 2002 Page(s): CD003913
01/01/2002 Authors: Glioma Meta-Analysis Trialists (GMT) Group
A phase II trial of subcutaneous amifostine and radiation therapy in patients with head and neck cancer.
Volume: 12 Page(s): 18 - 19
01/01/2002 Authors: Ann PR; Curran WJ
Induction and concurrent paclitaxel/carboplatin every 3 weeks with thoracic radiotherapy in locally advanced non-small-cell lung cancer: an interim report.
Clin Lung Cancer Volume: 3 Page(s): 125 - 132
11/01/2001 Authors: Movsas B; Hudes RS; Schol J; Mellenson M; Rosvold E; Nicolaou N; Litwin S; Wang H; Keenan E; Curran WJ
Phase I trial results and preclinical studies of recombinant human angiostatin (rhA) and radiotherapy.
CLINICAL CANCER RESEARCH Volume: 7 Page(s): 3709S - 3709S
11/01/2001 Authors: Dicker AP; Grant D; Williams T; Anne P; Bonanni R; Sidor C; Gubish E; Curran W
Neurocognitive outcome in brain metastases patients treated with accelerated-fractionation vs. accelerated-hyperfractionated radiotherapy: an analysis from Radiation Therapy Oncology Group Study 91-04.
Volume: 51 Page(s): 711 - 717
11/01/2001 Authors: Regine WF; Scott C; Murray K; Curran W
Pilot evaluation of 1p and 19q deletions in anaplastic oligodendrogliomas collected by a national cooperative cancer treatment group.
Am J Clin Oncol Volume: 24 Page(s): 506 - 508
10/01/2001 Authors: Jenkins RB; Curran W; Scott CB; Cairncross G
Assessment of lung cancer response after nonoperative therapy: tumor diameter, bidimensional product, and volume. A serial CT scan-based study.
Int J Radiat Oncol Biol Phys Volume: 51 Page(s): 56 - 61
09/01/2001 Authors: Werner-Wasik M; Xiao Y; Pequignot E; Curran WJ; Hauck W
Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.
Int J Radiat Oncol Biol Phys Volume: 51 Page(s): 113 - 119
09/01/2001 Authors: Langer CJ; Ruffer J; Rhodes H; Paulus R; Murray K; Movsas B; Curran W
Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: comparative observations of 125 patients treated at one institution.
Int J Radiat Oncol Biol Phys Volume: 50 Page(s): 1265 - 1278
08/01/2001 Authors: Andrews DW; Suarez O; Goldman HW; Downes MB; Bednarz G; Corn BW; Werner-Wasik M; Rosenstock J; Curran WJ
National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
J Natl Cancer Inst Volume: 93 Page(s): 979 - 989
07/04/2001 Authors: Eifel P; Axelson JA; Costa J; Crowley J; Curran WJ; Deshler A; Fulton S; Hendricks CB; Kemeny M; Kornblith AB
Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy.
Clin Lung Cancer Volume: 2 Page(s): 284 - 289
05/01/2001 Authors: Werner-Wasik M; Axelrod RS; Friedland DP; Hauck W; Rose LJ; Chapman AE; Grubbs S; DeShields M; Curran WJ
The radiotherapeutic management of invasive thymomas.
Chest Surg Clin N Am Volume: 11 Page(s): 457 - 466
05/01/2001 Authors: Dziuba SJ; Curran WJ
Combined-modality therapy for limited-stage small cell lung cancer.
Semin Oncol Volume: 28 Page(s): 14 - 22
04/01/2001 Authors: Curran WJ
Optimizing chemoradiation in locally advanced non-small-cell lung cancer.
Volume: 15 Page(s): 43 - 45
03/01/2001 Authors: Curran WJ; Choy H
Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507.
J Clin Oncol Volume: 19 Page(s): 1111 - 1117
02/15/2001 Authors: Fisher BJ; Scott C; Macdonald DR; Coughlin C; Curran WJ
Effectiveness of radiation therapy on non-small-cell lung cancer.
Clin Lung Cancer Volume: 2 Page(s): 182 - 190
02/01/2001 Authors: Gressen EL; Curran WJ
Therapy of limited stage small cell lung cancer.
Cancer Treat Res Volume: 105 Page(s): 229 - 252
01/01/2001 Authors: Curran WJ
Radiation Therapy Oncology Group. Research Plan 2002-2006. Major research objectives.
Int J Radiat Oncol Biol Phys Volume: 51 Page(s): 1 - 5
01/01/2001 Authors: Curran WJ; Radiation Therapy Oncology Group
Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients.
Int J Radiat Oncol Biol Phys Volume: 48 Page(s): 1351 - 1358
12/01/2000 Authors: Coughlin C; Scott C; Langer C; Coia L; Curran W; Rubin P
Predictors of severe esophagitis include use of concurrent chemotherapy, but not the length of irradiated esophagus: a multivariate analysis of patients with lung cancer treated with nonoperative therapy.
Int J Radiat Oncol Biol Phys Volume: 48 Page(s): 689 - 696
10/01/2000 Authors: Werner-Wasik M; Pequignot E; Leeper D; Hauck W; Curran W
Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases.
Int J Radiat Oncol Biol Phys Volume: 47 Page(s): 1001 - 1006
07/01/2000 Authors: Gaspar LE; Scott C; Murray K; Curran W
Follow-up of non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology Volume: 215 Suppl Page(s): 1363 - 1372
06/01/2000 Authors: Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA
Non-aggressive, non-surgical treatment of inoperable non-small cell lung cancer (NSCLC). American College of Radiology. ACR Appropriateness Criteria.
Radiology Volume: 215 Suppl Page(s): 1347 - 1362
06/01/2000 Authors: Graham MV; Byhardt RW; Sause WT; Curran WJ; Fuller D; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA
Neoadjuvant therapy for marginally resectable (clinical N2), non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology Volume: 215 Suppl Page(s): 1331 - 1345
06/01/2000 Authors: Byhardt RW; Sause WT; Curran WJ; Fuller D; Graham MV; Ko B; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA
Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria.
Radiology Volume: 215 Suppl Page(s): 1319 - 1330
06/01/2000 Authors: Komaki R; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Ko B; Weisenburger TH; Kaiser LR; Leibel SA
Postoperative radiotherapy in non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
Radiology Volume: 215 Suppl Page(s): 1295 - 1318
06/01/2000 Authors: Weisenburger TH; Graham MV; Sause WT; Byhardt RW; Curran WJ; Fuller D; Ko B; Komaki R; Kaiser LR; Leibel SA
Staging of non-small cell lung carcinoma. American College of Radiology. ACR Appropriateness Criteria.
Radiology Volume: 215 Suppl Page(s): 1281 - 1294
06/01/2000 Authors: Ko B; Sause WT; Byhardt RW; Curran WJ; Fuller D; Graham MV; Komaki R; Weisenburger TH; Kaiser LR; Leibel SA
Standard off-cord lung oblique fields do not include the entire mediastinum: a computed tomography simulator study.
Am J Clin Oncol Volume: 23 Page(s): 249 - 252
06/01/2000 Authors: DiBiase SJ; Werner-Wasik M; Croce R; Sweet J; Curran WJ
Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physicians.
Int J Radiat Oncol Biol Phys Volume: 47 Page(s): 203 - 208
04/01/2000 Authors: Cleeland CS; Janjan NA; Scott CB; Seiferheld WF; Curran WJ
Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer.
Am J Clin Oncol Volume: 23 Page(s): 160 - 163
04/01/2000 Authors: Gressen EL; Werner-Wasik M; Cohn J; Topham A; Curran WJ
Common toxicity criteria: version 2.0. an improved reference for grading the acute effects of cancer treatment: impact on radiotherapy.
Int J Radiat Oncol Biol Phys Volume: 47 Page(s): 13 - 47
04/01/2000 Authors: Trotti A; Byhardt R; Stetz J; Gwede C; Corn B; Fu K; Gunderson L; McCormick B; Morrisintegral M; Rich T
Phase II trial of sequential chemotherapy and radiotherapy for AIDS-related primary central nervous system lymphoma (PCNSL): An Eastern Cooperative Oncology Group (ECOG) study (E1493).
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES Volume: 23 Page(s): A30 - A30
03/01/2000 Authors: Ambinder RF; Lee S; Curran WJ; Sparano JA; Krigel RL; Schultz C; Freter CE; Kaplan L; VonRoenn JH
Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme.
J Clin Oncol Volume: 18 Page(s): 1254 - 1259
03/01/2000 Authors: Del Rowe J; Scott C; Werner-Wasik M; Bahary JP; Curran WJ; Urtasun RC; Fisher B
DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus.
Cancer Res Volume: 60 Page(s): 1245 - 1253
03/01/2000 Authors: DiBiase SJ; Zeng ZC; Chen R; Hyslop T; Curran WJ; Iliakis G
Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group.
Chest Volume: 117 Page(s): 358 - 364
02/01/2000 Authors: Sause W; Kolesar P; Taylor S IV; Johnson D; Livingston R; Komaki R; Emami B; Curran W; Byhardt R; Dar AR
Methodology and research by the Radiation Therapy Oncology Group (RTOG).
Rays Volume: 25 Page(s): 309 - 312
01/01/2000 Authors: Cox JD; Pajak TF; Curran WJ
Hyperfractionated radiotherapy for lung cancer.
Curr Oncol Rep Volume: 2 Page(s): 71 - 75
01/01/2000 Authors: Gressen EL; Curran WJ
A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404.
Int J Radiat Oncol Biol Phys Volume: 45 Page(s): 1109 - 1115
12/01/1999 Authors: Prados MD; Scott C; Sandler H; Buckner JC; Phillips T; Schultz C; Urtasun R; Davis R; Gutin P; Cascino TL
Induction paclitaxel and carboplatin (CBDCA) followed by concurrent chemo-radiation (TRT-CT) in unresectable, locally advanced non-small cell lung carcinoma: Report of Fox Chase Cancer Center 94-001
SEMINARS IN ONCOLOGY Volume: 26 Page(s): 26 - 26
12/01/1999 Authors: Langer C; Movsas B; Schol J; Keenan E; Hudes R; Curran W
Evaluation of the spatial accuracy of magnetic resonance imaging-based stereotactic target localization for gamma knife radiosurgery of functional disorders.
Neurosurgery Volume: 45 Page(s): 1156 - 1161
11/01/1999 Authors: Bednarz G; Downes MB; Corn BW; Curran WJ; Goldman HW
Procarbazine, lomustine, and vincristine (PCV) chemotherapy for anaplastic astrocytoma: A retrospective review of radiation therapy oncology group protocols comparing survival with carmustine or PCV adjuvant chemotherapy.
J Clin Oncol Volume: 17 Page(s): 3389 - 3395
11/01/1999 Authors: Prados MD; Scott C; Curran WJ; Nelson DF; Leibel S; Kramer S
Repair of DNA double-strand breaks and radiosensitivity to killing in an isogenic group of p53 mutant cell lines.
Int J Radiat Oncol Biol Phys Volume: 45 Page(s): 743 - 751
10/01/1999 Authors: DiBiase SJ; Guan J; Curran WJ; Iliakis G
Apoptosis as a predictor of paclitaxel-induced radiosensitization in human tumor cell lines.
Clin Cancer Res Volume: 5 Page(s): 2580 - 2587
09/01/1999 Authors: Kurdoglu B; Cheong N; Guan J; Corn BW; Curran WJ; Iliakis G
Prognostic factors and survival in patients with spinal cord gliomas after radiation therapy.
Am J Clin Oncol Volume: 22 Page(s): 344 - 351
08/01/1999 Authors: Abdel-Wahab M; Corn B; Wolfson A; Raub W; Gaspar LE; Curran W; Bustillo P; Rubinton P; Markoe A
Stereotactic radiosurgical pallidotomy and thalamotomy with the gamma knife: MR imaging findings with clinical correlation--preliminary experience.
Radiology Volume: 212 Page(s): 143 - 150
07/01/1999 Authors: Friedman DP; Goldman HW; Flanders AE; Gollomp SM; Curran WJ
A phase I dose escalation study of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent malignant glioma.
Int J Radiat Oncol Biol Phys Volume: 43 Page(s): 293 - 298
01/15/1999 Authors: Hudes RS; Corn BW; Werner-Wasik M; Andrews D; Rosenstock J; Thoron L; Downes B; Curran WJ
Immediate side effects of stereotactic radiotherapy and radiosurgery.
Int J Radiat Oncol Biol Phys Volume: 43 Page(s): 299 - 304
01/15/1999 Authors: Werner-Wasik M; Rudoler S; Preston PE; Hauck WW; Downes BM; Leeper D; Andrews D; Corn BW; Curran WJ
Introduction.
Semin Radiat Oncol Volume: 8 Page(s): 1
10/01/1998 Authors: Curran WJ
Radiation-induced toxicities: the role of radioprotectants.
Volume: 8 Page(s): 2 - 4
10/01/1998 Authors: Curran WJ
A generalized film technique for the verification of vertex fields used in the treatment of brain tumors.
Med Phys Volume: 25 Page(s): 1685 - 1691
09/01/1998 Authors: Huq MS; Yue N; Suntharalingam N; Curran WJ
Atypical and malignant meningiomas: an outcome report of seventeen cases.
J Neurooncol Volume: 39 Page(s): 65 - 70
08/01/1998 Authors: Coke CC; Corn BW; Werner-Wasik M; Xie Y; Curran WJ
Waldenstrm's macroglobulinemia resulting from localized gastric lymphoplasmacytoid lymphoma.
Am J Hematol Volume: 58 Page(s): 244 - 245
07/01/1998 Authors: Rosenthal JA; Curran WJ; Schuster SJ
Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Int J Radiat Oncol Biol Phys Volume: 40 Page(s): 653 - 659
02/01/1998 Authors: Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J
Patterns of tumor progression after radiotherapy for low-grade gliomas: analysis from the computed tomography/magnetic resonance imaging era.
Am J Clin Oncol Volume: 21 Page(s): 23 - 27
02/01/1998 Authors: Rudoler S; Corn BW; Werner-Wasik M; Flanders A; Preston PE; Tupchong L; Curran WJ
Issues in nonoperative management of locally advanced non-small-cell lung cancer.
Volume: 12 Page(s): 60 - 66
01/01/1998 Authors: Curran WJ; Werner-Wasik M
Validation and predictive power of Radiation Therapy Oncology Group (RTOG) recursive partitioning analysis classes for malignant glioma patients: a report using RTOG 90-06.
Int J Radiat Oncol Biol Phys Volume: 40 Page(s): 51 - 55
01/01/1998 Authors: Scott CB; Scarantino C; Urtasun R; Movsas B; Jones CU; Simpson JR; Fischbach AJ; Curran WJ
A prospective, randomized study addressing the need for physical simulation following virtual simulation.
Int J Radiat Oncol Biol Phys Volume: 39 Page(s): 1131 - 1135
12/01/1997 Authors: Valicenti RK; Waterman FM; Corn BW; Curran WJ
Stereotactic radiosurgery and radiotherapy: new developments and new directions.
Semin Oncol Volume: 24 Page(s): 707 - 714
12/01/1997 Authors: Corn BW; Curran WJ; Shrieve DC; Loeffler JS
A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
Int J Radiat Oncol Biol Phys Volume: 39 Page(s): 571 - 574
10/01/1997 Authors: Murray KJ; Scott C; Greenberg HM; Emami B; Seider M; Vora NL; Olson C; Whitton A; Movsas B; Curran W
Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
Int J Radiat Oncol Biol Phys Volume: 39 Page(s): 537 - 544
10/01/1997 Authors: Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR
Challenges in the design and conduct of phase III brain tumor therapy trials.
Neurology Volume: 49 Page(s): 912 - 917
10/01/1997 Authors: Perry JR; DeAngelis LM; Schold SC; Burger PC; Brem H; Brown MT; Curran WJ; Scott CB; Prados MD; Kaplan R
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: report of Fox Chase Cancer Center study 94-001.
Semin Oncol Volume: 24 Page(s): S12-89-S12-95
08/01/1997 Authors: Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: Report of Fox Chase Cancer Center Study 94-001
Volume: 24 Page(s): 89 - 95
08/01/1997 Authors: Langer CJ; Movsas B; Hudes R; Schol J; Keenan E; Kilpatrick D; Yeung C; Curran W
Influence of an oligodendroglial component on the survival of patients with anaplastic astrocytomas: a report of Radiation Therapy Oncology Group 83-02.
Volume: 38 Page(s): 911 - 914
07/15/1997 Authors: Donahue B; Scott CB; Nelson JS; Rotman M; Murray KJ; Nelson DF; Banker FL; Earle JD; Fischbach JA; Asbell SO
The influence of compliance on the interpretation of results from the Radiation Therapy Oncology Group Study 91-14
QUALITY OF LIFE RESEARCH Volume: 6 Page(s): 30 - 30
07/01/1997 Authors: Scott CB; Choucair AK; Urtasun R; Nelson D; Coia L; Curran WJ
Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000?
Cancer Volume: 79 Page(s): 2409 - 2413
06/15/1997 Authors: Corn BW; Marcus SM; Topham A; Hauck W; Curran WJ
Palliation of AIDS-related primary lymphoma of the brain: observations from a multi-institutional database.
Int J Radiat Oncol Biol Phys Volume: 38 Page(s): 601 - 605
06/01/1997 Authors: Corn BW; Donahue BR; Rosenstock JG; Cooper JS; Xie Y; Brandon AH; Hegde HH; Sherr DL; Fisher SA; Berson A
External beam irradiation for choroid metastases: identification of factors predisposing to long-term sequelae.
Int J Radiat Oncol Biol Phys Volume: 38 Page(s): 251 - 256
05/01/1997 Authors: Rudoler SB; Corn BW; Shields CL; De Potter P; Hyslop T; Shields JA; Curran WJ
Randomized study of chemotherapy/radiation therapy combinations for favorable patients with locally advanced inoperable nonsmall cell lung cancer: Radiation Therapy Oncology Group (RTOG) 92-04.
Int J Radiat Oncol Biol Phys Volume: 38 Page(s): 149 - 155
04/01/1997 Authors: Komaki R; Scott C; Ettinger D; Lee JS; Fossella FV; Curran W; Evans RF; Rubin P; Byhardt RW
Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14. Radiation Therapy Oncology Group.
Int J Radiat Oncol Biol Phys Volume: 38 Page(s): 9 - 20
04/01/1997 Authors: Choucair AK; Scott C; Urtasun R; Nelson D; Mousas B; Curran W
Dose estimation to critical organs from vertex field treatment of brain tumors.
Int J Radiat Oncol Biol Phys Volume: 37 Page(s): 1023 - 1029
03/15/1997 Authors: Das IJ; Cheng CW; Fein DA; Coia LR; Curran WJ; Fowble B
Efficient CT simulation of the four-field technique for conformal radiotherapy of prostate carcinoma.
Int J Radiat Oncol Biol Phys Volume: 37 Page(s): 953 - 957
03/01/1997 Authors: Valicenti RK; Waterman FM; Croce RJ; Corn B; Suntharalingam N; Curran WJ
Functional vision is improved in the majority of patients treated with external-beam radiotherapy for choroid metastases: a multivariate analysis of 188 patients.
J Clin Oncol Volume: 15 Page(s): 1244 - 1251
03/01/1997 Authors: Rudoler SB; Shields CL; Corn BW; De Potter P; Hyslop T; Curran WJ; Shields JA
Multiple fractionated stereotactic radiotherapy of residual pituitary macroadenomas: initial experience.
Stereotact Funct Neurosurg Volume: 69 Page(s): 183 - 190
01/01/1997 Authors: Coke C; Andrews DW; Corn BW; Werner-Wasik M; Downes B; McCune C; Curran WJ
Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience.
Cancer J Sci Am Volume: 3 Page(s): 52 - 56
01/01/1997 Authors: Corn BW; Donahue BR; Rosenstock JG; Hyslop T; Brandon AH; Hegde HH; Cooper JS; Sherr DL; Fisher SA; Berson A
Standard off-cord lung oblique fields do not include the entire mediastinum: A computerized tomography simulator study.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 39 Page(s): 320 - 320
01/01/1997 Authors: DiBiase SJ; Wasik MW; Croce R; Sweet J; Xie Y; Curran WJ
A phase I study of topotecan plus cranial radiation for glioblastoma multiforme: A report of radiation therapy oncology group (RTOG) study 95-07
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 39 Page(s): 271 - 271
01/01/1997 Authors: Macdonald DR; Kolesar P; Coughlin CT; Fisher BJ; Curran WJ
Phase II tumor volume-influenced dose escalation of accelerated hyperfractionated RT to 64.0 & 70.4 GY with BCNU for newly diagnosed radiosurgery-ineligible glioblastoma multiforme (GBM) patients (RTOG 9411)
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 39 Page(s): 270 - 270
01/01/1997 Authors: Coughlin C; Scott C; Langer C; Coia L; Curran W; Rubin P
RTOG: Updated results of randomized trials
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 39 Page(s): 127 - 127
01/01/1997 Authors: Curran WJ
Radiosurgery for glioma patients: hope or hype?
Int J Radiat Oncol Biol Phys Volume: 36 Page(s): 1279 - 1280
12/01/1996 Authors: Curran WJ; Scott CB
Elapsed radiation therapy treatment time as a predictor of survival in patients with advanced head and neck cancer who receive chemotherapy and radiation therapy.
Radiology Volume: 201 Page(s): 675 - 680
12/01/1996 Authors: Alden ME; O'Reilly RC; Topham A; Lowry LD; Brodovsky H; Curran WJ
Can we disentangle dose from volume in the radiosurgical management of arteriovenous malformations?
Int J Radiat Oncol Biol Phys Volume: 36 Page(s): 965 - 967
11/01/1996 Authors: Corn BW; Curran WJ
The influence of lymphangiography on the development of hypothyroidism in patients irradiated for Hodgkin's disease.
Int J Radiat Oncol Biol Phys Volume: 36 Page(s): 13 - 18
08/01/1996 Authors: Fein DA; Hanlon AL; Corn BW; Curran WJ; Coia LR
Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
Cancer Volume: 77 Page(s): 1535 - 1543
04/15/1996 Authors: Werner-Wasik M; Scott CB; Nelson DF; Gaspar LE; Murray KJ; Fischbach JA; Nelson JS; Weinstein AS; Curran WJ
Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06.
J Clin Oncol Volume: 14 Page(s): 1055 - 1064
04/01/1996 Authors: Lee JS; Scott C; Komaki R; Fossella FV; Dundas GS; McDonald S; Byhardt RW; Curran WJ
Race and prognosis of brain tumor patients entering multicenter clinical trials. A report from the Radiation Therapy Oncology Group.
Am J Clin Oncol Volume: 19 Page(s): 114 - 120
04/01/1996 Authors: Simpson JR; Scott CB; Rotman M; Curran WJ; Constine LS; Fischbach AJ; Asbell SO
Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. A prospectively controlled randomized study by the Radiation Therapy Group.
Int J Radiat Oncol Biol Phys Volume: 34 Page(s): 1097 - 1104
03/15/1996 Authors: Emami B; Scott C; Perez CA; Asbell S; Swift P; Grigsby P; Montesano A; Rubin P; Curran W; Delrowe J
Do overall treatment time, field size, and treatment energy influence local control of T1-T2 squamous cell carcinomas of the glottic larynx?
Int J Radiat Oncol Biol Phys Volume: 34 Page(s): 823 - 831
03/01/1996 Authors: Fein DA; Lee WR; Hanlon AL; Ridge JA; Curran WJ; Coia LR
Long-term survival results for patients with locally advanced, initially unresectable non-small cell lung cancer treated with aggressive concurrent chemoradiation.
Cancer J Sci Am Volume: 2 Page(s): 99 - 105
01/01/1996 Authors: Langer CJ; Curran WJ; Keller SM; Catalano RB; Litwin S; Blankstein KB; Haas N; Campli SN; Comis RL
Characteristics of a dedicated linear accelerator-based stereotactic radiosurgery-radiotherapy unit.
Radiother Oncol Volume: 38 Page(s): 61 - 68
01/01/1996 Authors: Das IJ; Downes MB; Corn BW; Curran WJ; Werner-Wasik M; Andrews DW
Use of multiplanar reformatted radiographic and digitally reconstructed radiographic images for planning conformal radiation therapy.
Radiographics Volume: 15 Page(s): 1483 - 1488
11/01/1995 Authors: Das IJ; McGee KP; Fein DA; Milito SJ; Shammo G; Curran WJ; Coia LR
Pretreatment hemoglobin level influences local control and survival of T1-T2 squamous cell carcinomas of the glottic larynx.
J Clin Oncol Volume: 13 Page(s): 2077 - 2083
08/01/1995 Authors: Fein DA; Lee WR; Hanlon AL; Ridge JA; Langer CJ; Curran WJ; Coia LR
Central pathology review in clinical trials for patients with malignant glioma. A Report of Radiation Therapy Oncology Group 83-02.
Cancer Volume: 76 Page(s): 307 - 313
07/15/1995 Authors: Scott CB; Nelson JS; Farnan NC; Curran WJ; Murray KJ; Fischbach AJ; Gaspar LE; Nelson DF
Management of primary central nervous system lymphoma for the patient with acquired immunodeficiency syndrome. Confronting a clinical catch-22.
Cancer Volume: 76 Page(s): 163 - 166
07/15/1995 Authors: Corn BW; Trock BJ; Curran WJ
Influence of a sampling review process for radiation oncology quality assurance in cooperative group clinical trials--results of the Radiation Therapy Oncology Group (RTOG) analysis.
Radiother Oncol Volume: 36 Page(s): 9 - 14
07/01/1995 Authors: Martin LA; Krall JM; Curran WJ; Leibel SA; Cox JD
Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas.
Int J Radiat Oncol Biol Phys Volume: 32 Page(s): 567 - 576
06/15/1995 Authors: Lee DJ; Cosmatos D; Marcial VA; Fu KK; Rotman M; Cooper JS; Ortiz HG; Beitler JJ; Abrams RA; Curran WJ
New therapeutic strategies involving radiation therapy for patients with non-small cell lung cancer.
Volume: 107 Page(s): 302S - 305S
06/01/1995 Authors: Curran WJ
Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer. Results of Radiation Therapy Oncology Group 90-15.
Cancer Volume: 75 Page(s): 2337 - 2344
05/01/1995 Authors: Byhardt RW; Scott CB; Ettinger DS; Curran WJ; Doggett RL; Coughlin C; Scarantino C; Rotman M; Emami B
Quality-adjusted survival analysis of malignant glioma. Patients treated with twice-daily radiation (RT) and carmustine: a report of Radiation Therapy Oncology Group (RTOG) 83-02.
Volume: 31 Page(s): 453 - 459
02/01/1995 Authors: Murray KJ; Nelson DF; Scott C; Fischbach AJ; Porter A; Farnan N; Curran WJ
Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer.
J Natl Cancer Inst Volume: 87 Page(s): 198 - 205
02/01/1995 Authors: Sause WT; Scott C; Taylor S; Johnson D; Livingston R; Komaki R; Emami B; Curran WJ; Byhardt RW; Turrisi AT
Preservation of cranial nerve function after treatment of acoustic neurinomas with fractionated stereotactic radiotherapy
STEREOTACTIC AND FUNCTIONAL NEUROSURGERY Volume: 64 Page(s): 165 - 182
01/01/1995 Authors: Andrews DW; Silverman CL; Glass J; Downes B; Riley RJ; Corn BW; WernerWasik M; Curran WJ; McCune CE; Rosenwasser RH
Preservation of cranial nerve function after treatment of acoustic neurinomas with fractionated stereotactic radiotherapy. Preliminary observations in 26 patients.
Stereotact Funct Neurosurg Volume: 64 Page(s): 165 - 182
01/01/1995 Authors: Andrews DW; Silverman CL; Glass J; Downes B; Riley RJ; Corn BW; Werner-Wasik M; Curran WJ; McCune CE; Rosenwasser RH
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose-escalation trial for malignant glioma (Radiation Therapy Oncology Group 83-02).
Cancer Volume: 74 Page(s): 2828 - 2835
11/15/1994 Authors: Corn BW; Yousem DM; Scott CB; Rotman M; Asbell SO; Nelson DF; Martin L; Curran WJ
Should patients with histologically unverified brain tumors receive cranial irradiation?
Int J Radiat Oncol Biol Phys Volume: 28 Page(s): 549 - 550
01/15/1994 Authors: Curran WJ
Analysis of early and late deaths on RTOG non-small cell carcinoma of the lung trials: comparison with CALGB 8433.
Lung Cancer Volume: 10 Page(s): 189 - 197
12/01/1993 Authors: Komaki R; Pajak TF; Byhardt RW; Emami B; Asbell SO; Roach M; Pedersen JE; Curran WJ; Lattin P; Russell AH
PREDICTIVE VALUE OF PERFUSION LUNG SCANS ON POST IRRADIATION PULMONARY-FUNCTION - RESPONSE
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 27 Page(s): 178 - 179
09/01/1993 Authors: CURRAN WJ; MOLDOFSKY PJ
Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28.
Int J Radiat Oncol Biol Phys Volume: 26 Page(s): 653 - 657
07/15/1993 Authors: Sause WT; Scott C; Krisch R; Rotman M; Sneed PK; Janjan N; Davis L; Curran W; Choi KN; Selim H
Report of phase II trial of concurrent chemoradiotherapy with radical thoracic irradiation (60 Gy), infusional fluorouracil, bolus cisplatin and etoposide for clinical stage IIIB and bulky IIIA non-small cell lung cancer.
Int J Radiat Oncol Biol Phys Volume: 26 Page(s): 469 - 478
06/15/1993 Authors: Langer CJ; Curran WJ; Keller SM; Catalano R; Fowler W; Blankstein K; Litwin S; Bagchi P; Nash S; Comis R
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
Int J Radiat Oncol Biol Phys Volume: 26 Page(s): 239 - 244
05/20/1993 Authors: Simpson JR; Horton J; Scott C; Curran WJ; Rubin P; Fischbach J; Isaacson S; Rotman M; Asbell SO; Nelson JS
Recursive partitioning analysis of prognostic factors in three Radiation Therapy Oncology Group malignant glioma trials.
J Natl Cancer Inst Volume: 85 Page(s): 704 - 710
05/05/1993 Authors: Curran WJ; Scott CB; Horton J; Nelson JS; Weinstein AS; Fischbach AJ; Chang CH; Rotman M; Asbell SO; Krisch RE
Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02.
J Clin Oncol Volume: 11 Page(s): 857 - 862
05/01/1993 Authors: Curran WJ; Scott CB; Weinstein AS; Martin LA; Nelson JS; Phillips TL; Murray K; Fischbach AJ; Yakar D; Schwade JG
Volumetric analysis of small bowel displacement from radiation portals with the use of a pelvic tissue expander.
Int J Radiat Oncol Biol Phys Volume: 25 Page(s): 885 - 893
04/02/1993 Authors: Herbert SH; Solin LJ; Hoffman JP; Schultz DJ; Curran WJ; Lanciano RM; Rosenblum N; Hogan M; Eisenberg B; Hanks GE
Postoperative complications after combined neoadjuvant treatment of lung cancer.
Ann Thorac Surg Volume: 55 Page(s): 986 - 989
04/01/1993 Authors: Fowler WC; Langer CJ; Curran WJ; Keller SM
Improved survival duration in patients with unresected solitary brain metastasis using accelerated hyperfractionated radiation therapy at total doses of 54.4 gray and greater. Results of Radiation Therapy Oncology Group 85-28.
Cancer Volume: 71 Page(s): 1362 - 1367
02/15/1993 Authors: Epstein BE; Scott CB; Sause WT; Rotman M; Sneed PK; Janjan NA; Davis LW; Selim H; Mohiuddin M; Wasserman TH
Radiation-induced chest-wall chondrosarcoma following surgical resection and radiotherapy for non-small-cell lung cancer.
J Natl Cancer Inst Volume: 85 Page(s): 162 - 163
01/20/1993 Authors: Sauter ER; Keller SM; Curran WJ; Russo J; Langer CJ
Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
Int J Radiat Oncol Biol Phys Volume: 25 Page(s): 193 - 207
01/15/1993 Authors: Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
STRATEGIES FOR PREVENTION AND MANAGEMENT OF RADIATION THERAPY-RELATED ACUTE TOXICITY
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 27 Page(s): 102 - 103
01/01/1993 Authors: CURRAN WJ; STROHL R
ANALYSIS OF CLINICAL-TRIALS EMPLOYING PREOPERATIVE CHEMOTHERAPY AND/OR THORACIC RADIATION-THERAPY (TRT) FOR MARGINALLY RESECTABLE NONSMALL CELL LUNG-CANCER
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 27 Page(s): 189 - 189
01/01/1993 Authors: CURRAN WJ; LANGER CJ; KELLER SM; COMIS RL
WHITE-MATTER CHANGES ARE SIGNIFICANTLY CORRELATED WITH RT DOSE - OBSERVATIONS FROM A RANDOMIZED DOSE-ESCALATION TRIAL FOR MALIGNANT GLIOMA (RTOG 83-02)
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 27 Page(s): 206 - 207
01/01/1993 Authors: YOUSEM D; CORN B; SCOTT C; ROTMAN M; ASBELL S; NELSON D; MARTIN L; CURRAN W
QUALITY-ADJUSTED SURVIVAL ANALYSIS OF MALIGNANT GLIOMA PATIENTS TREATED WITH TWICE-DAILY RADIATION (RT) AND CARMUSTINE - A REPORT OF RADIATION-THERAPY ONCOLOGY GROUP (RTOG) 83-02
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 27 Page(s): 207 - 207
01/01/1993 Authors: MURRAY KJ; NELSON DF; ISAACSON S; SCOTT C; FISCHBACH JA; PORTER A; FARNAN N; CURRAN W
PHASE-III STUDY OF INTERSTITIAL THERMORADIOTHERAPY COMPARED WITH INTERSTITIAL RADIOTHERAPY ALONE IN THE TREATMENT OF RECURRENT OR PERSISTENT HUMAN TUMORS - A PROSPECTIVELY CONTROLLED RANDOMIZED STUDY BY THE RADIATION-THERAPY ONCOLOGY GROUP
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 27 Page(s): 155 - 155
01/01/1993 Authors: EMAMI B; SCOTT C; PEREZ C; ASBELL S; SWIFT P; GRIGSBY P; MONTESANO A; RUBIN P; CURRAN W; DELROWE J
A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02.
Cancer Volume: 70 Page(s): 2909 - 2917
12/15/1992 Authors: Curran WJ; Scott CB; Nelson JS; Weinstein AS; Phillips TL; Murray K; Fischbach AJ; Yakar D; Schwade JG; Powlis WD
Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer.
J Natl Cancer Inst Volume: 84 Page(s): 1731 - 1735
11/18/1992 Authors: Graham MV; Geitz LM; Byhardt R; Asbell S; Roach M; Urtasun RC; Curran WJ; Lattin P; Russell AH; Cox JD
Clinical stage II non-small cell lung cancer treated with radiation therapy alone. The significance of clinically staged ipsilateral hilar adenopathy (N1 disease).
Cancer Volume: 70 Page(s): 2410 - 2417
11/15/1992 Authors: Rosenthal SA; Curran WJ; Herbert SH; Hughes EN; Sandler HM; Stafford PM; McKenna WG
Clinical implications of learned food aversions in patients with cancer treated with chemotherapy or radiation therapy.
Cancer Volume: 70 Page(s): 192 - 200
07/01/1992 Authors: Mattes RD; Curran WJ; Alavi J; Powlis W; Whittington R
Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials.
J Neurooncol Volume: 12 Page(s): 219 - 227
03/01/1992 Authors: Curran WJ; Scott CB; Horton J; Nelson JS; Weinstein AS; Nelson DF; Fischbach AJ; Chang CH; Rotman M; Asbell SO
Comparison of outcome between clinically staged, unresected superior sulcus tumors and other stage III non-small cell lung carcinomas treated with radiation therapy alone.
Cancer Volume: 69 Page(s): 363 - 369
01/15/1992 Authors: Herbert SH; Curran WJ; Stafford PM; Rosenthal SA; McKenna WG; Hughes EN
Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy?
Int J Radiat Oncol Biol Phys Volume: 24 Page(s): 25 - 30
01/01/1992 Authors: Curran WJ; Herbert SH; Stafford PM; Sandler HM; Rosenthal SA; McKenna WG; Hughes E; Dougherty MJ; Keller S
Adverse influence of younger age on outcome in patients with non-small cell lung carcinoma (NSCLC) treated with radiation therapy (RT) alone.
Int J Radiat Oncol Biol Phys Volume: 24 Page(s): 37 - 42
01/01/1992 Authors: Herbert SH; Curran WJ; Rosenthal SA; Stafford PM; McKenna WG; Hughes EN; Sandler HM
Observations on the predictive value of perfusion lung scans on post-irradiation pulmonary function among 210 patients with bronchogenic carcinoma.
Int J Radiat Oncol Biol Phys Volume: 24 Page(s): 31 - 36
01/01/1992 Authors: Curran WJ; Moldofsky PJ; Solin LJ
Proton MR spectroscopy of experimental radiation-induced white matter injury.
J Comput Assist Tomogr Volume: 16 Page(s): 543 - 548
01/01/1992 Authors: Yousem DM; Lenkinski RE; Evans S; Allen D; O'Brien R; Curran W; Schnall M; Bennett M; Wehrli SL; Grossman RI
A descriptive study of learned food aversions in radiotherapy patients.
Physiol Behav Volume: 50 Page(s): 1103 - 1109
12/01/1991 Authors: Mattes RD; Curran WJ; Powlis W; Whittington R
Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group protocol 83-11.
Cancer Volume: 68 Page(s): 509 - 516
08/01/1991 Authors: Curran WJ; Cox JD; Azarnia N; Byhardt RW; Shin KH; Emani B; Phillips TL; Selim H; Herskovic A; Mohiuddin M
Free magnesium levels in normal human brain and brain tumors: 31P chemical-shift imaging measurements at 1.5 T.
Proc Natl Acad Sci U S A Volume: 88 Page(s): 6810 - 6814
08/01/1991 Authors: Taylor JS; Vigneron DB; Murphy-Boesch J; Nelson SJ; Kessler HB; Coia L; Curran W; Brown TR
Decreasing gastrointestinal morbidity with the use of small bowel contrast during treatment planning for pelvic irradiation.
Int J Radiat Oncol Biol Phys Volume: 20 Page(s): 835 - 842
04/01/1991 Authors: Herbert SH; Curran WJ; Solin LJ; Stafford PM; Lanciano RM; Hanks GE
Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment of spontaneous feline oral squamous cell carcinoma.
Int J Radiat Oncol Biol Phys Volume: 20 Page(s): 703 - 708
04/01/1991 Authors: Evans SM; LaCreta F; Helfand S; VanWinkle T; Curran WJ; Brown DQ; Hanks G
Improvements observed in care and outcome in carcinoma of the larynx.
Int J Radiat Oncol Biol Phys Volume: 20 Page(s): 101 - 104
01/01/1991 Authors: Lustig RA; Krall JM; Curran WJ; Hanks GE
Elapsed treatment days--a critical item for radiotherapy quality control review in head and neck trials: RTOG report.
Int J Radiat Oncol Biol Phys Volume: 20 Page(s): 13 - 20
01/01/1991 Authors: Pajak TF; Laramore GE; Marcial VA; Fazekas JT; Cooper J; Rubin P; Curran WJ; Davis LW
Intracranial ependymomas in children.
Int J Radiat Oncol Biol Phys Volume: 19 Page(s): 1497 - 1502
12/01/1990 Authors: Goldwein JW; Leahy JM; Packer RJ; Sutton LN; Curran WJ; Rorke LB; Schut L; Littman PS; D'Angio GJ
Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium.
Gynecol Oncol Volume: 39 Page(s): 368 - 373
12/01/1990 Authors: Lanciano RM; Curran WJ; Greven KM; Fanning J; Stafford P; Randall ME; Hanks GE
The significance of histology in non-small cell lung cancer.
Cancer Treat Rev Volume: 17 Page(s): 409 - 425
12/01/1990 Authors: Rosenthal SA; Curran WJ
Concomitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Long-term results of the Radiation Therapy Oncology Group study 81-17.
Cancer Volume: 66 Page(s): 1861 - 1868
11/01/1990 Authors: Marcial VA; Pajak TF; Mohiuddin M; Cooper JS; al Sarraf M; Mowry PA; Curran W; Crissman J; Rodrguez M; Vlez-Garca E
Effectiveness of treatment for non-small cell lung cancer.
Ann Intern Med Volume: 113 Page(s): 637 - 638
10/15/1990 Authors: Curran WJ
Patterns of failure in patients with stage I, grade 3 carcinoma of the endometrium.
Int J Radiat Oncol Biol Phys Volume: 19 Page(s): 529 - 534
09/01/1990 Authors: Greven KM; Randall M; Fanning J; Bahktar M; Duray P; Peters A; Curran WJ
Recurrent intracranial ependymomas in children. Survival, patterns of failure, and prognostic factors.
Cancer Volume: 66 Page(s): 557 - 563
08/01/1990 Authors: Goldwein JW; Glauser TA; Packer RJ; Finlay JL; Sutton LN; Curran WJ; Laehy JM; Rorke LB; Schut L; D'Angio GJ
The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non-small cell lung cancer.
Int J Radiat Oncol Biol Phys Volume: 19 Page(s): 9 - 13
07/01/1990 Authors: Sandler HM; Curran WJ; Turrisi AT
Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function.
Cancer Volume: 65 Page(s): 2488 - 2493
06/01/1990 Authors: Curran WJ; Moldofsky PJ; Solin LJ
Lack of apparent difference in outcome between clinically staged IIIA and IIIB non-small-cell lung cancer treated with radiation therapy.
J Clin Oncol Volume: 8 Page(s): 409 - 415
03/01/1990 Authors: Curran WJ; Stafford PM
A simple dose calculation method for total body photon irradiation.
Int J Radiat Oncol Biol Phys Volume: 17 Page(s): 219 - 224
07/01/1989 Authors: Curran WJ; Galvin JM; D'Angio GJ
Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications.
Int J Radiat Oncol Biol Phys Volume: 17 Page(s): 35 - 39
07/01/1989 Authors: Greven KM; Curran WJ; Whittington R; Fanning J; Randall ME; Wilder J; Peters AJ
Experimental radiation injury: combined MR imaging and spectroscopy.
Radiology Volume: 169 Page(s): 305 - 309
11/01/1988 Authors: Grossman RI; Hecht-Leavitt CM; Evans SM; Lenkinski RE; Holland GA; Van Winkle TJ; McGrath JT; Curran WJ; Shetty A; Joseph PM
Cortical versus medullary thymomas: a useful morphologic distinction?
Hum Pathol Volume: 19 Page(s): 1335 - 1339
11/01/1988 Authors: Kornstein MJ; Curran WJ; Turrisi AT; Brooks JJ
Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection.
J Clin Oncol Volume: 6 Page(s): 1722 - 1727
11/01/1988 Authors: Curran WJ; Kornstein MJ; Brooks JJ; Turrisi AT
Vaginal recurrences of endometrial carcinoma: the prognostic value of staging by a primary vaginal carcinoma system.
Int J Radiat Oncol Biol Phys Volume: 15 Page(s): 803 - 808
10/01/1988 Authors: Curran WJ; Whittington R; Peters AJ; Fanning J
Toxicity of adjuvant therapy for resected locally advanced non-small-cell lung cancer.
J Clin Oncol Volume: 6 Page(s): 1355
08/01/1988 Authors: Corn BW; Curran WJ
Interstitial radiation therapy in the treatment of childhood soft-tissue sarcomas.
Int J Radiat Oncol Biol Phys Volume: 14 Page(s): 169 - 174
01/01/1988 Authors: Curran WJ; Littman P; Raney RB
CORTICAL VERSUS MEDULLARY THYMOMAS - A USEFUL MORPHOLOGIC CLASSIFICATION
LABORATORY INVESTIGATION Volume: 58 Page(s): A50 - A50
01/01/1988 Authors: KORNSTEIN MJ; CURRAN WJ; TURRISI A; BROOKS JJ
CORTICAL VERSUS MEDULLARY THYMOMAS - A USEFUL MORPHOLOGIC CLASSIFICATION
MODERN PATHOLOGY Volume: 1 Page(s): A50 - A50
01/01/1988 Authors: KORNSTEIN MJ; CURRAN WJ; TURRISI A; BROOKS JJ
HIGH-FIELD MRI OF EXPERIMENTAL RADIATION-INJURY - RESULTS OF PROTON, CHEMICAL-SHIFT, AND SODIUM IMAGING
AMERICAN JOURNAL OF NEURORADIOLOGY Volume: 8 Page(s): 932 - 932
09/01/1987 Authors: HECHTLEAVITT C; GROSSMAN RI; CURRAN WJ; EVANS S; SHETTY A; KASSAB E; MOORE B; MAZIE K; BIERY D; MCGRATH JT
Magnetic resonance imaging of cranial radiation lesions.
Int J Radiat Oncol Biol Phys Volume: 13 Page(s): 1093 - 1098
07/01/1987 Authors: Curran WJ; Hecht-Leavitt C; Schut L; Zimmerman RA; Nelson DF
INTRAORAL HYPERTHERMIA USING MICROWAVE ANTENNA AND A DENTAL MOLD
MEDICAL PHYSICS Volume: 14 Page(s): 493 - 493
05/01/1987 Authors: CHU J; SANDLER H; CURRAN W; SHAMMO G; RICHTER M; HANKS G
MR of brain radiation injury: experimental studies in cats.
AJNR Am J Neuroradiol Volume: 8 Page(s): 427 - 430
01/01/1987 Authors: Hecht-Leavitt C; Grossman RI; Curran WJ; McGrath JT; Biery DN; Joseph PM; Nelson DF
The value of magnetic resonance imaging in treatment planning of nasopharyngeal carcinoma.
Int J Radiat Oncol Biol Phys Volume: 12 Page(s): 2189 - 2196
12/01/1986 Authors: Curran WJ; Hackney DB; Blitzer PH; Bilaniuk L
MAGNETIC-RESONANCE OF NASOPHARYNGEAL CARCINOMAS
AMERICAN JOURNAL OF NEURORADIOLOGY Volume: 7 Page(s): 551 - 551
05/01/1986 Authors: HACKNEY DB; CURRAN WJ; BLITZER PH; BILANIUK LT; GROSSMAN RI; GOLDBERG HI; ZIMMERMAN RA
MRI WITH CRANIAL RADIATION EFFECTS
AMERICAN JOURNAL OF NEURORADIOLOGY Volume: 7 Page(s): 553 - 553
05/01/1986 Authors: HECHTLEAVITT C; CURRAN WJ; ZIMMERMAN RA; NELSON D; BILANIUK LT; HACKNEY DB; GOLDBERG HI; GROSSMAN RI
MRI AND TREATMENT PLANNING OF NASOPHARYNGEAL CARCINOMA
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS Volume: 9 Page(s): 107 - 107
04/01/1986 Authors: CURRAN WJ; HACKNEY DB; BLITZER PH
EVALUATION OF MRI FINDINGS OF RADIATION EFFECTS FOLLOWING CRANIAL IRRADIATION
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS Volume: 9 Page(s): 101 - 101
04/01/1986 Authors: CURRAN WJ; HECHTLEAVITT C; NELSON DF; SCHUT L; ZIMMERMAN RA
MRI-based treatment planning for brain stereotactic radiosurgery: Dosimetric validation of a learning-based pseudo-CT generation method.
Med Dosim Volume: 44 Page(s): 199 - 204
Authors: Wang T; Manohar N; Lei Y; Dhabaan A; Shu H-K; Liu T; Curran WJ; Yang X
Dose evaluation of MRI-based synthetic CT generated using a machine learning method for prostate cancer radiotherapy.
Med Dosim Volume: 44 Page(s): e64 - e70
Authors: Shafai-Erfani G; Wang T; Lei Y; Tian S; Patel P; Jani AB; Curran WJ; Liu T; Yang X
Dosimetric study on learning-based cone-beam CT correction in adaptive radiation therapy.
Med Dosim Volume: 44 Page(s): e71 - e79
Authors: Wang T; Lei Y; Manohar N; Tian S; Jani AB; Shu H-K; Higgins K; Dhabaan A; Patel P; Tang X